1	Spontaneous	spontaneous	JJ	_	2	NMOD
2	Autoimmunity	autoimmunity	NN	_	0	ROOT
3	in	in	IN	_	2	LOC
4	129	0	CD	_	9	NMOD
5	and	and	CC	_	4	COORD
6	C57BL	c0bl	NN	_	5	CONJ
7	/	/	HYPH	_	6	P
8	6	0	CD	_	6	NMOD
9	Mice	mouse	NNS	_	3	PMOD
10	—	—	:	_	2	P
11	Implications	implication	NNS	_	2	DEP
12	for	for	IN	_	11	NMOD
13	Autoimmunity	autoimmunity	NN	_	12	PMOD
14	Described	describe	VBN	_	11	NMOD
15	in	in	IN	_	14	LOC
16	Gene	gene	NN	_	18	AMOD
17	-	-	HYPH	_	16	P
18	Targeted	target	VBN	_	19	NMOD
19	Mice	mouse	NNS	_	15	PMOD

1	Abstract	abstract	NN	_	0	ROOT

1	Systemic	systemic	JJ	_	3	NMOD
2	lupus	lupus	NN	_	3	NMOD
3	erythematosus	erythematosus	NN	_	5	NMOD
4	(	(	-LRB-	_	5	P
5	SLE	sle	NN	_	7	SBJ
6	)	)	-RRB-	_	5	P
7	is	be	VBZ	_	0	ROOT
8	a	a	DT	_	11	NMOD
9	multisystem	multisystem	JJ	_	11	NMOD
10	autoimmune	autoimmune	JJ	_	11	NMOD
11	disorder	disorder	NN	_	7	PRD
12	in	in	IN	_	17	ADV
13	which	which	WDT	_	12	PMOD
14	complex	complex	JJ	_	16	NMOD
15	genetic	genetic	JJ	_	16	NMOD
16	factors	factor	NNS	_	17	SBJ
17	play	play	VBP	_	11	NMOD
18	an	an	DT	_	20	NMOD
19	important	important	JJ	_	20	NMOD
20	role	role	NN	_	17	OBJ
21	.	.	.	_	7	P

1	Several	several	JJ	_	2	NMOD
2	strains	strain	NNS	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	gene	gene	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	targeted	target	VBN	_	7	NMOD
7	mice	mouse	NNS	_	3	PMOD
8	have	have	VBP	_	0	ROOT
9	been	be	VBN	_	8	VC
10	reported	report	VBN	_	9	VC
11	to	to	TO	_	10	OPRD
12	develop	develop	VB	_	11	IM
13	SLE	sle	NN	_	12	OBJ
14	,	,	,	_	10	P
15	implicating	implicate	VBG	_	10	ADV
16	the	the	DT	_	18	NMOD
17	null	null	JJ	_	18	NMOD
18	genes	gene	NNS	_	15	OBJ
19	in	in	IN	_	15	LOC
20	the	the	DT	_	21	NMOD
21	causation	causation	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	disease	disease	NN	_	22	PMOD
24	.	.	.	_	8	P

1	However	however	RB	_	24	ADV
2	,	,	,	_	24	P
3	hybrid	hybrid	JJ	_	4	NMOD
4	strains	strain	NNS	_	24	SBJ
5	between	between	IN	_	4	NMOD
6	129	0	CD	_	11	NMOD
7	and	and	CC	_	6	COORD
8	C57BL	c0bl	NN	_	7	CONJ
9	/	/	HYPH	_	8	P
10	6	0	CD	_	8	NMOD
11	mice	mouse	NNS	_	5	PMOD
12	,	,	,	_	4	P
13	widely	widely	RB	_	14	ADV
14	used	use	VBN	_	4	NMOD
15	in	in	IN	_	14	ADV
16	the	the	DT	_	17	NMOD
17	generation	generation	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	gene	gene	NN	_	21	AMOD
20	-	-	HYPH	_	19	P
21	targeted	target	VBN	_	22	NMOD
22	mice	mouse	NNS	_	18	PMOD
23	,	,	,	_	24	P
24	develop	develop	VBP	_	0	ROOT
25	spontaneous	spontaneous	JJ	_	26	NMOD
26	autoimmunity	autoimmunity	NN	_	24	OBJ
27	.	.	.	_	24	P

1	Furthermore	furthermore	RB	_	7	ADV
2	,	,	,	_	7	P
3	the	the	DT	_	5	NMOD
4	genetic	genetic	JJ	_	5	NMOD
5	background	background	NN	_	7	SBJ
6	markedly	markedly	RB	_	7	ADV
7	influences	influence	VBZ	_	0	ROOT
8	the	the	DT	_	10	NMOD
9	autoimmune	autoimmune	JJ	_	10	NMOD
10	phenotype	phenotype	NN	_	7	OBJ
11	of	of	IN	_	10	NMOD
12	SLE	sle	NN	_	11	PMOD
13	in	in	IN	_	7	LOC
14	gene	gene	NN	_	16	AMOD
15	-	-	HYPH	_	14	P
16	targeted	target	VBN	_	17	NMOD
17	mice	mouse	NNS	_	13	PMOD
18	.	.	.	_	7	P

1	This	this	DT	_	2	SBJ
2	suggests	suggest	VBZ	_	0	ROOT
3	an	an	DT	_	5	NMOD
4	important	important	JJ	_	5	NMOD
5	role	role	NN	_	2	OBJ
6	in	in	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	expression	expression	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	autoimmunity	autoimmunity	NN	_	9	PMOD
11	of	of	IN	_	8	NMOD
12	as	as	RB	_	14	AMOD
13	-	-	HYPH	_	12	P
14	yet	yet	RB	_	16	AMOD
15	-	-	HYPH	_	14	P
16	uncharacterised	uncharacterised	JJ	_	18	NMOD
17	background	background	NN	_	18	NMOD
18	genes	gene	NNS	_	11	PMOD
19	originating	originate	VBG	_	18	NMOD
20	from	from	IN	_	19	ADV
21	these	these	DT	_	24	NMOD
22	parental	parental	JJ	_	24	NMOD
23	mouse	mouse	NN	_	24	NMOD
24	strains	strain	NNS	_	20	PMOD
25	.	.	.	_	2	P

1	Using	use	VBG	_	9	MNR
2	genome	genome	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	wide	wide	JJ	_	6	NMOD
5	linkage	linkage	NN	_	6	NMOD
6	analysis	analysis	NN	_	1	OBJ
7	,	,	,	_	9	P
8	we	we	PRP	_	9	SBJ
9	identified	identify	VBD	_	0	ROOT
10	several	several	JJ	_	12	NMOD
11	susceptibility	susceptibility	NN	_	12	NMOD
12	loci	locus	NNS	_	9	OBJ
13	,	,	,	_	12	P
14	derived	derive	VBN	_	12	NMOD
15	from	from	IN	_	14	ADV
16	129	0	CD	_	21	NMOD
17	and	and	CC	_	16	COORD
18	C57BL	c0bl	NN	_	17	CONJ
19	/	/	HYPH	_	18	P
20	6	0	CD	_	18	NMOD
21	mice	mouse	NNS	_	15	PMOD
22	,	,	,	_	12	P
23	mapped	map	VBN	_	12	NMOD
24	in	in	IN	_	23	LOC
25	the	the	DT	_	37	NMOD
26	lupus	lupus	NN	_	28	AMOD
27	-	-	HYPH	_	26	P
28	prone	prone	JJ	_	37	NMOD
29	hybrid	hybrid	NN	_	37	NMOD
30	(	(	-LRB-	_	33	P
31	129	0	CD	_	33	NMOD
32	×	×	SYM	_	33	P
33	C57BL	c0bl	NN	_	37	PRN
34	/	/	HYPH	_	33	P
35	6	0	CD	_	33	NMOD
36	)	)	-RRB-	_	33	P
37	model	model	NN	_	24	PMOD
38	.	.	.	_	9	P

1	By	by	IN	_	19	MNR
2	creating	create	VBG	_	1	PMOD
3	a	a	DT	_	8	NMOD
4	C57BL	c0bl	NN	_	8	NMOD
5	/	/	HYPH	_	4	P
6	6	0	CD	_	4	NMOD
7	congenic	congenic	JJ	_	8	NMOD
8	strain	strain	NN	_	2	OBJ
9	carrying	carry	VBG	_	8	NMOD
10	a	a	DT	_	16	NMOD
11	129	0	CD	_	13	AMOD
12	-	-	HYPH	_	11	P
13	derived	derive	VBN	_	16	NMOD
14	Chromosome	chromosome	NN	_	16	NMOD
15	1	0	CD	_	14	NMOD
16	segment	segment	NN	_	9	OBJ
17	,	,	,	_	19	P
18	we	we	PRP	_	19	SBJ
19	found	find	VBD	_	0	ROOT
20	that	that	IN	_	19	OBJ
21	this	this	DT	_	23	NMOD
22	129	0	CD	_	23	NMOD
23	interval	interval	NN	_	24	SBJ
24	was	be	VBD	_	20	SUB
25	sufficient	sufficient	JJ	_	24	PRD
26	to	to	TO	_	25	AMOD
27	mediate	mediate	VB	_	26	IM
28	the	the	DT	_	29	NMOD
29	loss	loss	NN	_	27	OBJ
30	of	of	IN	_	29	NMOD
31	tolerance	tolerance	NN	_	30	PMOD
32	to	to	IN	_	31	NMOD
33	nuclear	nuclear	JJ	_	34	NMOD
34	antigens	antigen	NNS	_	32	PMOD
35	,	,	,	_	29	P
36	which	which	WDT	_	37	SBJ
37	had	have	VBD	_	29	NMOD
38	previously	previously	RB	_	37	TMP
39	been	be	VBN	_	37	VC
40	attributed	attribute	VBN	_	39	VC
41	to	to	IN	_	40	ADV
42	a	a	DT	_	44	NMOD
43	disrupted	disrupt	VBN	_	44	NMOD
44	gene	gene	NN	_	41	PMOD
45	.	.	.	_	19	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	demonstrate	demonstrate	VBP	_	0	ROOT
4	important	important	JJ	_	6	NMOD
5	epistatic	epistatic	JJ	_	6	NMOD
6	modifiers	modifier	NNS	_	3	OBJ
7	of	of	IN	_	6	NMOD
8	autoimmunity	autoimmunity	NN	_	7	PMOD
9	in	in	IN	_	8	LOC
10	129	0	CD	_	16	NMOD
11	and	and	CC	_	10	COORD
12	C57BL	c0bl	NN	_	11	CONJ
13	/	/	HYPH	_	12	P
14	6	0	CD	_	12	NMOD
15	mouse	mouse	NN	_	16	NMOD
16	strains	strain	NNS	_	9	PMOD
17	,	,	,	_	8	P
18	widely	widely	RB	_	19	ADV
19	used	use	VBN	_	8	NMOD
20	in	in	IN	_	19	ADV
21	gene	gene	NN	_	22	NMOD
22	targeting	targeting	NN	_	20	PMOD
23	.	.	.	_	3	P

1	These	these	DT	_	4	NMOD
2	background	background	NN	_	4	NMOD
3	gene	gene	NN	_	4	NMOD
4	influences	influence	NNS	_	5	SBJ
5	may	may	MD	_	0	ROOT
6	account	account	VB	_	5	VC
7	for	for	IN	_	6	ADV
8	some	some	DT	_	7	PMOD
9	,	,	,	_	8	P
10	or	or	CC	_	8	COORD
11	even	even	RB	_	12	NMOD
12	all	all	DT	_	10	CONJ
13	,	,	,	_	8	P
14	of	of	IN	_	8	NMOD
15	the	the	DT	_	17	NMOD
16	autoimmune	autoimmune	JJ	_	17	NMOD
17	traits	trait	NNS	_	14	PMOD
18	described	describe	VBN	_	17	NMOD
19	in	in	IN	_	18	LOC
20	some	some	DT	_	24	NMOD
21	gene	gene	NN	_	23	AMOD
22	-	-	HYPH	_	21	P
23	targeted	target	VBN	_	24	NMOD
24	models	model	NNS	_	19	PMOD
25	of	of	IN	_	24	NMOD
26	SLE	sle	NN	_	25	PMOD
27	.	.	.	_	5	P

1	Introduction	introduction	NN	_	0	ROOT

1	Systemic	systemic	JJ	_	3	NMOD
2	lupus	lupus	NN	_	3	NMOD
3	erythematosus	erythematosus	NN	_	5	NMOD
4	(	(	-LRB-	_	5	P
5	SLE	sle	NN	_	7	SBJ
6	)	)	-RRB-	_	5	P
7	is	be	VBZ	_	0	ROOT
8	a	a	DT	_	11	NMOD
9	chronic	chronic	JJ	_	11	NMOD
10	autoimmune	autoimmune	JJ	_	11	NMOD
11	disease	disease	NN	_	7	PRD
12	characterised	characterise	VBN	_	11	NMOD
13	by	by	IN	_	12	LGS
14	the	the	DT	_	15	NMOD
15	production	production	NN	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	autoantibodies	autoantibody	NNS	_	19	NMOD
18	(	(	-LRB-	_	19	P
19	auto-Abs	auto-abs	NNS	_	16	PMOD
20	)	)	-RRB-	_	19	P
21	against	against	IN	_	15	NMOD
22	a	a	DT	_	24	NMOD
23	wide	wide	JJ	_	24	NMOD
24	spectrum	spectrum	NN	_	21	PMOD
25	of	of	IN	_	24	NMOD
26	self	self	NN	_	28	NMOD
27	-	-	HYPH	_	26	P
28	antigens	antigen	NNS	_	25	PMOD
29	,	,	,	_	28	P
30	mainly	mainly	RB	_	31	PMOD
31	from	from	IN	_	28	NMOD
32	subcellular	subcellular	JJ	_	33	NMOD
33	compartments	compartment	NNS	_	31	PMOD
34	,	,	,	_	33	P
35	especially	especially	RB	_	38	NMOD
36	the	the	DT	_	38	NMOD
37	cell	cell	NN	_	38	NMOD
38	nucleus	nucleus	NN	_	33	APPO
39	.	.	.	_	7	P

1	Genetic	genetic	JJ	_	2	NMOD
2	predisposition	predisposition	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	an	an	DT	_	6	NMOD
5	important	important	JJ	_	6	NMOD
6	contributor	contributor	NN	_	3	PRD
7	to	to	IN	_	6	NMOD
8	susceptibility	susceptibility	NN	_	7	PMOD
9	to	to	IN	_	8	NMOD
10	SLE	sle	NN	_	9	PMOD
11	in	in	IN	_	3	LOC
12	both	both	CC	_	13	COORD
13	humans	human	NNS	_	11	PMOD
14	and	and	CC	_	13	COORD
15	animals	animal	NNS	_	14	CONJ
16	(	(	-LRB-	_	17	P
17	Vyse	vyse	NNP	_	3	CIT
18	and	and	CC	_	17	COORD
19	Todd	todd	NNP	_	18	CONJ
20	1996	0	CD	_	17	DEP
21	;	;	:	_	17	P
22	Harley	harley	NNP	_	17	DEP
23	et	et	FW	_	17	DEP
24	al.	al.	FW	_	17	DEP
25	1998	0	CD	_	17	DEP
26	;	;	:	_	17	P
27	Theofilopoulos	theofilopoulos	NNP	_	17	DEP
28	and	and	CC	_	27	COORD
29	Kono	kono	NNP	_	28	CONJ
30	1999	0	CD	_	17	DEP
31	;	;	:	_	17	P
32	Wakeland	wakeland	NNP	_	17	DEP
33	et	et	FW	_	17	DEP
34	al.	al.	FW	_	17	DEP
35	2001	0	CD	_	17	DEP
36	)	)	-RRB-	_	17	P
37	.	.	.	_	3	P

1	Genes	gene	NNS	_	5	SBJ
2	in	in	IN	_	1	LOC
3	multiple	multiple	JJ	_	4	NMOD
4	pathways	pathway	NNS	_	2	PMOD
5	participate	participate	VBP	_	0	ROOT
6	in	in	IN	_	5	ADV
7	mediating	mediate	VBG	_	6	PMOD
8	disease	disease	NN	_	9	NMOD
9	pathogenesis	pathogenesis	NN	_	7	OBJ
10	,	,	,	_	5	P
11	and	and	CC	_	5	COORD
12	epistatic	epistatic	JJ	_	13	NMOD
13	interactions	interaction	NNS	_	17	SBJ
14	amongst	amongst	IN	_	13	NMOD
15	these	these	DT	_	16	NMOD
16	genes	gene	NNS	_	14	PMOD
17	influence	influence	VBP	_	11	CONJ
18	the	the	DT	_	19	NMOD
19	expression	expression	NN	_	17	OBJ
20	of	of	IN	_	19	NMOD
21	disease	disease	NN	_	20	PMOD
22	.	.	.	_	5	P

1	In	in	IN	_	32	ADV
2	this	this	DT	_	3	NMOD
3	context	context	NN	_	1	PMOD
4	,	,	,	_	32	P
5	both	both	CC	_	8	COORD
6	genetic	genetic	JJ	_	7	NMOD
7	linkage	linkage	NN	_	8	NMOD
8	studies	study	NNS	_	32	SBJ
9	in	in	IN	_	8	LOC
10	spontaneous	spontaneous	JJ	_	14	NMOD
11	lupus	lupus	NN	_	13	AMOD
12	-	-	HYPH	_	11	P
13	prone	prone	JJ	_	14	NMOD
14	models	model	NNS	_	9	PMOD
15	and	and	CC	_	8	COORD
16	synthetic	synthetic	JJ	_	18	NMOD
17	murine	murine	JJ	_	18	NMOD
18	models	model	NNS	_	15	CONJ
19	of	of	IN	_	18	NMOD
20	autoimmunity	autoimmunity	NN	_	19	PMOD
21	generated	generate	VBN	_	18	NMOD
22	by	by	IN	_	21	MNR
23	targeted	target	VBN	_	24	NMOD
24	disruption	disruption	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	specific	specific	JJ	_	27	NMOD
27	genes	gene	NNS	_	25	PMOD
28	modulating	modulate	VBG	_	27	NMOD
29	the	the	DT	_	31	NMOD
30	immune	immune	JJ	_	31	NMOD
31	system	system	NN	_	28	OBJ
32	have	have	VBP	_	0	ROOT
33	widely	widely	RB	_	32	ADV
34	been	be	VBN	_	32	VC
35	used	use	VBN	_	34	VC
36	to	to	TO	_	35	PRP
37	investigate	investigate	VB	_	36	IM
38	the	the	DT	_	39	NMOD
39	complexity	complexity	NN	_	37	OBJ
40	of	of	IN	_	39	NMOD
41	SLE	sle	NN	_	40	PMOD
42	.	.	.	_	32	P

1	The	the	DT	_	5	NMOD
2	best	well	RBS	_	4	AMOD
3	-	-	HYPH	_	2	P
4	studied	study	VBN	_	5	NMOD
5	strains	strain	NNS	_	16	SBJ
6	of	of	IN	_	5	NMOD
7	mice	mouse	NNS	_	6	PMOD
8	that	that	WDT	_	10	SBJ
9	spontaneously	spontaneously	RB	_	10	TMP
10	develop	develop	VBP	_	7	NMOD
11	a	a	DT	_	15	NMOD
12	lupus	lupus	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	like	like	JJ	_	15	NMOD
15	pathology	pathology	NN	_	10	OBJ
16	are	be	VBP	_	0	ROOT
17	the	the	DT	_	26	NMOD
18	New	new	NNP	_	19	NMOD
19	Zealand	zealand	NNP	_	20	NMOD
20	Black	black	NN	_	24	NMOD
21	/	/	HYPH	_	20	P
22	New	new	NNP	_	23	NMOD
23	Zealand	zealand	NNP	_	24	NMOD
24	White	white	NN	_	26	NMOD
25	hybrid	hybrid	NN	_	26	NMOD
26	strain	strain	NN	_	16	PRD
27	(	(	-LRB-	_	30	P
28	NZB	nzb	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	WF1	wf0	NN	_	26	PRN
31	)	)	-RRB-	_	30	P
32	;	;	:	_	26	P
33	the	the	DT	_	40	NMOD
34	MRL	mrl	NN	_	36	NMOD
35	/	/	HYPH	_	34	P
36	Mp	mp	NN	_	40	NMOD
37	lpr	lpr	NN	_	39	NMOD
38	/	/	HYPH	_	37	P
39	lpr	lpr	NN	_	40	NMOD
40	strain	strain	NN	_	26	CONJ
41	,	,	,	_	40	P
42	which	which	WDT	_	43	SBJ
43	carries	carry	VBZ	_	40	NMOD
44	the	the	DT	_	46	NMOD
45	lpr	lpr	NN	_	46	NMOD
46	mutation	mutation	NN	_	43	OBJ
47	of	of	IN	_	46	NMOD
48	the	the	DT	_	51	NMOD
49	FAS	fa	NN	_	50	NMOD
50	receptor	receptor	NN	_	51	NMOD
51	gene	gene	NN	_	47	PMOD
52	;	;	:	_	40	P
53	and	and	CC	_	40	COORD
54	the	the	DT	_	56	NMOD
55	BXSB	bxsb	NN	_	56	NMOD
56	strain	strain	NN	_	53	CONJ
57	,	,	,	_	56	P
58	which	which	WDT	_	59	SBJ
59	carries	carry	VBZ	_	56	NMOD
60	the	the	DT	_	68	NMOD
61	Y	y	NN	_	62	NMOD
62	chromosome	chromosome	NN	_	64	NMOD
63	autoimmune	autoimmune	JJ	_	64	NMOD
64	accelerator	accelerator	NN	_	66	NMOD
65	(	(	-LRB-	_	66	P
66	Yaa	yaa	NNP	_	68	NMOD
67	)	)	-RRB-	_	66	P
68	gene	gene	NN	_	59	OBJ
69	(	(	-LRB-	_	70	P
70	Theofilopoulos	theofilopoulos	NNP	_	68	NMOD
71	and	and	CC	_	70	COORD
72	Dixon	dixon	NNP	_	71	CONJ
73	1985	0	CD	_	70	DEP
74	)	)	-RRB-	_	70	P
75	.	.	.	_	16	P

1	Extensive	extensive	JJ	_	4	NMOD
2	genetic	genetic	JJ	_	3	NMOD
3	mapping	mapping	NN	_	4	NMOD
4	studies	study	NNS	_	9	SBJ
5	in	in	IN	_	4	LOC
6	all	all	DT	_	8	NMOD
7	three	three	CD	_	8	NMOD
8	strains	strain	NNS	_	5	PMOD
9	have	have	VBP	_	0	ROOT
10	identified	identify	VBN	_	9	VC
11	multiple	multiple	JJ	_	12	NMOD
12	intervals	interval	NNS	_	10	OBJ
13	associated	associate	VBN	_	12	NMOD
14	with	with	IN	_	13	ADV
15	disease	disease	NN	_	16	NMOD
16	susceptibility	susceptibility	NN	_	14	PMOD
17	.	.	.	_	9	P

1	Interestingly	interestingly	RB	_	9	ADV
2	,	,	,	_	9	P
3	the	the	DT	_	4	NMOD
4	majority	majority	NN	_	9	SBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	intervals	interval	NNS	_	5	PMOD
8	detected	detect	VBN	_	7	NMOD
9	are	be	VBP	_	0	ROOT
10	strain	strain	NN	_	12	AMOD
11	-	-	HYPH	_	10	P
12	specific	specific	JJ	_	9	PRD
13	,	,	,	_	9	P
14	confirming	confirm	VBG	_	9	ADV
15	the	the	DT	_	17	NMOD
16	genetic	genetic	JJ	_	17	NMOD
17	complexity	complexity	NN	_	14	OBJ
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	20	NMOD
20	disease	disease	NN	_	18	PMOD
21	and	and	CC	_	14	COORD
22	indicating	indicate	VBG	_	21	CONJ
23	the	the	DT	_	24	NMOD
24	presence	presence	NN	_	22	OBJ
25	of	of	IN	_	24	NMOD
26	extensive	extensive	JJ	_	27	NMOD
27	heterogeneity	heterogeneity	NN	_	25	PMOD
28	in	in	IN	_	22	LOC
29	the	the	DT	_	30	NMOD
30	genes	gene	NNS	_	28	PMOD
31	contributing	contribute	VBG	_	30	NMOD
32	to	to	IN	_	31	ADV
33	the	the	DT	_	34	NMOD
34	pathogenesis	pathogenesis	NN	_	32	PMOD
35	of	of	IN	_	34	NMOD
36	the	the	DT	_	37	NMOD
37	disease	disease	NN	_	35	PMOD
38	.	.	.	_	9	P

1	However	however	RB	_	6	ADV
2	,	,	,	_	6	P
3	some	some	DT	_	5	NMOD
4	susceptibility	susceptibility	NN	_	5	NMOD
5	loci	locus	NNS	_	6	SBJ
6	have	have	VBP	_	0	ROOT
7	been	be	VBN	_	6	VC
8	mapped	map	VBN	_	7	VC
9	to	to	IN	_	8	ADV
10	similar	similar	JJ	_	12	NMOD
11	chromosome	chromosome	NN	_	12	NMOD
12	locations	location	NNS	_	9	PMOD
13	in	in	IN	_	12	LOC
14	different	different	JJ	_	15	NMOD
15	strains	strain	NNS	_	13	PMOD
16	,	,	,	_	8	P
17	suggesting	suggest	VBG	_	8	ADV
18	that	that	IN	_	17	OBJ
19	at	at	RB	_	22	NMOD
20	least	least	RBS	_	19	AMOD
21	some	some	DT	_	22	NMOD
22	susceptibility	susceptibility	NN	_	23	SBJ
23	may	may	MD	_	18	SUB
24	be	be	VB	_	23	VC
25	shared	share	VBN	_	24	VC
26	amongst	amongst	IN	_	25	ADV
27	lupus	lupus	NN	_	29	AMOD
28	-	-	HYPH	_	27	P
29	prone	prone	JJ	_	30	NMOD
30	strains	strain	NNS	_	26	PMOD
31	.	.	.	_	6	P

1	Amongst	amongst	IN	_	10	ADV
2	these	these	DT	_	5	NMOD
3	shared	share	VBN	_	5	NMOD
4	susceptibility	susceptibility	NN	_	5	NMOD
5	loci	locus	NNS	_	1	PMOD
6	,	,	,	_	10	P
7	the	the	DT	_	9	NMOD
8	most	most	RBS	_	9	NMOD
9	striking	striking	JJ	_	10	SBJ
10	are	be	VBP	_	0	ROOT
11	loci	locus	NNS	_	10	PRD
12	on	on	IN	_	11	LOC
13	distal	distal	JJ	_	14	NMOD
14	Chromosome	chromosome	NN	_	12	PMOD
15	1	0	CD	_	14	NMOD
16	,	,	,	_	11	P
17	for	for	IN	_	24	ADV
18	which	which	WDT	_	17	PMOD
19	important	important	JJ	_	21	NMOD
20	contributing	contribute	VBG	_	21	NMOD
21	genes	gene	NNS	_	22	SBJ
22	have	have	VBP	_	11	NMOD
23	been	be	VBN	_	22	VC
24	found	find	VBN	_	23	VC
25	in	in	IN	_	24	LOC
26	New	new	NNP	_	27	NMOD
27	Zealand	zealand	NNP	_	30	NMOD
28	and	and	CC	_	27	COORD
29	BXSB	bxsb	NN	_	28	CONJ
30	models	model	NNS	_	25	PMOD
31	(	(	-LRB-	_	32	P
32	Theofilopoulos	theofilopoulos	NNP	_	24	CIT
33	and	and	CC	_	32	COORD
34	Kono	kono	NNP	_	33	CONJ
35	1999	0	CD	_	32	DEP
36	;	;	:	_	32	P
37	Wakeland	wakeland	NNP	_	32	DEP
38	et	et	FW	_	32	DEP
39	al.	al.	FW	_	32	DEP
40	2001	0	CD	_	32	DEP
41	)	)	-RRB-	_	32	P
42	.	.	.	_	10	P

1	Although	although	IN	_	43	ADV
2	considerable	considerable	JJ	_	3	NMOD
3	efforts	effort	NNS	_	4	SBJ
4	have	have	VBP	_	1	SUB
5	been	be	VBN	_	4	VC
6	made	make	VBN	_	5	VC
7	to	to	TO	_	3	NMOD
8	identify	identify	VB	_	7	IM
9	the	the	DT	_	10	NMOD
10	genes	gene	NNS	_	8	OBJ
11	responsible	responsible	JJ	_	10	NMOD
12	for	for	IN	_	11	AMOD
13	the	the	DT	_	14	NMOD
14	development	development	NN	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	disease	disease	NN	_	15	PMOD
18	,	,	,	_	43	P
19	with	with	IN	_	43	ADV
20	the	the	DT	_	21	NMOD
21	exception	exception	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	the	the	DT	_	25	NMOD
24	lpr	lpr	NN	_	25	NMOD
25	mutation	mutation	NN	_	22	PMOD
26	,	,	,	_	43	P
27	none	none	NN	_	43	SBJ
28	of	of	IN	_	27	NMOD
29	the	the	DT	_	31	NMOD
30	genetic	genetic	JJ	_	31	NMOD
31	contributions	contribution	NNS	_	28	PMOD
32	to	to	IN	_	31	NMOD
33	disease	disease	NN	_	32	PMOD
34	in	in	IN	_	31	LOC
35	the	the	DT	_	42	NMOD
36	three	three	CD	_	42	NMOD
37	well	well	RB	_	39	AMOD
38	-	-	HYPH	_	37	P
39	documented	document	VBN	_	42	NMOD
40	murine	murine	JJ	_	42	NMOD
41	SLE	sle	NN	_	42	NMOD
42	strains	strain	NNS	_	34	PMOD
43	have	have	VBP	_	0	ROOT
44	yet	yet	RB	_	43	TMP
45	been	be	VBN	_	43	VC
46	fully	fully	RB	_	45	ADV
47	resolved	resolve	VBN	_	45	VC
48	at	at	IN	_	47	ADV
49	the	the	DT	_	53	NMOD
50	molecular	molecular	JJ	_	53	NMOD
51	or	or	CC	_	50	COORD
52	protein	protein	NN	_	51	CONJ
53	level	level	NN	_	48	PMOD
54	.	.	.	_	43	P

1	Thus	thus	RB	_	15	ADV
2	,	,	,	_	15	P
3	targeted	target	VBN	_	5	NMOD
4	genetic	genetic	JJ	_	5	NMOD
5	disruption	disruption	NN	_	15	SBJ
6	of	of	IN	_	5	NMOD
7	candidate	candidate	NN	_	8	NMOD
8	genes	gene	NNS	_	6	PMOD
9	encoding	encode	VBG	_	8	NMOD
10	proteins	protein	NNS	_	9	OBJ
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	immune	immune	JJ	_	14	NMOD
14	system	system	NN	_	11	PMOD
15	has	have	VBZ	_	0	ROOT
16	been	be	VBN	_	15	VC
17	extensively	extensively	RB	_	16	ADV
18	used	use	VBN	_	16	VC
19	to	to	TO	_	18	PRP
20	examine	examine	VB	_	19	IM
21	their	their	PRP$	_	22	NMOD
22	role	role	NN	_	20	OBJ
23	in	in	IN	_	22	NMOD
24	immune	immune	JJ	_	25	NMOD
25	regulation	regulation	NN	_	23	PMOD
26	.	.	.	_	15	P

1	However	however	RB	_	11	ADV
2	,	,	,	_	11	P
3	the	the	DT	_	6	NMOD
4	most	most	RBS	_	5	AMOD
5	surprising	surprising	JJ	_	6	NMOD
6	result	result	NN	_	11	SBJ
7	of	of	IN	_	6	NMOD
8	this	this	DT	_	10	NMOD
9	powerful	powerful	JJ	_	10	NMOD
10	approach	approach	NN	_	7	PMOD
11	has	have	VBZ	_	0	ROOT
12	been	be	VBN	_	11	VC
13	the	the	DT	_	15	NMOD
14	high	high	JJ	_	15	NMOD
15	frequency	frequency	NN	_	12	PRD
16	with	with	IN	_	22	ADV
17	which	which	WDT	_	16	PMOD
18	such	such	JJ	_	19	NMOD
19	mutations	mutation	NNS	_	20	SBJ
20	have	have	VBP	_	15	NMOD
21	been	be	VBN	_	20	VC
22	associated	associate	VBN	_	21	VC
23	with	with	IN	_	22	ADV
24	an	an	DT	_	26	NMOD
25	autoimmune	autoimmune	JJ	_	26	NMOD
26	phenotype	phenotype	NN	_	23	PMOD
27	.	.	.	_	11	P

1	In	in	IN	_	6	ADV
2	this	this	DT	_	3	NMOD
3	regard	regard	NN	_	1	PMOD
4	,	,	,	_	6	P
5	it	it	PRP	_	6	SBJ
6	is	be	VBZ	_	0	ROOT
7	of	of	IN	_	6	PRD
8	note	note	NN	_	7	PMOD
9	that	that	IN	_	6	OBJ
10	hybrid	hybrid	JJ	_	11	NMOD
11	strains	strain	NNS	_	31	SBJ
12	between	between	IN	_	11	NMOD
13	129	0	CD	_	18	NMOD
14	and	and	CC	_	13	COORD
15	C57BL	c0bl	NN	_	14	CONJ
16	/	/	HYPH	_	15	P
17	6	0	CD	_	15	NMOD
18	mice	mouse	NNS	_	12	PMOD
19	,	,	,	_	11	P
20	widely	widely	RB	_	21	ADV
21	used	use	VBN	_	11	NMOD
22	in	in	IN	_	21	ADV
23	the	the	DT	_	24	NMOD
24	generation	generation	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	gene	gene	NN	_	28	AMOD
27	-	-	HYPH	_	26	P
28	targeted	target	VBN	_	29	NMOD
29	mice	mouse	NNS	_	25	PMOD
30	,	,	,	_	31	P
31	are	be	VBP	_	9	SUB
32	spontaneously	spontaneously	RB	_	31	MNR
33	predisposed	predispose	VBN	_	31	PRD
34	to	to	IN	_	33	AMOD
35	development	development	NN	_	34	PMOD
36	of	of	IN	_	35	NMOD
37	humoral	humoral	JJ	_	38	NMOD
38	autoimmunity	autoimmunity	NN	_	36	PMOD
39	with	with	IN	_	38	NMOD
40	low	low	JJ	_	41	NMOD
41	levels	level	NNS	_	39	PMOD
42	of	of	IN	_	41	NMOD
43	glomerulonephritis	glomerulonephritis	NN	_	42	PMOD
44	(	(	-LRB-	_	45	P
45	Obata	obata	NNP	_	31	CIT
46	et	et	FW	_	45	DEP
47	al.	al.	FW	_	45	DEP
48	1979	0	CD	_	45	DEP
49	;	;	:	_	45	P
50	Botto	botto	NNP	_	45	DEP
51	et	et	FW	_	45	DEP
52	al.	al.	FW	_	45	DEP
53	1998	0	CD	_	45	DEP
54	;	;	:	_	45	P
55	Bickerstaff	bickerstaff	NNP	_	45	DEP
56	et	et	FW	_	45	DEP
57	al.	al.	FW	_	45	DEP
58	1999	0	CD	_	45	DEP
59	;	;	:	_	45	P
60	Santiago	santiago	NNP	_	45	DEP
61	-	-	HYPH	_	60	P
62	Raber	raber	NNP	_	45	DEP
63	et	et	FW	_	45	DEP
64	al.	al.	FW	_	45	DEP
65	2001	0	CD	_	45	DEP
66	)	)	-RRB-	_	45	P
67	.	.	.	_	6	P

1	Furthermore	furthermore	RB	_	7	ADV
2	,	,	,	_	7	P
3	the	the	DT	_	5	NMOD
4	genetic	genetic	JJ	_	5	NMOD
5	background	background	NN	_	7	SBJ
6	markedly	markedly	RB	_	7	ADV
7	influences	influence	VBZ	_	0	ROOT
8	the	the	DT	_	10	NMOD
9	autoimmune	autoimmune	JJ	_	10	NMOD
10	phenotype	phenotype	NN	_	7	OBJ
11	in	in	IN	_	7	LOC
12	gene	gene	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	targeted	target	VBN	_	15	NMOD
15	mice	mouse	NNS	_	11	PMOD
16	(	(	-LRB-	_	17	P
17	Bolland	bolland	NNP	_	7	CIT
18	and	and	CC	_	17	COORD
19	Ravetch	ravetch	NNP	_	18	CONJ
20	2000	0	CD	_	17	DEP
21	;	;	:	_	17	P
22	Santiago	santiago	NNP	_	17	DEP
23	-	-	HYPH	_	22	P
24	Raber	raber	NNP	_	17	DEP
25	et	et	FW	_	17	DEP
26	al.	al.	FW	_	17	DEP
27	2001	0	CD	_	17	DEP
28	;	;	:	_	17	P
29	Mitchell	mitchell	NNP	_	17	DEP
30	et	et	FW	_	17	DEP
31	al.	al.	FW	_	17	DEP
32	2002	0	CD	_	17	DEP
33	)	)	-RRB-	_	17	P
34	.	.	.	_	7	P

1	These	these	DT	_	2	NMOD
2	observations	observation	NNS	_	3	SBJ
3	led	lead	VBD	_	0	ROOT
4	to	to	IN	_	3	ADV
5	the	the	DT	_	6	NMOD
6	hypothesis	hypothesis	NN	_	4	PMOD
7	that	that	IN	_	6	NMOD
8	the	the	DT	_	10	NMOD
9	autoimmune	autoimmune	JJ	_	10	NMOD
10	phenotype	phenotype	NN	_	18	SBJ
11	described	describe	VBN	_	10	NMOD
12	in	in	IN	_	11	LOC
13	some	some	DT	_	17	NMOD
14	gene	gene	NN	_	16	AMOD
15	-	-	HYPH	_	14	P
16	targeted	target	VBN	_	17	NMOD
17	mice	mouse	NNS	_	12	PMOD
18	might	might	MD	_	7	SUB
19	be	be	VB	_	18	VC
20	due	due	IN	_	19	PRD
21	primarily	primarily	RB	_	20	PMOD
22	to	to	IN	_	20	PMOD
23	combinations	combination	NNS	_	20	PMOD
24	of	of	IN	_	23	NMOD
25	as	as	RB	_	27	AMOD
26	-	-	HYPH	_	25	P
27	yet	yet	RB	_	29	AMOD
28	-	-	HYPH	_	27	P
29	uncharacterised	uncharacterised	JJ	_	31	NMOD
30	background	background	NN	_	31	NMOD
31	genes	gene	NNS	_	24	PMOD
32	,	,	,	_	31	P
33	originating	originate	VBG	_	31	NMOD
34	from	from	IN	_	33	ADV
35	129	0	CD	_	41	NMOD
36	and	and	CC	_	35	COORD
37	C57BL	c0bl	NN	_	36	CONJ
38	/	/	HYPH	_	37	P
39	6	0	CD	_	37	NMOD
40	mice	mouse	NNS	_	41	NMOD
41	strains	strain	NNS	_	34	PMOD
42	,	,	,	_	23	P
43	interacting	interact	VBG	_	23	NMOD
44	or	or	CC	_	43	COORD
45	not	not	RB	_	44	CONJ
46	with	with	IN	_	43	ADV
47	the	the	DT	_	49	NMOD
48	mutated	mutate	VBN	_	49	NMOD
49	allele	allele	NN	_	46	PMOD
50	.	.	.	_	3	P

1	To	to	TO	_	6	PRP
2	test	test	VB	_	1	IM
3	this	this	DT	_	2	OBJ
4	,	,	,	_	6	P
5	we	we	PRP	_	6	SBJ
6	conducted	conduct	VBD	_	0	ROOT
7	a	a	DT	_	12	NMOD
8	genome	genome	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	wide	wide	JJ	_	12	NMOD
11	scan	scan	NN	_	12	NMOD
12	analysis	analysis	NN	_	6	OBJ
13	of	of	IN	_	12	NMOD
14	two	two	CD	_	16	NMOD
15	large	large	JJ	_	16	NMOD
16	cohorts	cohort	NNS	_	13	PMOD
17	of	of	IN	_	16	NMOD
18	(	(	-LRB-	_	26	P
19	129	0	CD	_	21	NMOD
20	×	×	SYM	_	21	P
21	C57BL	c0bl	NN	_	26	NMOD
22	/	/	HYPH	_	21	P
23	6	0	CD	_	21	NMOD
24	)	)	-RRB-	_	26	P
25	F2	f0	NN	_	26	NMOD
26	mice	mouse	NNS	_	17	PMOD
27	,	,	,	_	16	P
28	one	one	CD	_	31	SBJ
29	of	of	IN	_	28	NMOD
30	which	which	WDT	_	29	PMOD
31	carried	carry	VBD	_	16	NMOD
32	a	a	DT	_	33	NMOD
33	mutation	mutation	NN	_	31	OBJ
34	in	in	IN	_	31	LOC
35	the	the	DT	_	40	NMOD
36	serum	serum	NN	_	39	NMOD
37	amyloid	amyloid	NN	_	39	NMOD
38	P	p	NN	_	39	NMOD
39	component	component	NN	_	40	NMOD
40	gene	gene	NN	_	34	PMOD
41	(	(	-LRB-	_	42	P
42	Apcs	apc	NN	_	40	PRN
43	)	)	-RRB-	_	42	P
44	.	.	.	_	6	P

1	The	the	DT	_	5	NMOD
2	Apcs	apc	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	deficient	deficient	JJ	_	5	NMOD
5	mice	mouse	NNS	_	12	SBJ
6	(	(	-LRB-	_	7	P
7	Apcs	apc	NN	_	5	PRN
8	−	−	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	−	−	SYM	_	7	P
11	)	)	-RRB-	_	7	P
12	were	be	VBD	_	52	DEP
13	chosen	choose	VBN	_	12	VC
14	as	as	IN	_	13	ADV
15	an	an	DT	_	16	NMOD
16	example	example	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	a	a	DT	_	22	NMOD
19	gene	gene	NN	_	21	AMOD
20	-	-	HYPH	_	19	P
21	targeted	target	VBN	_	22	NMOD
22	strain	strain	NN	_	17	PMOD
23	previously	previously	RB	_	24	TMP
24	reported	report	VBN	_	22	NMOD
25	to	to	TO	_	24	OPRD
26	develop	develop	VB	_	25	IM
27	a	a	DT	_	31	NMOD
28	lupus	lupus	NN	_	30	AMOD
29	-	-	HYPH	_	28	P
30	like	like	JJ	_	31	NMOD
31	disease	disease	NN	_	26	OBJ
32	on	on	IN	_	26	LOC
33	the	the	DT	_	40	NMOD
34	hybrid	hybrid	NN	_	40	NMOD
35	genetic	genetic	JJ	_	40	NMOD
36	background	background	NN	_	40	NMOD
37	(	(	-LRB-	_	40	P
38	129	0	CD	_	40	NMOD
39	×	×	SYM	_	40	P
40	C57BL	c0bl	NN	_	32	PMOD
41	/	/	HYPH	_	40	P
42	6	0	CD	_	40	NMOD
43	)	)	-RRB-	_	40	P
44	;	;	:	_	52	P
45	autoimmunity	autoimmunity	NN	_	52	SBJ
46	in	in	IN	_	45	LOC
47	Apcs	apc	NN	_	51	NMOD
48	−	−	SYM	_	47	P
49	/	/	HYPH	_	47	P
50	−	−	SYM	_	47	P
51	mice	mouse	NNS	_	46	PMOD
52	persists	persist	VBZ	_	0	ROOT
53	even	even	RB	_	54	PMOD
54	after	after	IN	_	52	TMP
55	backcrossing	backcross	VBG	_	54	PMOD
56	the	the	DT	_	58	NMOD
57	mutated	mutate	VBN	_	58	NMOD
58	gene	gene	NN	_	55	OBJ
59	onto	onto	IN	_	55	ADV
60	C57BL	c0bl	NN	_	59	PMOD
61	/	/	HYPH	_	60	P
62	6	0	CD	_	60	NMOD
63	(	(	-LRB-	_	64	P
64	Bickerstaff	bickerstaff	NNP	_	55	CIT
65	et	et	FW	_	64	DEP
66	al.	al.	FW	_	64	DEP
67	1999	0	CD	_	64	DEP
68	)	)	-RRB-	_	64	P
69	.	.	.	_	52	P

1	We	we	PRP	_	2	SBJ
2	chose	choose	VBD	_	0	ROOT
3	this	this	DT	_	5	NMOD
4	targeted	target	VBN	_	5	NMOD
5	gene	gene	NN	_	2	OBJ
6	in	in	IN	_	2	ADV
7	particular	particular	JJ	_	6	PMOD
8	to	to	TO	_	2	PRP
9	study	study	VB	_	8	IM
10	since	since	IN	_	2	PRP
11	the	the	DT	_	13	NMOD
12	Apcs	apc	NN	_	13	NMOD
13	gene	gene	NN	_	14	SBJ
14	is	be	VBZ	_	10	SUB
15	located	locate	VBN	_	14	VC
16	on	on	IN	_	15	ADV
17	Chromosome	chromosome	NN	_	16	PMOD
18	1	0	CD	_	17	NMOD
19	,	,	,	_	17	P
20	approximately	approximately	RB	_	21	QMOD
21	94	0	CD	_	22	NMOD
22	cM	cm	NN	_	23	ADV
23	from	from	IN	_	17	NMOD
24	the	the	DT	_	25	NMOD
25	centromere	centromere	NN	_	23	PMOD
26	,	,	,	_	17	P
27	within	within	IN	_	17	LOC
28	a	a	DT	_	29	NMOD
29	region	region	NN	_	27	PMOD
30	where	where	WRB	_	75	LOC
31	several	several	JJ	_	35	NMOD
32	lupus	lupus	NN	_	34	NMOD
33	-	-	HYPH	_	32	P
34	susceptibility	susceptibility	NN	_	35	NMOD
35	loci	locus	NNS	_	73	SBJ
36	,	,	,	_	35	P
37	designated	designate	VBN	_	35	NMOD
38	Sle1	sle0	NN	_	37	OPRD
39	(	(	-LRB-	_	40	P
40	Morel	morel	NNP	_	38	NMOD
41	et	et	FW	_	40	DEP
42	al.	al.	FW	_	40	DEP
43	2001	0	CD	_	40	DEP
44	)	)	-RRB-	_	40	P
45	,	,	,	_	38	P
46	Nba2	nba0	NN	_	38	CONJ
47	(	(	-LRB-	_	48	P
48	Drake	drake	NNP	_	46	NMOD
49	et	et	FW	_	48	DEP
50	al.	al.	FW	_	48	DEP
51	1995	0	CD	_	48	DEP
52	;	;	:	_	48	P
53	Vyse	vyse	NNP	_	48	DEP
54	et	et	FW	_	48	DEP
55	al.	al.	FW	_	48	DEP
56	1997	0	CD	_	48	DEP
57	)	)	-RRB-	_	48	P
58	,	,	,	_	46	P
59	and	and	CC	_	46	COORD
60	Bxs3	bxs0	NN	_	59	CONJ
61	(	(	-LRB-	_	62	P
62	Hogarth	hogarth	NNP	_	60	NMOD
63	et	et	FW	_	62	DEP
64	al.	al.	FW	_	62	DEP
65	1998	0	CD	_	62	DEP
66	;	;	:	_	62	P
67	Haywood	haywood	NNP	_	62	DEP
68	et	et	FW	_	62	DEP
69	al.	al.	FW	_	62	DEP
70	2000	0	CD	_	62	DEP
71	)	)	-RRB-	_	62	P
72	,	,	,	_	73	P
73	have	have	VBP	_	29	NMOD
74	been	be	VBN	_	73	VC
75	mapped	map	VBN	_	74	VC
76	in	in	IN	_	75	ADV
77	NZW	nzw	NN	_	86	NMOD
78	,	,	,	_	77	P
79	NZB	nzb	NN	_	77	CONJ
80	,	,	,	_	79	P
81	and	and	CC	_	79	COORD
82	BXSB	bxsb	NN	_	81	CONJ
83	lupus	lupus	NN	_	85	AMOD
84	-	-	HYPH	_	83	P
85	prone	prone	JJ	_	86	NMOD
86	strains	strain	NNS	_	76	PMOD
87	,	,	,	_	75	P
88	respectively	respectively	RB	_	75	ADV
89	.	.	.	_	2	P

1	This	this	DT	_	2	NMOD
2	region	region	NN	_	3	SBJ
3	contains	contain	VBZ	_	0	ROOT
4	several	several	JJ	_	5	NMOD
5	genes	gene	NNS	_	3	OBJ
6	,	,	,	_	5	P
7	including	include	VBG	_	5	NMOD
8	those	those	DT	_	7	PMOD
9	encoding	encode	VBG	_	8	NMOD
10	FcγRII	fcγrii	NN	_	9	OBJ
11	,	,	,	_	8	P
12	the	the	DT	_	14	NMOD
13	complement	complement	NN	_	14	NMOD
14	receptor	receptor	NN	_	21	NMOD
15	CR1	cr0	NN	_	21	NMOD
16	/	/	HYPH	_	15	P
17	2	0	CD	_	15	NMOD
18	(	(	-LRB-	_	21	P
19	CD35	cd0	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	CD21	cd0	NN	_	8	APPO
22	)	)	-RRB-	_	21	P
23	,	,	,	_	21	P
24	and	and	CC	_	21	COORD
25	the	the	DT	_	30	NMOD
26	decay	decay	NN	_	28	AMOD
27	-	-	HYPH	_	26	P
28	accelerating	accelerate	VBG	_	30	NMOD
29	factor	factor	NN	_	30	NMOD
30	CD55	cd0	NN	_	24	CONJ
31	(	(	-LRB-	_	32	P
32	Prodeus	prodeus	NNP	_	21	NMOD
33	et	et	FW	_	32	DEP
34	al.	al.	FW	_	32	DEP
35	1998	0	CD	_	32	DEP
36	;	;	:	_	32	P
37	Bolland	bolland	NNP	_	32	DEP
38	and	and	CC	_	37	COORD
39	Ravetch	ravetch	NNP	_	38	CONJ
40	2000	0	CD	_	32	DEP
41	;	;	:	_	32	P
42	Miwa	miwa	NNP	_	32	DEP
43	et	et	FW	_	32	DEP
44	al.	al.	FW	_	32	DEP
45	2002	0	CD	_	32	DEP
46	;	;	:	_	32	P
47	Wu	wu	NNP	_	32	DEP
48	et	et	FW	_	32	DEP
49	al.	al.	FW	_	32	DEP
50	2002	0	CD	_	32	DEP
51	)	)	-RRB-	_	32	P
52	,	,	,	_	21	P
53	which	which	WDT	_	54	SBJ
54	have	have	VBP	_	21	NMOD
55	each	each	DT	_	54	ADV
56	been	be	VBN	_	54	VC
57	implicated	implicate	VBN	_	56	VC
58	in	in	IN	_	57	ADV
59	the	the	DT	_	60	NMOD
60	causation	causation	NN	_	58	PMOD
61	of	of	IN	_	60	NMOD
62	SLE	sle	NN	_	61	PMOD
63	when	when	WRB	_	64	TMP
64	inactivated	inactivate	VBN	_	57	TMP
65	by	by	IN	_	64	MNR
66	gene	gene	NN	_	65	PMOD
67	-	-	HYPH	_	66	P
68	targeting	target	VBG	_	66	NMOD
69	in	in	IN	_	64	LOC
70	129	0	CD	_	73	NMOD
71	embryonic	embryonic	JJ	_	73	NMOD
72	stem	stem	NN	_	73	NMOD
73	cells	cell	NNS	_	69	PMOD
74	.	.	.	_	3	P

1	Here	here	RB	_	3	ADV
2	we	we	PRP	_	3	SBJ
3	show	show	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	there	there	EX	_	6	SBJ
6	are	be	VBP	_	4	SUB
7	multiple	multiple	JJ	_	9	NMOD
8	genetic	genetic	JJ	_	9	NMOD
9	loci	locus	NNS	_	6	PRD
10	,	,	,	_	9	P
11	derived	derive	VBN	_	9	NMOD
12	from	from	IN	_	11	ADV
13	both	both	CC	_	14	COORD
14	129	0	CD	_	19	NMOD
15	and	and	CC	_	14	COORD
16	C57BL	c0bl	NN	_	15	CONJ
17	/	/	HYPH	_	16	P
18	6	0	CD	_	16	NMOD
19	mice	mouse	NNS	_	12	PMOD
20	,	,	,	_	9	P
21	contributing	contribute	VBG	_	9	NMOD
22	to	to	IN	_	21	ADV
23	autoimmunity	autoimmunity	NN	_	22	PMOD
24	.	.	.	_	3	P

1	Furthermore	furthermore	RB	_	44	ADV
2	,	,	,	_	44	P
3	a	a	DT	_	7	NMOD
4	129	0	CD	_	6	AMOD
5	-	-	HYPH	_	4	P
6	derived	derive	VBN	_	7	NMOD
7	interval	interval	NN	_	44	SBJ
8	on	on	IN	_	7	LOC
9	distal	distal	JJ	_	10	NMOD
10	Chromosome	chromosome	NN	_	8	PMOD
11	1	0	CD	_	10	NMOD
12	,	,	,	_	44	P
13	when	when	WRB	_	14	TMP
14	transferred	transfer	VBN	_	44	TMP
15	onto	onto	IN	_	14	LOC
16	the	the	DT	_	20	NMOD
17	C57BL	c0bl	NN	_	20	NMOD
18	/	/	HYPH	_	17	P
19	6	0	CD	_	17	NMOD
20	genome	genome	NN	_	15	PMOD
21	,	,	,	_	20	P
22	a	a	DT	_	23	NMOD
23	combination	combination	NN	_	20	APPO
24	commonly	commonly	RB	_	25	ADV
25	created	create	VBN	_	23	NMOD
26	by	by	IN	_	25	MNR
27	backcrossing	backcross	VBG	_	26	PMOD
28	onto	onto	IN	_	27	ADV
29	C57BL	c0bl	NN	_	28	PMOD
30	/	/	HYPH	_	29	P
31	6	0	CD	_	29	NMOD
32	a	a	DT	_	33	NMOD
33	gene	gene	NN	_	27	OBJ
34	that	that	WDT	_	35	SBJ
35	has	have	VBZ	_	33	NMOD
36	been	be	VBN	_	35	VC
37	inactivated	inactivate	VBN	_	36	VC
38	in	in	IN	_	37	LOC
39	129	0	CD	_	42	NMOD
40	embryonic	embryonic	JJ	_	42	NMOD
41	stem	stem	NN	_	42	NMOD
42	cells	cell	NNS	_	38	PMOD
43	,	,	,	_	44	P
44	was	be	VBD	_	0	ROOT
45	sufficient	sufficient	JJ	_	44	PRD
46	to	to	TO	_	45	AMOD
47	cause	cause	VB	_	46	IM
48	humoral	humoral	JJ	_	49	NMOD
49	autoimmunity	autoimmunity	NN	_	47	OBJ
50	in	in	IN	_	47	ADV
51	its	its	PRP$	_	53	NMOD
52	own	own	JJ	_	53	NMOD
53	right	right	NN	_	50	PMOD
54	,	,	,	_	47	P
55	irrespective	irrespective	RB	_	47	ADV
56	of	of	IN	_	55	AMOD
57	the	the	DT	_	58	NMOD
58	presence	presence	NN	_	56	PMOD
59	of	of	IN	_	58	NMOD
60	the	the	DT	_	63	NMOD
61	mutated	mutate	VBN	_	63	NMOD
62	Apcs	apc	NN	_	63	NMOD
63	gene	gene	NN	_	59	PMOD
64	.	.	.	_	44	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	demonstrate	demonstrate	VBP	_	0	ROOT
4	important	important	JJ	_	6	NMOD
5	epistatic	epistatic	JJ	_	6	NMOD
6	interactions	interaction	NNS	_	3	OBJ
7	between	between	IN	_	6	NMOD
8	genes	gene	NNS	_	7	PMOD
9	from	from	IN	_	8	NMOD
10	129	0	CD	_	15	NMOD
11	and	and	CC	_	10	COORD
12	C57BL	c0bl	NN	_	11	CONJ
13	/	/	HYPH	_	12	P
14	6	0	CD	_	12	NMOD
15	genomes	genome	NNS	_	9	PMOD
16	on	on	IN	_	6	NMOD
17	the	the	DT	_	18	NMOD
18	development	development	NN	_	16	PMOD
19	of	of	IN	_	18	NMOD
20	autoimmunity	autoimmunity	NN	_	19	PMOD
21	and	and	CC	_	3	COORD
22	illustrate	illustrate	VBP	_	21	CONJ
23	the	the	DT	_	25	NMOD
24	important	important	JJ	_	25	NMOD
25	effects	effect	NNS	_	22	OBJ
26	of	of	IN	_	25	NMOD
27	background	background	NN	_	28	NMOD
28	genes	gene	NNS	_	26	PMOD
29	in	in	IN	_	22	ADV
30	the	the	DT	_	31	NMOD
31	analysis	analysis	NN	_	29	PMOD
32	and	and	CC	_	31	COORD
33	interpretation	interpretation	NN	_	32	CONJ
34	of	of	IN	_	31	NMOD
35	autoimmune	autoimmune	JJ	_	36	NMOD
36	phenotypes	phenotype	NNS	_	34	PMOD
37	associated	associate	VBN	_	36	NMOD
38	with	with	IN	_	37	ADV
39	targeted	target	VBN	_	41	NMOD
40	genetic	genetic	JJ	_	41	NMOD
41	disruptions	disruption	NNS	_	38	PMOD
42	.	.	.	_	3	P

1	Results	result	NNS	_	0	ROOT

1	Disease	disease	NN	_	2	NMOD
2	Traits	trait	NNS	_	0	ROOT
3	in	in	IN	_	2	LOC
4	(	(	-LRB-	_	26	P
5	129	0	CD	_	11	NMOD
6	×	×	SYM	_	5	P
7	C57BL	c0bl	NN	_	5	NMOD
8	/	/	HYPH	_	7	P
9	6	0	CD	_	7	NMOD
10	)	)	-RRB-	_	11	P
11	F2	f0	NN	_	26	NMOD
12	and	and	CC	_	11	COORD
13	(	(	-LRB-	_	20	P
14	129	0	CD	_	16	NMOD
15	×	×	SYM	_	16	P
16	C57BL	c0bl	NN	_	20	NMOD
17	/	/	HYPH	_	16	P
18	6	0	CD	_	16	NMOD
19	)	)	-RRB-	_	20	P
20	F2	f0	NN	_	12	CONJ
21	.	.	HYPH	_	11	P
22	Apcs	apc	NN	_	26	NMOD
23	−	−	SYM	_	22	P
24	/	/	HYPH	_	22	P
25	−	−	SYM	_	22	P
26	Mice	mouse	NNS	_	3	PMOD

1	To	to	TO	_	26	PRP
2	investigate	investigate	VB	_	1	IM
3	the	the	DT	_	5	NMOD
4	genetic	genetic	JJ	_	5	NMOD
5	basis	base	NN	_	2	OBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	11	NMOD
8	lupus	lupus	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	like	like	JJ	_	11	NMOD
11	disease	disease	NN	_	6	PMOD
12	observed	observe	VBN	_	11	NMOD
13	in	in	IN	_	12	LOC
14	the	the	DT	_	23	NMOD
15	(	(	-LRB-	_	23	P
16	129	0	CD	_	18	NMOD
17	×	×	SYM	_	18	P
18	C57BL	c0bl	NN	_	23	NMOD
19	/	/	HYPH	_	18	P
20	6	0	CD	_	18	NMOD
21	)	)	-RRB-	_	23	P
22	hybrid	hybrid	NN	_	23	NMOD
23	mice	mouse	NNS	_	13	PMOD
24	,	,	,	_	26	P
25	we	we	PRP	_	26	SBJ
26	generated	generate	VBD	_	0	ROOT
27	two	two	CD	_	29	NMOD
28	large	large	JJ	_	29	NMOD
29	cohorts	cohort	NNS	_	26	OBJ
30	of	of	IN	_	29	NMOD
31	(	(	-LRB-	_	38	P
32	129	0	CD	_	34	NMOD
33	×	×	SYM	_	34	P
34	C57BL	c0bl	NN	_	38	NMOD
35	/	/	HYPH	_	34	P
36	6	0	CD	_	34	NMOD
37	)	)	-RRB-	_	38	P
38	F2	f0	NN	_	39	NMOD
39	animals	animal	NNS	_	30	PMOD
40	,	,	,	_	29	P
41	one	one	CD	_	29	APPO
42	carrying	carry	VBG	_	41	NMOD
43	a	a	DT	_	44	NMOD
44	mutation	mutation	NN	_	42	OBJ
45	in	in	IN	_	42	LOC
46	the	the	DT	_	48	NMOD
47	Apcs	apc	NN	_	48	NMOD
48	gene	gene	NN	_	45	PMOD
49	,	,	,	_	26	P
50	and	and	CC	_	26	COORD
51	monitored	monitor	VBD	_	50	CONJ
52	them	them	PRP	_	51	OBJ
53	for	for	IN	_	51	TMP
54	1	0	CD	_	55	NMOD
55	y	y	NN	_	53	PMOD
56	under	under	IN	_	51	ADV
57	identical	identical	JJ	_	59	NMOD
58	environmental	environmental	JJ	_	59	NMOD
59	conditions	condition	NNS	_	56	PMOD
60	.	.	.	_	26	P

1	Since	since	IN	_	18	PRP
2	female	female	JJ	_	3	NMOD
3	mice	mouse	NNS	_	8	SBJ
4	in	in	IN	_	8	LOC
5	the	the	DT	_	7	NMOD
6	original	original	JJ	_	7	NMOD
7	reports	report	NNS	_	4	PMOD
8	showed	show	VBD	_	1	SUB
9	a	a	DT	_	11	NMOD
10	higher	high	JJR	_	11	NMOD
11	penetrance	penetrance	NN	_	8	OBJ
12	of	of	IN	_	11	NMOD
13	disease	disease	NN	_	12	PMOD
14	,	,	,	_	18	P
15	the	the	DT	_	17	NMOD
16	present	present	JJ	_	17	NMOD
17	study	study	NN	_	18	SBJ
18	was	be	VBD	_	0	ROOT
19	conducted	conduct	VBN	_	18	VC
20	only	only	RB	_	19	ADV
21	on	on	IN	_	19	ADV
22	female	female	JJ	_	23	NMOD
23	mice	mouse	NNS	_	21	PMOD
24	.	.	.	_	18	P

1	The	the	DT	_	2	NMOD
2	results	result	NNS	_	12	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	phenotypic	phenotypic	JJ	_	6	NMOD
6	analysis	analysis	NN	_	3	PMOD
7	at	at	IN	_	2	TMP
8	1	0	CD	_	9	NMOD
9	y	y	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	age	age	NN	_	10	PMOD
12	are	be	VBP	_	0	ROOT
13	summarised	summarise	VBN	_	12	VC
14	in	in	IN	_	13	LOC
15	Tables	table	NNS	_	16	NMOD
16	1	0	CD	_	14	PMOD
17	and	and	CC	_	16	COORD
18	2	0	CD	_	17	CONJ
19	.	.	.	_	12	P

1	As	as	IN	_	24	ADV
2	previously	previously	RB	_	3	TMP
3	reported	report	VBN	_	1	SUB
4	(	(	-LRB-	_	5	P
5	Botto	botto	NNP	_	3	CIT
6	et	et	FW	_	5	DEP
7	al.	al.	FW	_	5	DEP
8	1998	0	CD	_	5	DEP
9	)	)	-RRB-	_	5	P
10	,	,	,	_	24	P
11	the	the	DT	_	23	NMOD
12	wild	wild	JJ	_	14	NMOD
13	-	-	HYPH	_	12	P
14	type	type	NN	_	23	NMOD
15	(	(	-LRB-	_	23	P
16	129	0	CD	_	18	NMOD
17	×	×	SYM	_	18	P
18	C57BL	c0bl	NN	_	23	NMOD
19	/	/	HYPH	_	18	P
20	6	0	CD	_	18	NMOD
21	)	)	-RRB-	_	23	P
22	F2	f0	NN	_	23	NMOD
23	mice	mouse	NNS	_	24	SBJ
24	developed	develop	VBD	_	0	ROOT
25	lupus	lupus	NN	_	26	NMOD
26	traits	trait	NNS	_	24	OBJ
27	with	with	IN	_	26	NMOD
28	elevated	elevate	VBN	_	29	NMOD
29	levels	level	NNS	_	27	PMOD
30	of	of	IN	_	29	NMOD
31	auto-Abs	auto-abs	NNS	_	30	PMOD
32	,	,	,	_	29	P
33	starting	start	VBG	_	29	NMOD
34	from	from	IN	_	33	TMP
35	6	0	CD	_	36	NMOD
36	mo	mo	NN	_	34	PMOD
37	of	of	IN	_	36	NMOD
38	age	age	NN	_	37	PMOD
39	(	(	-LRB-	_	42	P
40	data	datum	NNS	_	42	SBJ
41	not	not	RB	_	42	ADV
42	shown	show	VBN	_	33	PRN
43	)	)	-RRB-	_	42	P
44	,	,	,	_	26	P
45	and	and	CC	_	26	COORD
46	histological	histological	JJ	_	47	NMOD
47	evidence	evidence	NN	_	45	CONJ
48	of	of	IN	_	47	NMOD
49	proliferative	proliferative	JJ	_	50	NMOD
50	glomerulonephritis	glomerulonephritis	NN	_	48	PMOD
51	.	.	.	_	24	P

1	In	in	IN	_	25	ADV
2	agreement	agreement	NN	_	1	PMOD
3	with	with	IN	_	2	NMOD
4	our	our	PRP$	_	6	NMOD
5	previous	previous	JJ	_	6	NMOD
6	observations	observation	NNS	_	3	PMOD
7	(	(	-LRB-	_	8	P
8	Bickerstaff	bickerstaff	NNP	_	6	NMOD
9	et	et	FW	_	8	DEP
10	al.	al.	FW	_	8	DEP
11	1999	0	CD	_	8	DEP
12	)	)	-RRB-	_	8	P
13	,	,	,	_	25	P
14	the	the	DT	_	15	NMOD
15	titres	titre	NNS	_	25	SBJ
16	of	of	IN	_	15	NMOD
17	anti-nuclear	anti-nuclear	JJ	_	18	NMOD
18	Abs	ab	NNS	_	20	NMOD
19	(	(	-LRB-	_	20	P
20	ANAs	ana	NNS	_	16	PMOD
21	)	)	-RRB-	_	20	P
22	and	and	CC	_	20	COORD
23	anti-chromatin	anti-chromatin	JJ	_	24	NMOD
24	Ab	ab	NN	_	22	CONJ
25	were	be	VBD	_	0	ROOT
26	considerably	considerably	RB	_	27	AMOD
27	greater	great	JJR	_	25	PRD
28	in	in	IN	_	25	LOC
29	the	the	DT	_	43	NMOD
30	(	(	-LRB-	_	43	P
31	129	0	CD	_	33	NMOD
32	×	×	SYM	_	33	P
33	C57BL	c0bl	NN	_	37	NMOD
34	/	/	HYPH	_	33	P
35	6	0	CD	_	33	NMOD
36	)	)	-RRB-	_	37	P
37	F2	f0	NN	_	39	NMOD
38	.	.	HYPH	_	37	P
39	Apcs	apc	NN	_	43	NMOD
40	−	−	SYM	_	39	P
41	/	/	HYPH	_	39	P
42	−	−	SYM	_	39	P
43	mice	mouse	NNS	_	28	PMOD
44	compared	compare	VBN	_	25	ADV
45	with	with	IN	_	44	PMOD
46	the	the	DT	_	50	NMOD
47	strain	strain	NN	_	49	AMOD
48	-	-	HYPH	_	47	P
49	matched	match	VBN	_	50	NMOD
50	controls	control	NNS	_	45	PMOD
51	.	.	.	_	25	P

1	However	however	RB	_	45	ADV
2	,	,	,	_	45	P
3	in	in	IN	_	45	ADV
4	contrast	contrast	NN	_	3	PMOD
5	to	to	IN	_	4	NMOD
6	our	our	PRP$	_	8	NMOD
7	original	original	JJ	_	8	NMOD
8	findings	finding	NNS	_	5	PMOD
9	,	,	,	_	45	P
10	the	the	DT	_	11	NMOD
11	levels	level	NNS	_	45	SBJ
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	18	NMOD
14	other	other	JJ	_	18	NMOD
15	two	two	CD	_	18	NMOD
16	disease	disease	NN	_	18	NMOD
17	serological	serological	JJ	_	18	NMOD
18	markers	marker	NNS	_	12	PMOD
19	analysed	analyse	VBN	_	18	NMOD
20	(	(	-LRB-	_	36	P
21	anti-single	anti-single	VBN	_	23	AMOD
22	-	-	HYPH	_	21	P
23	stranded	strand	VBN	_	24	NMOD
24	DNA	dna	NN	_	26	NMOD
25	[	[	-LRB-	_	26	P
26	ssDNA	ssdna	NN	_	36	NMOD
27	]	]	-RRB-	_	26	P
28	and	and	CC	_	26	COORD
29	anti-double	anti-double	VBN	_	31	AMOD
30	-	-	HYPH	_	29	P
31	stranded	strand	VBN	_	32	NMOD
32	DNA	dna	NN	_	34	NMOD
33	[	[	-LRB-	_	34	P
34	dsDNA	dsdna	NN	_	28	CONJ
35	]	]	-RRB-	_	34	P
36	Abs	ab	NNS	_	18	PRN
37	)	)	-RRB-	_	36	P
38	and	and	CC	_	11	COORD
39	the	the	DT	_	40	NMOD
40	severity	severity	NN	_	38	CONJ
41	of	of	IN	_	40	NMOD
42	the	the	DT	_	44	NMOD
43	renal	renal	JJ	_	44	NMOD
44	pathology	pathology	NN	_	41	PMOD
45	were	be	VBD	_	0	ROOT
46	not	not	RB	_	45	ADV
47	different	different	JJ	_	45	PRD
48	between	between	IN	_	45	ADV
49	the	the	DT	_	52	NMOD
50	two	two	CD	_	52	NMOD
51	experimental	experimental	JJ	_	52	NMOD
52	groups	group	NNS	_	48	PMOD
53	.	.	.	_	45	P

1	In	in	IN	_	38	ADV
2	view	view	NN	_	1	PMOD
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	possibility	possibility	NN	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	an	an	DT	_	8	NMOD
8	association	association	NN	_	6	PMOD
9	between	between	IN	_	8	NMOD
10	the	the	DT	_	15	NMOD
11	fixed	fix	VBN	_	15	NMOD
12	129	0	CD	_	14	AMOD
13	-	-	HYPH	_	12	P
14	derived	derive	VBN	_	15	NMOD
15	segment	segment	NN	_	9	PMOD
16	flanking	flank	VBG	_	15	NMOD
17	the	the	DT	_	20	NMOD
18	mutated	mutate	VBN	_	20	NMOD
19	Apcs	apc	NN	_	20	NMOD
20	gene	gene	NN	_	16	OBJ
21	and	and	CC	_	15	COORD
22	the	the	DT	_	24	NMOD
23	autoimmune	autoimmune	JJ	_	24	NMOD
24	traits	trait	NNS	_	21	CONJ
25	observed	observe	VBN	_	24	NMOD
26	,	,	,	_	38	P
27	the	the	DT	_	32	NMOD
28	genome	genome	NN	_	30	AMOD
29	-	-	HYPH	_	28	P
30	wide	wide	JJ	_	32	NMOD
31	linkage	linkage	NN	_	32	NMOD
32	analysis	analysis	NN	_	38	SBJ
33	of	of	IN	_	32	NMOD
34	the	the	DT	_	37	NMOD
35	two	two	CD	_	37	NMOD
36	experimental	experimental	JJ	_	37	NMOD
37	cohorts	cohort	NNS	_	33	PMOD
38	was	be	VBD	_	0	ROOT
39	carried	carry	VBN	_	38	VC
40	out	out	RP	_	39	PRT
41	separately	separately	RB	_	39	MNR
42	.	.	.	_	38	P

1	Mapping	mapping	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Loci	locus	NNS	_	2	PMOD
4	Predisposing	predispose	VBG	_	3	NMOD
5	to	to	IN	_	4	ADV
6	Lupus	lupus	NN	_	5	PMOD
7	in	in	IN	_	1	LOC
8	the	the	DT	_	10	NMOD
9	Hybrid	hybrid	NN	_	10	NMOD
10	Strain	strain	NN	_	14	NMOD
11	(	(	-LRB-	_	14	P
12	129	0	CD	_	14	NMOD
13	×	×	SYM	_	14	P
14	C57BL	c0bl	NN	_	7	PMOD
15	/	/	HYPH	_	14	P
16	6	0	CD	_	14	NMOD
17	)	)	-RRB-	_	14	P

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	genotyped	genotyped	VBN	_	2	VC
4	with	with	IN	_	3	ADV
5	143	0	CD	_	7	NMOD
6	microsatellite	microsatellite	NN	_	7	NMOD
7	markers	marker	NNS	_	4	PMOD
8	distributed	distribute	VBN	_	7	NMOD
9	throughout	throughout	IN	_	8	ADV
10	the	the	DT	_	11	NMOD
11	autosomes	autosome	NNS	_	9	PMOD
12	such	such	JJ	_	13	SUB
13	that	that	IN	_	3	ADV
14	98	0	CD	_	15	NMOD
15	%	%	NN	_	19	SBJ
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	18	NMOD
18	genes	gene	NNS	_	16	PMOD
19	were	be	VBD	_	13	SUB
20	within	within	IN	_	19	PRD
21	20	0	CD	_	22	NMOD
22	cM	cm	NNS	_	20	PMOD
23	of	of	IN	_	22	NMOD
24	an	an	DT	_	26	NMOD
25	informative	informative	JJ	_	26	NMOD
26	marker	marker	NN	_	23	PMOD
27	.	.	.	_	2	P

1	A	a	DT	_	2	NMOD
2	summary	summary	NN	_	17	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	9	NMOD
5	genome	genome	NN	_	7	AMOD
6	-	-	HYPH	_	5	P
7	wide	wide	JJ	_	9	NMOD
8	linkage	linkage	NN	_	9	NMOD
9	analysis	analysis	NN	_	3	PMOD
10	for	for	IN	_	2	NMOD
11	each	each	DT	_	10	PMOD
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	15	NMOD
14	disease	disease	NN	_	15	NMOD
15	traits	trait	NNS	_	12	PMOD
16	measured	measure	VBN	_	15	NMOD
17	is	be	VBZ	_	0	ROOT
18	shown	show	VBN	_	17	VC
19	in	in	IN	_	18	LOC
20	Table	table	NN	_	19	PMOD
21	3	0	CD	_	20	NMOD
22	.	.	.	_	17	P

1	The	the	DT	_	2	NMOD
2	areas	area	NNS	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	linkage	linkage	NN	_	3	PMOD
5	were	be	VBD	_	0	ROOT
6	defined	define	VBN	_	5	VC
7	according	accord	VBG	_	6	ADV
8	to	to	IN	_	7	PMOD
9	the	the	DT	_	11	NMOD
10	parental	parental	JJ	_	11	NMOD
11	origin	origin	NN	_	8	PMOD
12	,	,	,	_	11	P
13	129	0	CD	_	11	APPO
14	or	or	CC	_	13	COORD
15	C57BL	c0bl	NN	_	14	CONJ
16	/	/	HYPH	_	15	P
17	6	0	CD	_	15	NMOD
18	.	.	.	_	5	P

1	Only	only	RB	_	2	NMOD
2	linkages	linkage	NNS	_	8	SBJ
3	identified	identify	VBN	_	2	NMOD
4	in	in	IN	_	3	LOC
5	both	both	DT	_	7	NMOD
6	experimental	experimental	JJ	_	7	NMOD
7	groups	group	NNS	_	4	PMOD
8	are	be	VBP	_	0	ROOT
9	reported	report	VBN	_	8	VC
10	in	in	IN	_	9	LOC
11	Table	table	NN	_	10	PMOD
12	3	0	CD	_	11	NMOD
13	,	,	,	_	9	P
14	with	with	IN	_	9	ADV
15	the	the	DT	_	16	NMOD
16	exception	exception	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	22	NMOD
19	Chromosome	chromosome	NN	_	22	NMOD
20	1	0	CD	_	19	NMOD
21	distal	distal	JJ	_	22	NMOD
22	segment	segment	NN	_	17	PMOD
23	,	,	,	_	22	P
24	where	where	WRB	_	31	LOC
25	the	the	DT	_	27	NMOD
26	linkage	linkage	NN	_	27	NMOD
27	analysis	analysis	NN	_	28	SBJ
28	could	could	MD	_	22	NMOD
29	not	not	RB	_	28	ADV
30	be	be	VB	_	28	VC
31	applied	apply	VBN	_	30	VC
32	to	to	IN	_	31	ADV
33	the	the	DT	_	47	NMOD
34	(	(	-LRB-	_	43	P
35	129	0	CD	_	37	NMOD
36	×	×	SYM	_	37	P
37	C57BL	c0bl	NN	_	41	NMOD
38	/	/	HYPH	_	37	P
39	6	0	CD	_	37	NMOD
40	)	)	-RRB-	_	41	P
41	F2	f0	NN	_	43	NMOD
42	.	.	HYPH	_	41	P
43	Apcs	apc	NN	_	47	NMOD
44	−	−	SYM	_	43	P
45	/	/	HYPH	_	43	P
46	−	−	SYM	_	43	P
47	mice	mouse	NNS	_	32	PMOD
48	as	as	IN	_	31	PRP
49	this	this	DT	_	50	NMOD
50	region	region	NN	_	51	SBJ
51	was	be	VBD	_	48	SUB
52	of	of	IN	_	51	PRD
53	fixed	fix	VBN	_	55	NMOD
54	129	0	CD	_	55	NMOD
55	origin	origin	NN	_	52	PMOD
56	.	.	.	_	8	P

1	Chromosomes	chromosome	NNS	_	13	SBJ
2	where	where	WRB	_	4	LOC
3	linkages	linkage	NNS	_	4	SBJ
4	were	be	VBD	_	1	NMOD
5	present	present	JJ	_	4	PRD
6	only	only	RB	_	7	PMOD
7	in	in	IN	_	4	LOC
8	one	one	CD	_	7	PMOD
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	two	two	CD	_	12	NMOD
12	cohorts	cohort	NNS	_	9	PMOD
13	are	be	VBP	_	0	ROOT
14	shown	show	VBN	_	13	VC
15	in	in	IN	_	14	LOC
16	Figures	figure	NNS	_	17	NMOD
17	1	0	CD	_	15	PMOD
18	–	–	SYM	_	19	P
19	3	0	CD	_	17	NMOD
20	.	.	.	_	13	P

1	The	the	DT	_	8	NMOD
2	quantitative	quantitative	JJ	_	4	NMOD
3	trait	trait	NN	_	4	NMOD
4	linkage	linkage	NN	_	6	NMOD
5	(	(	-LRB-	_	6	P
6	QTL	qtl	NN	_	8	NMOD
7	)	)	-RRB-	_	6	P
8	analysis	analysis	NN	_	9	SBJ
9	identified	identify	VBD	_	0	ROOT
10	several	several	JJ	_	11	NMOD
11	intervals	interval	NNS	_	9	OBJ
12	on	on	IN	_	11	LOC
13	Chromosome	chromosome	NN	_	12	PMOD
14	1	0	CD	_	13	NMOD
15	with	with	IN	_	11	NMOD
16	linkage	linkage	NN	_	15	PMOD
17	to	to	IN	_	16	NMOD
18	disease	disease	NN	_	20	NMOD
19	serological	serological	JJ	_	20	NMOD
20	markers	marker	NNS	_	17	PMOD
21	,	,	,	_	9	P
22	and	and	CC	_	9	COORD
23	these	these	DT	_	24	NMOD
24	regions	region	NNS	_	25	SBJ
25	were	be	VBD	_	22	CONJ
26	all	all	RB	_	25	ADV
27	derived	derive	VBN	_	25	VC
28	from	from	IN	_	27	ADV
29	the	the	DT	_	32	NMOD
30	129	0	CD	_	32	NMOD
31	mouse	mouse	NN	_	32	NMOD
32	strain	strain	NN	_	28	PMOD
33	(	(	-LRB-	_	39	P
34	see	see	VB	_	39	DEP
35	Table	table	NN	_	34	OBJ
36	3	0	CD	_	35	NMOD
37	;	;	:	_	39	P
38	Figures	figure	NNS	_	39	NMOD
39	4	0	CD	_	27	PRN
40	and	and	CC	_	39	COORD
41	5	0	CD	_	40	CONJ
42	)	)	-RRB-	_	39	P
43	.	.	.	_	9	P

1	Interestingly	interestingly	RB	_	44	ADV
2	,	,	,	_	44	P
3	whilst	whilst	IN	_	44	ADV
4	ANA	ana	NN	_	8	NMOD
5	and	and	CC	_	4	COORD
6	anti-chromatin	anti-chromatin	JJ	_	7	NMOD
7	Ab	ab	NN	_	5	CONJ
8	levels	level	NNS	_	9	SBJ
9	showed	show	VBD	_	3	SUB
10	suggestive	suggestive	JJ	_	13	NMOD
11	or	or	CC	_	10	COORD
12	significant	significant	JJ	_	11	CONJ
13	linkages	linkage	NNS	_	9	OBJ
14	only	only	RB	_	15	PMOD
15	to	to	IN	_	13	NMOD
16	the	the	DT	_	18	NMOD
17	telomeric	telomeric	JJ	_	18	NMOD
18	region	region	NN	_	15	PMOD
19	of	of	IN	_	18	NMOD
20	Chromosome	chromosome	NN	_	19	PMOD
21	1	0	CD	_	20	NMOD
22	,	,	,	_	13	P
23	with	with	IN	_	13	NMOD
24	an	an	DT	_	26	NMOD
25	estimated	estimate	VBN	_	26	NMOD
26	peak	peak	NN	_	27	SBJ
27	occurring	occur	VBG	_	23	PMOD
28	at	at	IN	_	27	LOC
29	a	a	DT	_	30	NMOD
30	position	position	NN	_	28	PMOD
31	approximately	approximately	RB	_	32	QMOD
32	90	0	CD	_	33	NMOD
33	cM	cm	NN	_	34	ADV
34	near	near	IN	_	30	NMOD
35	the	the	DT	_	37	NMOD
36	Apcs	apc	NN	_	37	NMOD
37	gene	gene	NN	_	34	PMOD
38	,	,	,	_	44	P
39	anti-dsDNA	anti-dsdna	JJ	_	43	NMOD
40	or	or	CC	_	39	COORD
41	anti-ssDNA	anti-ssdna	JJ	_	40	CONJ
42	Ab	ab	NN	_	43	NMOD
43	production	production	NN	_	44	SBJ
44	was	be	VBD	_	0	ROOT
45	also	also	RB	_	44	ADV
46	linked	link	VBN	_	44	VC
47	to	to	IN	_	46	ADV
48	other	other	JJ	_	49	NMOD
49	segments	segment	NNS	_	47	PMOD
50	on	on	IN	_	49	LOC
51	Chromosome	chromosome	NN	_	50	PMOD
52	1	0	CD	_	51	NMOD
53	,	,	,	_	46	P
54	indicating	indicate	VBG	_	46	ADV
55	a	a	DT	_	59	NMOD
56	more	more	RBR	_	57	AMOD
57	complex	complex	JJ	_	59	NMOD
58	genetic	genetic	JJ	_	59	NMOD
59	contribution	contribution	NN	_	54	OBJ
60	from	from	IN	_	54	ADV
61	the	the	DT	_	64	NMOD
62	129	0	CD	_	64	NMOD
63	mouse	mouse	NN	_	64	NMOD
64	strain	strain	NN	_	60	PMOD
65	.	.	.	_	44	P

1	Guided	guide	VBN	_	7	ADV
2	by	by	IN	_	1	LGS
3	these	these	DT	_	4	NMOD
4	observations	observation	NNS	_	2	PMOD
5	,	,	,	_	7	P
6	we	we	PRP	_	7	SBJ
7	investigated	investigate	VBD	_	0	ROOT
8	whether	whether	IN	_	7	OBJ
9	the	the	DT	_	11	NMOD
10	increased	increase	VBN	_	11	NMOD
11	levels	level	NNS	_	25	SBJ
12	of	of	IN	_	11	NMOD
13	ANA	ana	NN	_	16	NMOD
14	and	and	CC	_	16	COORD
15	anti-chromatin	anti-chromatin	JJ	_	16	NMOD
16	Ab	ab	NN	_	12	PMOD
17	observed	observe	VBN	_	11	NMOD
18	in	in	IN	_	17	LOC
19	the	the	DT	_	24	NMOD
20	Apcs	apc	NN	_	24	NMOD
21	−	−	SYM	_	20	P
22	/	/	HYPH	_	20	P
23	−	−	SYM	_	20	P
24	mice	mouse	NNS	_	18	PMOD
25	were	be	VBD	_	8	SUB
26	caused	cause	VBN	_	25	VC
27	by	by	IN	_	26	LGS
28	a	a	DT	_	29	NMOD
29	gene	gene	NN	_	27	PMOD
30	(	(	-LRB-	_	29	P
31	s	s	AFX	_	29	NMOD
32	)	)	-RRB-	_	29	P
33	within	within	IN	_	29	LOC
34	the	the	DT	_	37	NMOD
35	fixed	fix	VBN	_	37	NMOD
36	129	0	CD	_	37	NMOD
37	region	region	NN	_	33	PMOD
38	surrounding	surround	VBG	_	37	NMOD
39	the	the	DT	_	42	NMOD
40	mutated	mutate	VBN	_	42	NMOD
41	Apcs	apc	NN	_	42	NMOD
42	gene	gene	NN	_	38	OBJ
43	,	,	,	_	26	P
44	rather	rather	RB	_	45	ADV
45	than	than	IN	_	26	COORD
46	caused	cause	VBN	_	45	CONJ
47	by	by	IN	_	46	LGS
48	the	the	DT	_	51	NMOD
49	mutated	mutate	VBN	_	51	NMOD
50	Apcs	apc	NN	_	51	NMOD
51	gene	gene	NN	_	52	NMOD
52	itself	itself	PRP	_	47	PMOD
53	.	.	.	_	7	P

1	We	we	PRP	_	2	SBJ
2	compared	compare	VBD	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	levels	level	NNS	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	these	these	DT	_	7	NMOD
7	auto-Abs	auto-abs	NNS	_	5	PMOD
8	between	between	IN	_	4	NMOD
9	all	all	DT	_	23	NMOD
10	(	(	-LRB-	_	23	P
11	129	0	CD	_	13	NMOD
12	×	×	SYM	_	13	P
13	C57BL	c0bl	NN	_	17	NMOD
14	/	/	HYPH	_	13	P
15	6	0	CD	_	13	NMOD
16	)	)	-RRB-	_	17	P
17	F2	f0	NN	_	19	NMOD
18	.	.	HYPH	_	17	P
19	Apcs	apc	NN	_	23	NMOD
20	−	−	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	−	−	SYM	_	19	P
23	mice	mouse	NNS	_	8	PMOD
24	and	and	CC	_	23	COORD
25	a	a	DT	_	26	NMOD
26	group	group	NN	_	24	CONJ
27	of	of	IN	_	26	NMOD
28	33	0	CD	_	32	NMOD
29	wild	wild	JJ	_	31	NMOD
30	-	-	HYPH	_	29	P
31	type	type	NN	_	32	NMOD
32	mice	mouse	NNS	_	27	PMOD
33	that	that	WDT	_	34	SBJ
34	were	be	VBD	_	32	NMOD
35	selected	select	VBN	_	34	VC
36	for	for	IN	_	35	PRP
37	being	be	VBG	_	36	PMOD
38	homozygous	homozygous	JJ	_	39	NMOD
39	129	0	CD	_	37	PRD
40	in	in	IN	_	37	LOC
41	the	the	DT	_	42	NMOD
42	region	region	NN	_	40	PMOD
43	of	of	IN	_	42	NMOD
44	Chromosome	chromosome	NN	_	43	PMOD
45	1	0	CD	_	44	NMOD
46	between	between	IN	_	42	NMOD
47	microsatellites	microsatellites	NNS	_	48	NMOD
48	D1Mit105	d0mit0	NN	_	46	PMOD
49	and	and	CC	_	48	COORD
50	D1Mit	d0mit	NN	_	49	CONJ
51	223	0	CD	_	50	NMOD
52	(	(	-LRB-	_	56	P
53	80	0	CD	_	56	NMOD
54	–	–	SYM	_	53	P
55	106	0	CD	_	53	QMOD
56	cM	cm	NN	_	42	PRN
57	)	)	-RRB-	_	56	P
58	(	(	-LRB-	_	60	P
59	Figure	figure	NN	_	60	NMOD
60	6A	0a	NN	_	2	PRN
61	–	–	SYM	_	62	P
62	6D	0d	NN	_	60	NMOD
63	)	)	-RRB-	_	60	P
64	.	.	.	_	2	P

1	In	in	IN	_	13	ADV
2	contrast	contrast	NN	_	1	PMOD
3	to	to	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	results	result	NNS	_	3	PMOD
6	reported	report	VBN	_	5	NMOD
7	in	in	IN	_	6	LOC
8	Table	table	NN	_	7	PMOD
9	1	0	CD	_	8	NMOD
10	,	,	,	_	13	P
11	this	this	DT	_	12	NMOD
12	comparison	comparison	NN	_	13	SBJ
13	showed	show	VBD	_	0	ROOT
14	no	no	DT	_	16	NMOD
15	significant	significant	JJ	_	16	NMOD
16	differences	difference	NNS	_	13	OBJ
17	between	between	IN	_	16	NMOD
18	the	the	DT	_	21	NMOD
19	two	two	CD	_	21	NMOD
20	experimental	experimental	JJ	_	21	NMOD
21	groups	group	NNS	_	17	PMOD
22	.	.	.	_	13	P

1	This	this	DT	_	2	NMOD
2	result	result	NN	_	3	SBJ
3	demonstrates	demonstrate	VBZ	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	,	,	,	_	4	P
6	most	most	RBS	_	7	AMOD
7	likely	likely	RB	_	20	ADV
8	,	,	,	_	20	P
9	the	the	DT	_	13	NMOD
10	129	0	CD	_	12	AMOD
11	-	-	HYPH	_	10	P
12	derived	derive	VBN	_	13	NMOD
13	region	region	NN	_	20	SBJ
14	and	and	CC	_	13	COORD
15	not	not	RB	_	14	ADV
16	the	the	DT	_	17	NMOD
17	lack	lack	NN	_	14	CONJ
18	of	of	IN	_	17	NMOD
19	Apcs	apc	NN	_	18	PMOD
20	was	be	VBD	_	4	SUB
21	mediating	mediate	VBG	_	20	VC
22	the	the	DT	_	23	NMOD
23	production	production	NN	_	21	OBJ
24	of	of	IN	_	23	NMOD
25	ANA	ana	NN	_	24	PMOD
26	and	and	CC	_	25	COORD
27	anti-chromatin	anti-chromatin	JJ	_	28	NMOD
28	Ab	ab	NN	_	26	CONJ
29	.	.	.	_	3	P

1	Consistent	consistent	JJ	_	7	ADV
2	with	with	IN	_	1	AMOD
3	this	this	DT	_	4	NMOD
4	explanation	explanation	NN	_	2	PMOD
5	,	,	,	_	7	P
6	we	we	PRP	_	7	SBJ
7	found	find	VBD	_	0	ROOT
8	that	that	IN	_	7	OBJ
9	the	the	DT	_	11	NMOD
10	129	0	CD	_	11	NMOD
11	mice	mouse	NNS	_	12	SBJ
12	have	have	VBP	_	8	SUB
13	significantly	significantly	RB	_	14	AMOD
14	higher	high	JJR	_	15	NMOD
15	levels	level	NNS	_	12	OBJ
16	of	of	IN	_	15	NMOD
17	Apcs	apc	NN	_	16	PMOD
18	in	in	IN	_	15	NMOD
19	circulation	circulation	NN	_	18	PMOD
20	compared	compare	VBN	_	12	ADV
21	with	with	IN	_	20	PMOD
22	the	the	DT	_	26	NMOD
23	C57BL	c0bl	NN	_	26	NMOD
24	/	/	HYPH	_	23	P
25	6	0	CD	_	23	NMOD
26	mice	mouse	NNS	_	21	PMOD
27	(	(	-LRB-	_	66	P
28	median	median	NN	_	43	DEP
29	,	,	,	_	28	P
30	83	0	CD	_	31	NMOD
31	mg	mg	NNS	_	28	DEP
32	/	/	SYM	_	33	P
33	l	l	NN	_	31	NMOD
34	;	;	:	_	43	P
35	range	range	NN	_	43	DEP
36	,	,	,	_	35	P
37	25	0	CD	_	35	DEP
38	–	–	SYM	_	39	P
39	208	0	CD	_	37	NMOD
40	;	;	:	_	43	P
41	n	n	NN	_	43	SBJ
42	=	=	SYM	_	43	P
43	16	0	CD	_	62	DEP
44	versus	versus	CC	_	43	COORD
45	median	median	NN	_	60	DEP
46	,	,	,	_	45	P
47	5	0	CD	_	48	NMOD
48	mg	mg	NN	_	45	DEP
49	/	/	SYM	_	50	P
50	l	l	NN	_	48	NMOD
51	;	;	:	_	60	P
52	range	range	NN	_	60	DEP
53	,	,	,	_	52	P
54	4	0	CD	_	52	DEP
55	–	–	SYM	_	56	P
56	9	0	CD	_	54	NMOD
57	;	;	:	_	60	P
58	n	n	NN	_	60	SBJ
59	=	=	SYM	_	60	P
60	10	0	CD	_	44	CONJ
61	,	,	,	_	60	P
62	respectively	respectively	RB	_	66	ADV
63	;	;	:	_	66	P
64	p	p	NN	_	66	SBJ
65	<	<	SYM	_	66	P
66	0.0001	0	CD	_	7	PRN
67	)	)	-RRB-	_	66	P
68	.	.	.	_	7	P

1	The	the	DT	_	5	NMOD
2	C57BL	c0bl	NN	_	5	NMOD
3	/	/	HYPH	_	2	P
4	6	0	CD	_	2	NMOD
5	strain	strain	NN	_	6	SBJ
6	has	have	VBZ	_	0	ROOT
7	previously	previously	RB	_	6	TMP
8	been	be	VBN	_	6	VC
9	reported	report	VBN	_	8	VC
10	to	to	TO	_	9	OPRD
11	be	be	VB	_	10	IM
12	one	one	CD	_	11	PRD
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	16	NMOD
15	murine	murine	JJ	_	16	NMOD
16	strains	strain	NNS	_	13	PMOD
17	defined	define	VBN	_	16	NMOD
18	as	as	IN	_	17	ADV
19	low	low	JJ	_	21	NMOD
20	Apcs	apc	NN	_	21	NMOD
21	producers	producer	NNS	_	18	PMOD
22	(	(	-LRB-	_	23	P
23	Pepys	pepys	NNP	_	9	CIT
24	et	et	FW	_	23	DEP
25	al.	al.	FW	_	23	DEP
26	1979	0	CD	_	23	DEP
27	;	;	:	_	23	P
28	Baltz	baltz	NNP	_	23	DEP
29	et	et	FW	_	23	DEP
30	al.	al.	FW	_	23	DEP
31	1980	0	CD	_	23	DEP
32	)	)	-RRB-	_	23	P
33	.	.	.	_	6	P

1	In	in	IN	_	15	ADV
2	addition	addition	NN	_	1	PMOD
3	,	,	,	_	15	P
4	sequence	sequence	NN	_	5	NMOD
5	analysis	analysis	NN	_	15	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	11	NMOD
8	entire	entire	JJ	_	11	NMOD
9	Apcs	apc	NN	_	11	NMOD
10	coding	code	VBG	_	11	NMOD
11	region	region	NN	_	6	PMOD
12	in	in	IN	_	5	LOC
13	both	both	DT	_	14	NMOD
14	strains	strain	NNS	_	12	PMOD
15	failed	fail	VBD	_	0	ROOT
16	to	to	TO	_	15	OPRD
17	identify	identify	VB	_	16	IM
18	any	any	DT	_	21	NMOD
19	coding	code	VBG	_	20	NMOD
20	sequence	sequence	NN	_	21	NMOD
21	polymorphisms	polymorphism	NNS	_	17	OBJ
22	in	in	IN	_	17	LOC
23	the	the	DT	_	25	NMOD
24	Apcs	apc	NN	_	25	NMOD
25	gene	gene	NN	_	22	PMOD
26	(	(	-LRB-	_	29	P
27	data	datum	NNS	_	29	SBJ
28	not	not	RB	_	29	ADV
29	shown	show	VBN	_	17	PRN
30	)	)	-RRB-	_	29	P
31	,	,	,	_	17	P
32	indicating	indicate	VBG	_	17	ADV
33	that	that	IN	_	32	OBJ
34	a	a	DT	_	36	NMOD
35	structural	structural	JJ	_	36	NMOD
36	variant	variant	NN	_	40	SBJ
37	of	of	IN	_	36	NMOD
38	the	the	DT	_	39	NMOD
39	protein	protein	NN	_	37	PMOD
40	is	be	VBZ	_	33	SUB
41	unlikely	unlikely	JJ	_	40	PRD
42	to	to	TO	_	41	AMOD
43	be	be	VB	_	42	IM
44	the	the	DT	_	45	NMOD
45	explanation	explanation	NN	_	43	PRD
46	for	for	IN	_	45	NMOD
47	our	our	PRP$	_	48	NMOD
48	findings	finding	NNS	_	46	PMOD
49	.	.	.	_	15	P

1	This	this	DT	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	consistent	consistent	JJ	_	2	PRD
4	with	with	IN	_	3	AMOD
5	a	a	DT	_	7	NMOD
6	previous	previous	JJ	_	7	NMOD
7	report	report	NN	_	4	PMOD
8	by	by	IN	_	7	NMOD
9	Drake	drake	NNP	_	8	PMOD
10	et	et	FW	_	11	AMOD
11	al.	al.	FW	_	9	NMOD
12	(	(	-LRB-	_	9	P
13	1996	0	CD	_	9	TMP
14	)	)	-RRB-	_	9	P
15	that	that	WDT	_	16	SBJ
16	showed	show	VBD	_	7	NMOD
17	no	no	DT	_	21	NMOD
18	Apcs	apc	NN	_	20	NMOD
19	coding	code	VBG	_	20	NMOD
20	sequence	sequence	NN	_	21	NMOD
21	differences	difference	NNS	_	16	OBJ
22	amongst	amongst	IN	_	16	ADV
23	several	several	JJ	_	28	NMOD
24	autoimmune	autoimmune	JJ	_	28	NMOD
25	and	and	CC	_	24	COORD
26	nonautoimmune	nonautoimmune	JJ	_	25	CONJ
27	murine	murine	JJ	_	28	NMOD
28	strains	strain	NNS	_	22	PMOD
29	.	.	.	_	2	P

1	In	in	IN	_	18	ADV
2	addition	addition	NN	_	1	PMOD
3	to	to	IN	_	2	NMOD
4	the	the	DT	_	8	NMOD
5	129	0	CD	_	7	AMOD
6	-	-	HYPH	_	5	P
7	derived	derive	VBN	_	8	NMOD
8	segments	segment	NNS	_	3	PMOD
9	,	,	,	_	18	P
10	in	in	IN	_	18	LOC
11	both	both	DT	_	12	NMOD
12	cohorts	cohort	NNS	_	10	PMOD
13	the	the	DT	_	17	NMOD
14	C57BL	c0bl	NN	_	17	NMOD
15	/	/	HYPH	_	14	P
16	6	0	CD	_	14	NMOD
17	strain	strain	NN	_	18	SBJ
18	contributed	contribute	VBD	_	0	ROOT
19	to	to	IN	_	18	ADV
20	the	the	DT	_	22	NMOD
21	autoimmune	autoimmune	JJ	_	22	NMOD
22	traits	trait	NNS	_	19	PMOD
23	with	with	IN	_	18	ADV
24	one	one	CD	_	27	NMOD
25	major	major	JJ	_	27	NMOD
26	susceptibility	susceptibility	NN	_	27	NMOD
27	locus	locus	NN	_	23	PMOD
28	on	on	IN	_	27	LOC
29	Chromosome	chromosome	NN	_	28	PMOD
30	3	0	CD	_	29	NMOD
31	.	.	.	_	18	P

1	A	a	DT	_	3	NMOD
2	genomic	genomic	JJ	_	3	NMOD
3	region	region	NN	_	19	SBJ
4	between	between	IN	_	3	NMOD
5	D3Mit40	d0mit0	NN	_	4	PMOD
6	and	and	CC	_	5	COORD
7	D3Mit13	d0mit0	NN	_	6	CONJ
8	,	,	,	_	3	P
9	with	with	IN	_	3	NMOD
10	an	an	DT	_	12	NMOD
11	estimated	estimate	VBN	_	12	NMOD
12	peak	peak	NN	_	9	PMOD
13	at	at	IN	_	12	NMOD
14	position	position	NN	_	17	NMOD
15	approximately	approximately	RB	_	16	QMOD
16	51	0	CD	_	17	NMOD
17	cM	cm	NNS	_	13	PMOD
18	,	,	,	_	19	P
19	showed	show	VBD	_	0	ROOT
20	a	a	DT	_	22	NMOD
21	significant	significant	JJ	_	22	NMOD
22	linkage	linkage	NN	_	19	OBJ
23	to	to	IN	_	22	NMOD
24	ANA	ana	NN	_	25	NMOD
25	production	production	NN	_	23	PMOD
26	and	and	CC	_	22	COORD
27	weaker	weak	JJR	_	28	NMOD
28	linkages	linkage	NNS	_	26	CONJ
29	to	to	IN	_	28	NMOD
30	anti-ssDNA	anti-ssdna	JJ	_	33	NMOD
31	and	and	CC	_	30	COORD
32	anti-chromatin	anti-chromatin	JJ	_	31	CONJ
33	production	production	NN	_	29	PMOD
34	(	(	-LRB-	_	35	P
35	see	see	VB	_	22	PRN
36	Table	table	NN	_	39	NMOD
37	3	0	CD	_	36	NMOD
38	;	;	:	_	39	P
39	Figure	figure	NN	_	35	OBJ
40	7	0	CD	_	39	NMOD
41	)	)	-RRB-	_	35	P
42	.	.	.	_	19	P

1	The	the	DT	_	3	NMOD
2	high	high	JJ	_	3	NMOD
3	frequency	frequency	NN	_	29	SBJ
4	of	of	IN	_	3	NMOD
5	autoimmune	autoimmune	JJ	_	6	NMOD
6	phenotype	phenotype	NN	_	4	PMOD
7	in	in	IN	_	3	LOC
8	the	the	DT	_	18	NMOD
9	(	(	-LRB-	_	18	P
10	129	0	CD	_	12	NMOD
11	×	×	SYM	_	12	P
12	C57BL	c0bl	NN	_	18	NMOD
13	/	/	HYPH	_	12	P
14	6	0	CD	_	12	NMOD
15	)	)	-RRB-	_	12	P
16	hybrid	hybrid	JJ	_	12	NMOD
17	genetic	genetic	JJ	_	18	NMOD
18	background	background	NN	_	7	PMOD
19	and	and	CC	_	3	COORD
20	its	its	PRP$	_	21	NMOD
21	absence	absence	NN	_	19	CONJ
22	in	in	IN	_	21	LOC
23	either	either	DT	_	22	PMOD
24	of	of	IN	_	23	NMOD
25	the	the	DT	_	28	NMOD
26	inbred	inbred	JJ	_	28	NMOD
27	parental	parental	JJ	_	28	NMOD
28	strains	strain	NNS	_	24	PMOD
29	imply	imply	VBP	_	0	ROOT
30	that	that	IN	_	29	OBJ
31	there	there	EX	_	32	SBJ
32	are	be	VBP	_	30	SUB
33	essential	essential	JJ	_	34	NMOD
34	interactions	interaction	NNS	_	32	PRD
35	between	between	IN	_	34	NMOD
36	129	0	CD	_	43	AMOD
37	-	-	HYPH	_	36	P
38	and	and	CC	_	36	COORD
39	C57BL	c0bl	NN	_	38	CONJ
40	/	/	HYPH	_	39	P
41	6	0	CD	_	39	NMOD
42	-	-	HYPH	_	39	P
43	derived	derive	VBN	_	44	NMOD
44	alleles	allele	NNS	_	35	PMOD
45	for	for	IN	_	32	PRP
46	the	the	DT	_	47	NMOD
47	expression	expression	NN	_	45	PMOD
48	of	of	IN	_	47	NMOD
49	autoimmunity	autoimmunity	NN	_	48	PMOD
50	.	.	.	_	29	P

1	We	we	PRP	_	2	SBJ
2	investigated	investigate	VBD	_	0	ROOT
3	further	far	RB	_	2	ADV
4	the	the	DT	_	5	NMOD
5	effects	effect	NNS	_	2	OBJ
6	of	of	IN	_	5	NMOD
7	genes	gene	NNS	_	6	PMOD
8	from	from	IN	_	7	NMOD
9	the	the	DT	_	13	NMOD
10	C57BL	c0bl	NN	_	13	NMOD
11	/	/	HYPH	_	10	P
12	6	0	CD	_	10	NMOD
13	background	background	NN	_	8	PMOD
14	by	by	IN	_	2	MNR
15	repeating	repeat	VBG	_	14	PMOD
16	the	the	DT	_	18	NMOD
17	linkage	linkage	NN	_	18	NMOD
18	analysis	analysis	NN	_	15	OBJ
19	in	in	IN	_	15	LOC
20	(	(	-LRB-	_	28	P
21	129	0	CD	_	23	NMOD
22	×	×	SYM	_	23	P
23	C57BL	c0bl	NN	_	28	NMOD
24	/	/	HYPH	_	23	P
25	6	0	CD	_	23	NMOD
26	)	)	-RRB-	_	28	P
27	F2	f0	NN	_	28	NMOD
28	mice	mouse	NNS	_	19	PMOD
29	,	,	,	_	15	P
30	whilst	whilst	IN	_	15	ADV
31	controlling	control	VBG	_	30	SUB
32	for	for	IN	_	31	ADV
33	the	the	DT	_	37	NMOD
34	very	very	RB	_	35	AMOD
35	strong	strong	JJ	_	37	NMOD
36	129	0	CD	_	37	NMOD
37	effect	effect	NN	_	32	PMOD
38	on	on	IN	_	37	NMOD
39	distal	distal	JJ	_	40	NMOD
40	Chromosome	chromosome	NN	_	38	PMOD
41	1	0	CD	_	40	NMOD
42	,	,	,	_	31	P
43	as	as	IN	_	31	ADV
44	previously	previously	RB	_	45	ADV
45	described	describe	VBN	_	43	SUB
46	(	(	-LRB-	_	47	P
47	Zeng	zeng	NNP	_	45	CIT
48	1994	0	CD	_	47	DEP
49	)	)	-RRB-	_	47	P
50	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	results	result	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	5	NMOD
5	analysis	analysis	NN	_	3	PMOD
6	showed	show	VBD	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	the	the	DT	_	10	NMOD
9	statistical	statistical	JJ	_	10	NMOD
10	support	support	NN	_	25	SBJ
11	for	for	IN	_	10	NMOD
12	the	the	DT	_	13	NMOD
13	linkage	linkage	NN	_	11	PMOD
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	19	NMOD
16	C57BL	c0bl	NN	_	19	NMOD
17	/	/	HYPH	_	16	P
18	6	0	CD	_	16	NMOD
19	locus	locus	NN	_	14	PMOD
20	on	on	IN	_	13	NMOD
21	Chromosome	chromosome	NN	_	20	PMOD
22	3	0	CD	_	21	NMOD
23	for	for	IN	_	13	NMOD
24	ANA	ana	NN	_	23	PMOD
25	increased	increase	VBD	_	7	SUB
26	from	from	IN	_	25	ADV
27	logarithm	logarithm	NN	_	31	NMOD
28	of	of	IN	_	27	NMOD
29	odds	odds	NNS	_	28	PMOD
30	(	(	-LRB-	_	31	P
31	LOD	lod	NN	_	26	PMOD
32	)	)	-RRB-	_	31	P
33	5.4	0	CD	_	31	NMOD
34	to	to	IN	_	26	PMOD
35	LOD	lod	NN	_	34	PMOD
36	6.4	0	CD	_	35	NMOD
37	.	.	.	_	6	P

1	In	in	IN	_	15	ADV
2	contrast	contrast	NN	_	1	PMOD
3	to	to	IN	_	2	NMOD
4	these	these	DT	_	6	NMOD
5	strong	strong	JJ	_	6	NMOD
6	associations	association	NNS	_	3	PMOD
7	with	with	IN	_	6	NMOD
8	disease	disease	NN	_	10	NMOD
9	serological	serological	JJ	_	10	NMOD
10	markers	marker	NNS	_	7	PMOD
11	,	,	,	_	15	P
12	the	the	DT	_	14	NMOD
13	QTL	qtl	NN	_	14	NMOD
14	analysis	analysis	NN	_	15	SBJ
15	identified	identify	VBD	_	0	ROOT
16	only	only	RB	_	19	NMOD
17	two	two	CD	_	19	NMOD
18	potential	potential	JJ	_	19	NMOD
19	linkages	linkage	NNS	_	23	NMOD
20	to	to	IN	_	19	NMOD
21	glomerulonephritis	glomerulonephritis	NN	_	20	PMOD
22	:	:	:	_	23	P
23	one	one	CD	_	15	OBJ
24	in	in	IN	_	23	LOC
25	the	the	DT	_	29	NMOD
26	wild	wild	JJ	_	28	NMOD
27	-	-	HYPH	_	26	P
28	type	type	NN	_	29	NMOD
29	mice	mouse	NNS	_	24	PMOD
30	on	on	IN	_	23	LOC
31	Chromosome	chromosome	NN	_	30	PMOD
32	7	0	CD	_	31	NMOD
33	across	across	IN	_	23	NMOD
34	a	a	DT	_	37	NMOD
35	10	0	CD	_	36	NMOD
36	cM	cm	NN	_	37	NMOD
37	region	region	NN	_	33	PMOD
38	between	between	IN	_	37	NMOD
39	D7Mit246	d0mit0	NN	_	38	PMOD
40	(	(	-LRB-	_	42	P
41	15	0	CD	_	42	NMOD
42	cM	cm	NN	_	39	PRN
43	)	)	-RRB-	_	42	P
44	and	and	CC	_	39	COORD
45	D7Mit145	d0mit0	NN	_	44	CONJ
46	(	(	-LRB-	_	48	P
47	26.5	0	CD	_	48	NMOD
48	cM	cm	NN	_	45	PRN
49	)	)	-RRB-	_	48	P
50	of	of	IN	_	23	NMOD
51	129	0	CD	_	52	NMOD
52	origin	origin	NN	_	50	PMOD
53	(	(	-LRB-	_	59	P
54	LOD	lod	NN	_	59	DEP
55	2.86	0	CD	_	54	NMOD
56	,	,	,	_	59	P
57	p	p	NN	_	59	SBJ
58	=	=	SYM	_	59	P
59	0.0013	0	CD	_	52	PRN
60	)	)	-RRB-	_	59	P
61	,	,	,	_	23	P
62	and	and	CC	_	23	COORD
63	one	one	CD	_	62	CONJ
64	on	on	IN	_	63	LOC
65	Chromosome	chromosome	NN	_	64	PMOD
66	17	0	CD	_	65	NMOD
67	between	between	IN	_	63	NMOD
68	D17Mit100	d0mit0	NN	_	67	PMOD
69	(	(	-LRB-	_	71	P
70	11.7	0	CD	_	71	NMOD
71	cM	cm	NN	_	68	PRN
72	)	)	-RRB-	_	71	P
73	and	and	CC	_	68	COORD
74	D17Mit216	d0mit0	NN	_	73	CONJ
75	(	(	-LRB-	_	77	P
76	29.4	0	CD	_	77	NMOD
77	cM	cm	NN	_	74	PRN
78	)	)	-RRB-	_	77	P
79	from	from	IN	_	63	NMOD
80	the	the	DT	_	84	NMOD
81	C57BL	c0bl	NN	_	84	NMOD
82	/	/	HYPH	_	81	P
83	6	0	CD	_	81	NMOD
84	strain	strain	NN	_	79	PMOD
85	(	(	-LRB-	_	111	P
86	LOD	lod	NN	_	111	DEP
87	1.3	0	CD	_	86	NMOD
88	,	,	,	_	86	P
89	p	p	NN	_	91	SBJ
90	=	=	SYM	_	91	P
91	0.049	0	CD	_	86	DEP
92	and	and	CC	_	86	COORD
93	LOD	lod	NN	_	92	CONJ
94	1.67	0	CD	_	93	NMOD
95	,	,	,	_	93	P
96	p	p	NN	_	98	SBJ
97	=	=	SYM	_	98	P
98	0.021	0	CD	_	93	DEP
99	in	in	IN	_	111	LOC
100	the	the	DT	_	109	NMOD
101	wild	wild	JJ	_	103	NMOD
102	-	-	HYPH	_	101	P
103	type	type	NN	_	109	NMOD
104	and	and	CC	_	103	COORD
105	Apcs	apc	NN	_	104	CONJ
106	−	−	SYM	_	105	P
107	/	/	HYPH	_	105	P
108	−	−	SYM	_	105	P
109	mice	mouse	NNS	_	99	PMOD
110	,	,	,	_	111	P
111	respectively	respectively	RB	_	63	PRN
112	)	)	-RRB-	_	111	P
113	.	.	.	_	15	P

1	Histological	histological	JJ	_	2	NMOD
2	evidence	evidence	NN	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	glomerulonephritis	glomerulonephritis	NN	_	3	PMOD
5	was	be	VBD	_	0	ROOT
6	only	only	RB	_	5	ADV
7	found	find	VBN	_	5	VC
8	in	in	IN	_	7	LOC
9	approximately	approximately	RB	_	10	QMOD
10	20	0	CD	_	11	NMOD
11	%	%	NN	_	8	PMOD
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	14	NMOD
14	mice	mouse	NNS	_	12	PMOD
15	in	in	IN	_	14	NMOD
16	each	each	DT	_	17	NMOD
17	cohort	cohort	NN	_	15	PMOD
18	,	,	,	_	7	P
19	which	which	WDT	_	20	SBJ
20	reduces	reduce	VBZ	_	7	ADV
21	the	the	DT	_	22	NMOD
22	power	power	NN	_	20	OBJ
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	26	NMOD
25	QTL	qtl	NN	_	26	NMOD
26	analysis	analysis	NN	_	23	PMOD
27	for	for	IN	_	20	ADV
28	this	this	DT	_	30	NMOD
29	disease	disease	NN	_	30	NMOD
30	trait	trait	NN	_	27	PMOD
31	.	.	.	_	5	P

1	Production	production	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	a	a	DT	_	12	NMOD
4	C57BL	c0bl	NN	_	8	NMOD
5	/	/	HYPH	_	4	P
6	6	0	CD	_	4	NMOD
7	.	.	HYPH	_	4	P
8	129	0	CD	_	12	NMOD
9	Chromosome	chromosome	NN	_	12	NMOD
10	1	0	CD	_	9	NMOD
11	Congenic	congenic	JJ	_	12	NMOD
12	Line	line	NN	_	2	PMOD
13	and	and	CC	_	1	COORD
14	Its	its	PRP$	_	16	NMOD
15	Phenotypic	phenotypic	JJ	_	16	NMOD
16	Analysis	analysis	NN	_	13	CONJ

1	We	we	PRP	_	2	SBJ
2	generated	generate	VBD	_	0	ROOT
3	a	a	DT	_	8	NMOD
4	C57BL	c0bl	NN	_	8	NMOD
5	/	/	HYPH	_	4	P
6	6	0	CD	_	4	NMOD
7	congenic	congenic	JJ	_	8	NMOD
8	line	line	NN	_	2	OBJ
9	carrying	carry	VBG	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	telomeric	telomeric	JJ	_	12	NMOD
12	region	region	NN	_	9	OBJ
13	of	of	IN	_	12	NMOD
14	Chromosome	chromosome	NN	_	13	PMOD
15	1	0	CD	_	14	NMOD
16	from	from	IN	_	9	ADV
17	the	the	DT	_	20	NMOD
18	129	0	CD	_	20	NMOD
19	mouse	mouse	NN	_	20	NMOD
20	strain	strain	NN	_	16	PMOD
21	,	,	,	_	2	P
22	in	in	IN	_	2	PRP
23	order	order	NN	_	22	PMOD
24	to	to	TO	_	23	NMOD
25	dissect	dissect	VB	_	24	IM
26	the	the	DT	_	30	NMOD
27	complex	complex	JJ	_	30	NMOD
28	polygenic	polygenic	JJ	_	30	NMOD
29	disease	disease	NN	_	30	NMOD
30	phenotype	phenotype	NN	_	25	OBJ
31	of	of	IN	_	30	NMOD
32	the	the	DT	_	44	NMOD
33	(	(	-LRB-	_	44	P
34	C57BL	c0bl	NN	_	40	NMOD
35	/	/	HYPH	_	34	P
36	6	0	CD	_	34	NMOD
37	×	×	SYM	_	40	P
38	129	0	NN	_	40	NMOD
39	/	/	HYPH	_	38	P
40	Sv	sv	NN	_	44	NMOD
41	)	)	-RRB-	_	44	P
42	F2	f0	NN	_	44	NMOD
43	hybrid	hybrid	NN	_	44	NMOD
44	strain	strain	NN	_	31	PMOD
45	into	into	IN	_	25	ADV
46	its	its	PRP$	_	49	NMOD
47	individual	individual	JJ	_	49	NMOD
48	genetic	genetic	JJ	_	49	NMOD
49	components	component	NNS	_	45	PMOD
50	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	129	0	CD	_	3	NMOD
3	interval	interval	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	backcrossed	backcross	VBN	_	4	VC
6	seven	seven	CD	_	7	NMOD
7	times	time	NNS	_	5	TMP
8	onto	onto	IN	_	5	ADV
9	C57BL	c0bl	NN	_	8	PMOD
10	/	/	HYPH	_	9	P
11	6	0	CD	_	9	NMOD
12	,	,	,	_	4	P
13	and	and	CC	_	4	COORD
14	at	at	IN	_	26	ADV
15	each	each	DT	_	16	NMOD
16	generation	generation	NN	_	14	PMOD
17	the	the	DT	_	18	NMOD
18	presence	presence	NN	_	26	SBJ
19	or	or	CC	_	18	COORD
20	absence	absence	NN	_	19	CONJ
21	of	of	IN	_	18	NMOD
22	the	the	DT	_	25	NMOD
23	Chromosome	chromosome	NN	_	25	NMOD
24	1	0	CD	_	23	NMOD
25	interval	interval	NN	_	21	PMOD
26	was	be	VBD	_	13	CONJ
27	determined	determine	VBN	_	26	VC
28	with	with	IN	_	27	MNR
29	several	several	JJ	_	31	NMOD
30	microsatellite	microsatellite	NN	_	31	NMOD
31	markers	marker	NNS	_	28	PMOD
32	.	.	.	_	4	P

1	Each	each	DT	_	3	NMOD
2	backcrossed	backcross	VBN	_	3	NMOD
3	generation	generation	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	screened	screen	VBN	_	4	VC
6	with	with	IN	_	5	MNR
7	more	more	JJR	_	10	NMOD
8	than	than	IN	_	7	QMOD
9	three	three	CD	_	7	QMOD
10	markers	marker	NNS	_	6	PMOD
11	per	per	IN	_	10	NMOD
12	chromosome	chromosome	NN	_	11	PMOD
13	to	to	TO	_	5	PRP
14	facilitate	facilitate	VB	_	13	IM
15	the	the	DT	_	16	NMOD
16	removal	removal	NN	_	14	OBJ
17	of	of	IN	_	16	NMOD
18	unselected	unselected	JJ	_	21	NMOD
19	129	0	CD	_	21	NMOD
20	genomic	genomic	JJ	_	21	NMOD
21	regions	region	NNS	_	17	PMOD
22	.	.	.	_	4	P

1	At	at	IN	_	19	ADV
2	the	the	DT	_	3	NMOD
3	end	end	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	backcrossing	backcrossing	NN	_	4	PMOD
7	,	,	,	_	19	P
8	the	the	DT	_	14	NMOD
9	129	0	CD	_	11	AMOD
10	-	-	HYPH	_	9	P
11	derived	derive	VBN	_	14	NMOD
12	Chromosome	chromosome	NN	_	14	NMOD
13	1	0	CD	_	12	NMOD
14	interval	interval	NN	_	19	SBJ
15	in	in	IN	_	14	LOC
16	the	the	DT	_	18	NMOD
17	congenic	congenic	JJ	_	18	NMOD
18	mice	mouse	NNS	_	15	PMOD
19	extended	extend	VBN	_	0	ROOT
20	from	from	IN	_	19	ADV
21	microsatellite	microsatellite	NN	_	22	NMOD
22	marker	marker	NN	_	23	NMOD
23	D1Mit105	d0mit0	NN	_	20	PMOD
24	to	to	IN	_	20	PMOD
25	D1Mit223	d0mit0	NN	_	24	PMOD
26	(	(	-LRB-	_	30	P
27	80	0	CD	_	30	NMOD
28	–	–	SYM	_	27	P
29	106	0	CD	_	27	QMOD
30	cM	cm	NNS	_	25	PRN
31	)	)	-RRB-	_	30	P
32	,	,	,	_	19	P
33	which	which	WDT	_	34	SBJ
34	encompasses	encompass	VBZ	_	19	ADV
35	the	the	DT	_	39	NMOD
36	most	most	RBS	_	37	AMOD
37	important	important	JJ	_	39	NMOD
38	129	0	CD	_	39	NMOD
39	interval	interval	NN	_	34	OBJ
40	identified	identify	VBN	_	39	NMOD
41	by	by	IN	_	40	LGS
42	the	the	DT	_	44	NMOD
43	linkage	linkage	NN	_	44	NMOD
44	studies	study	NNS	_	41	PMOD
45	in	in	IN	_	40	LOC
46	the	the	DT	_	57	NMOD
47	(	(	-LRB-	_	57	P
48	C57BL	c0bl	NN	_	54	NMOD
49	/	/	HYPH	_	48	P
50	6	0	CD	_	48	NMOD
51	×	×	SYM	_	54	P
52	129	0	NN	_	54	NMOD
53	/	/	HYPH	_	52	P
54	Sv	sv	NN	_	57	NMOD
55	)	)	-RRB-	_	57	P
56	F2	f0	NN	_	57	NMOD
57	mice	mouse	NNS	_	45	PMOD
58	.	.	.	_	19	P

1	Female	female	JJ	_	5	NMOD
2	Chromosome	chromosome	NN	_	5	NMOD
3	1	0	CD	_	2	NMOD
4	congenic	congenic	JJ	_	5	NMOD
5	mice	mouse	NNS	_	53	SBJ
6	(	(	-LRB-	_	7	P
7	C57BL	c0bl	NN	_	5	PRN
8	/	/	HYPH	_	7	P
9	6	0	CD	_	7	NMOD
10	.	.	HYPH	_	9	P
11	129	0	CD	_	7	NMOD
12	[	[	-LRB-	_	13	P
13	D1Mit105	d0mit0	NN	_	7	PRN
14	–	–	SYM	_	15	P
15	223	0	CD	_	13	NMOD
16	]	]	-RRB-	_	13	P
17	)	)	-RRB-	_	7	P
18	,	,	,	_	5	P
19	together	together	RB	_	20	PMOD
20	with	with	IN	_	5	NMOD
21	sex	sex	NN	_	23	AMOD
22	-	-	HYPH	_	21	P
23	matched	match	VBN	_	28	NMOD
24	Apcs	apc	NN	_	28	NMOD
25	−	−	SYM	_	24	P
26	/	/	HYPH	_	24	P
27	−	−	SYM	_	24	P
28	mice	mouse	NNS	_	42	NMOD
29	backcrossed	backcross	VBN	_	28	NMOD
30	onto	onto	IN	_	29	ADV
31	C57BL	c0bl	NN	_	30	PMOD
32	/	/	HYPH	_	31	P
33	6	0	CD	_	31	NMOD
34	for	for	IN	_	29	TMP
35	ten	ten	CD	_	36	NMOD
36	generations	generation	NNS	_	34	PMOD
37	(	(	-LRB-	_	42	P
38	C57BL	c0bl	NN	_	42	NMOD
39	/	/	HYPH	_	38	P
40	6	0	CD	_	38	NMOD
41	.	.	HYPH	_	38	P
42	Apcs	apc	NN	_	20	PMOD
43	−	−	SYM	_	42	P
44	/	/	HYPH	_	42	P
45	−	−	SYM	_	42	P
46	)	)	-RRB-	_	42	P
47	and	and	CC	_	42	COORD
48	C57BL	c0bl	NN	_	51	NMOD
49	/	/	HYPH	_	48	P
50	6	0	CD	_	48	NMOD
51	controls	control	NNS	_	47	CONJ
52	,	,	,	_	53	P
53	were	be	VBD	_	0	ROOT
54	monitored	monitor	VBN	_	53	VC
55	for	for	IN	_	54	PRP
56	the	the	DT	_	57	NMOD
57	presence	presence	NN	_	55	PMOD
58	of	of	IN	_	57	NMOD
59	lupus	lupus	NN	_	58	PMOD
60	.	.	.	_	53	P

1	In	in	IN	_	20	LOC
2	the	the	DT	_	11	NMOD
3	C57BL	c0bl	NN	_	7	NMOD
4	/	/	HYPH	_	3	P
5	6	0	CD	_	3	NMOD
6	.	.	HYPH	_	3	P
7	Apcs	apc	NN	_	11	NMOD
8	−	−	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	−	−	SYM	_	7	P
11	mice	mouse	NNS	_	1	PMOD
12	,	,	,	_	20	P
13	the	the	DT	_	15	NMOD
14	129	0	CD	_	15	NMOD
15	genome	genome	NN	_	20	SBJ
16	around	around	IN	_	15	LOC
17	the	the	DT	_	19	NMOD
18	Apcs	apc	NN	_	19	NMOD
19	locus	locus	NN	_	16	PMOD
20	was	be	VBD	_	0	ROOT
21	mapped	map	VBN	_	20	VC
22	as	as	IN	_	21	ADV
23	a	a	DT	_	24	NMOD
24	stretch	stretch	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	approximately	approximately	RB	_	27	QMOD
27	17	0	CD	_	28	NMOD
28	cM	cm	NN	_	25	PMOD
29	,	,	,	_	24	P
30	positioned	position	VBN	_	24	NMOD
31	from	from	IN	_	30	ADV
32	87.9	0	CD	_	33	NMOD
33	cM	cm	NN	_	31	PMOD
34	(	(	-LRB-	_	35	P
35	D1Mit15	d0mit0	NN	_	33	PRN
36	)	)	-RRB-	_	35	P
37	to	to	IN	_	31	PMOD
38	105	0	CD	_	39	NMOD
39	cM	cm	NN	_	37	PMOD
40	(	(	-LRB-	_	41	P
41	D1Mit17	d0mit0	NN	_	39	PRN
42	)	)	-RRB-	_	41	P
43	.	.	.	_	20	P

1	Thus	thus	RB	_	6	ADV
2	,	,	,	_	6	P
3	the	the	DT	_	5	NMOD
4	congenic	congenic	JJ	_	5	NMOD
5	line	line	NN	_	6	SBJ
6	carried	carry	VBD	_	0	ROOT
7	a	a	DT	_	10	NMOD
8	similar	similar	JJ	_	10	NMOD
9	129	0	CD	_	10	NMOD
10	region	region	NN	_	6	OBJ
11	(	(	-LRB-	_	15	P
12	80	0	CD	_	15	NMOD
13	–	–	SYM	_	12	P
14	106	0	CD	_	12	QMOD
15	cM	cm	NN	_	10	PRN
16	)	)	-RRB-	_	15	P
17	to	to	IN	_	10	NMOD
18	the	the	DT	_	19	NMOD
19	one	one	CD	_	17	PMOD
20	present	present	JJ	_	19	NMOD
21	in	in	IN	_	20	LOC
22	the	the	DT	_	31	NMOD
23	C57BL	c0bl	NN	_	27	NMOD
24	/	/	HYPH	_	23	P
25	6	0	CD	_	23	NMOD
26	.	.	HYPH	_	23	P
27	Apcs	apc	NN	_	31	NMOD
28	−	−	SYM	_	27	P
29	/	/	HYPH	_	27	P
30	−	−	SYM	_	27	P
31	mice	mouse	NNS	_	21	PMOD
32	(	(	-LRB-	_	36	P
33	87.9	0	CD	_	36	NMOD
34	–	–	SYM	_	33	P
35	105	0	CD	_	33	QMOD
36	cM	cm	NN	_	31	PRN
37	)	)	-RRB-	_	36	P
38	.	.	.	_	6	P

1	At	at	IN	_	9	TMP
2	1	0	CD	_	3	NMOD
3	y	y	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	age	age	NN	_	4	PMOD
6	,	,	,	_	9	P
7	all	all	DT	_	8	NMOD
8	animals	animal	NNS	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	sacrificed	sacrifice	VBN	_	9	VC
11	,	,	,	_	9	P
12	the	the	DT	_	13	NMOD
13	auto-Abs	auto-abs	NNS	_	14	SBJ
14	assessed	assess	VBN	_	9	GAP
15	,	,	,	_	14	P
16	and	and	CC	_	14	COORD
17	the	the	DT	_	19	NMOD
18	renal	renal	JJ	_	19	NMOD
19	histology	histology	NN	_	20	SBJ
20	examined	examine	VBN	_	16	GAP
21	.	.	.	_	9	P

1	The	the	DT	_	2	NMOD
2	results	result	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	5	NMOD
5	analysis	analysis	NN	_	3	PMOD
6	are	be	VBP	_	0	ROOT
7	shown	show	VBN	_	6	VC
8	in	in	IN	_	7	ADV
9	Figure	figure	NN	_	8	PMOD
10	8	0	CD	_	9	NMOD
11	.	.	.	_	6	P

1	As	as	IN	_	15	ADV
2	previously	previously	RB	_	3	TMP
3	reported	report	VBN	_	1	SUB
4	(	(	-LRB-	_	5	P
5	Bickerstaff	bickerstaff	NNP	_	15	CIT
6	et	et	FW	_	5	DEP
7	al.	al.	FW	_	5	DEP
8	1999	0	CD	_	5	DEP
9	)	)	-RRB-	_	5	P
10	,	,	,	_	15	P
11	the	the	DT	_	12	NMOD
12	levels	level	NNS	_	15	SBJ
13	of	of	IN	_	12	NMOD
14	auto-Abs	auto-abs	NNS	_	13	PMOD
15	were	be	VBD	_	0	ROOT
16	markedly	markedly	RB	_	15	ADV
17	increased	increase	VBN	_	15	VC
18	in	in	IN	_	17	LOC
19	the	the	DT	_	24	NMOD
20	C57BL	c0bl	NN	_	24	NMOD
21	/	/	HYPH	_	20	P
22	6	0	CD	_	20	NMOD
23	.	.	HYPH	_	20	P
24	Apcs	apc	NN	_	18	PMOD
25	−	−	SYM	_	24	P
26	/	/	HYPH	_	24	P
27	−	−	SYM	_	24	P
28	compared	compare	VBN	_	17	ADV
29	to	to	IN	_	28	PMOD
30	the	the	DT	_	37	NMOD
31	wild	wild	JJ	_	33	NMOD
32	-	-	HYPH	_	31	P
33	type	type	NN	_	37	NMOD
34	C57BL	c0bl	NN	_	37	NMOD
35	/	/	HYPH	_	34	P
36	6	0	CD	_	34	NMOD
37	controls	control	NNS	_	29	PMOD
38	.	.	.	_	15	P

1	However	however	RB	_	16	ADV
2	,	,	,	_	16	P
3	the	the	DT	_	14	NMOD
4	C57BL	c0bl	NN	_	10	NMOD
5	/	/	HYPH	_	4	P
6	6	0	CD	_	4	NMOD
7	.	.	HYPH	_	4	P
8	129	0	CD	_	4	NMOD
9	(	(	-LRB-	_	10	P
10	D1Mit105	d0mit0	NN	_	14	NMOD
11	–	–	SYM	_	12	P
12	223	0	CD	_	10	NMOD
13	)	)	-RRB-	_	14	P
14	animals	animal	NNS	_	16	SBJ
15	also	also	RB	_	16	ADV
16	expressed	express	VBD	_	0	ROOT
17	high	high	JJ	_	18	NMOD
18	levels	level	NNS	_	16	OBJ
19	of	of	IN	_	18	NMOD
20	auto-Abs	auto-abs	NNS	_	19	PMOD
21	,	,	,	_	16	P
22	and	and	CC	_	16	COORD
23	these	these	DT	_	24	NMOD
24	titres	titre	NNS	_	25	SBJ
25	were	be	VBD	_	22	CONJ
26	not	not	RB	_	25	ADV
27	different	different	JJ	_	25	PRD
28	from	from	IN	_	27	AMOD
29	those	those	DT	_	28	PMOD
30	detected	detect	VBN	_	29	NMOD
31	in	in	IN	_	30	LOC
32	the	the	DT	_	35	NMOD
33	matched	match	VBN	_	35	NMOD
34	congenic	congenic	JJ	_	35	NMOD
35	mice	mouse	NNS	_	31	PMOD
36	containing	contain	VBG	_	35	NMOD
37	a	a	DT	_	39	NMOD
38	null	null	JJ	_	39	NMOD
39	mutation	mutation	NN	_	36	OBJ
40	of	of	IN	_	39	NMOD
41	the	the	DT	_	43	NMOD
42	Apcs	apc	NN	_	43	NMOD
43	gene	gene	NN	_	40	PMOD
44	.	.	.	_	16	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	4	SBJ
3	clearly	clearly	RB	_	4	ADV
4	demonstrated	demonstrate	VBD	_	0	ROOT
5	that	that	IN	_	4	OBJ
6	epistatic	epistatic	JJ	_	7	NMOD
7	interactions	interaction	NNS	_	19	SBJ
8	between	between	IN	_	7	NMOD
9	129	0	CD	_	10	NMOD
10	loci	locus	NNS	_	8	PMOD
11	on	on	IN	_	10	LOC
12	Chromosome	chromosome	NN	_	11	PMOD
13	1	0	CD	_	12	NMOD
14	and	and	CC	_	10	COORD
15	C57BL	c0bl	NN	_	18	NMOD
16	/	/	HYPH	_	15	P
17	6	0	CD	_	15	NMOD
18	genes	gene	NNS	_	14	CONJ
19	were	be	VBD	_	5	SUB
20	sufficient	sufficient	JJ	_	19	PRD
21	to	to	TO	_	20	AMOD
22	mediate	mediate	VB	_	21	IM
23	the	the	DT	_	24	NMOD
24	loss	loss	NN	_	22	OBJ
25	of	of	IN	_	24	NMOD
26	tolerance	tolerance	NN	_	25	PMOD
27	to	to	IN	_	26	NMOD
28	nuclear	nuclear	JJ	_	29	NMOD
29	autoantigens	autoantigens	NNS	_	27	PMOD
30	.	.	.	_	4	P

1	However	however	RB	_	16	ADV
2	,	,	,	_	16	P
3	in	in	IN	_	16	ADV
4	contrast	contrast	NN	_	3	PMOD
5	to	to	IN	_	4	NMOD
6	the	the	DT	_	8	NMOD
7	serological	serological	JJ	_	8	NMOD
8	data	datum	NNS	_	5	PMOD
9	,	,	,	_	16	P
10	the	the	DT	_	12	NMOD
11	histological	histological	JJ	_	12	NMOD
12	assessment	assessment	NN	_	16	SBJ
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	15	NMOD
15	kidneys	kidney	NNS	_	13	PMOD
16	showed	show	VBD	_	0	ROOT
17	evidence	evidence	NN	_	16	OBJ
18	of	of	IN	_	17	NMOD
19	markedly	markedly	RB	_	21	NMOD
20	increased	increase	VBN	_	21	NMOD
21	glomerulonephritis	glomerulonephritis	NN	_	18	PMOD
22	in	in	IN	_	17	LOC
23	the	the	DT	_	28	NMOD
24	C57BL	c0bl	NN	_	28	NMOD
25	/	/	HYPH	_	24	P
26	6	0	CD	_	24	NMOD
27	.	.	HYPH	_	24	P
28	Apcs	apc	NN	_	22	PMOD
29	−	−	SYM	_	28	P
30	/	/	HYPH	_	28	P
31	−	−	SYM	_	28	P
32	compared	compare	VBN	_	17	NMOD
33	to	to	IN	_	32	PMOD
34	both	both	CC	_	36	COORD
35	control	control	NN	_	36	NMOD
36	groups	group	NNS	_	33	PMOD
37	(	(	-LRB-	_	38	P
38	Figure	figure	NN	_	36	PRN
39	9	0	CD	_	38	NMOD
40	)	)	-RRB-	_	38	P
41	,	,	,	_	16	P
42	suggesting	suggest	VBG	_	16	ADV
43	that	that	IN	_	42	OBJ
44	the	the	DT	_	45	NMOD
45	lack	lack	NN	_	59	SBJ
46	of	of	IN	_	45	NMOD
47	Apcs	apc	NN	_	46	PMOD
48	,	,	,	_	59	P
49	when	when	WRB	_	50	TMP
50	combined	combine	VBN	_	59	TMP
51	with	with	IN	_	50	ADV
52	other	other	JJ	_	57	NMOD
53	C57BL	c0bl	NN	_	57	NMOD
54	/	/	HYPH	_	53	P
55	6	0	CD	_	53	NMOD
56	susceptibility	susceptibility	NN	_	57	NMOD
57	alleles	allele	NNS	_	51	PMOD
58	,	,	,	_	59	P
59	can	can	MD	_	43	SUB
60	induce	induce	VB	_	59	VC
61	the	the	DT	_	62	NMOD
62	development	development	NN	_	60	OBJ
63	of	of	IN	_	62	NMOD
64	severe	severe	JJ	_	66	NMOD
65	renal	renal	JJ	_	66	NMOD
66	damage	damage	NN	_	63	PMOD
67	.	.	.	_	16	P

1	Discussion	discussion	NN	_	0	ROOT

1	There	there	EX	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	accumulating	accumulate	VBG	_	4	NMOD
4	evidence	evidence	NN	_	2	PRD
5	that	that	IN	_	4	NMOD
6	background	background	NN	_	7	NMOD
7	genes	gene	NNS	_	8	SBJ
8	may	may	MD	_	5	SUB
9	influence	influence	VB	_	8	VC
10	the	the	DT	_	11	NMOD
11	expression	expression	NN	_	9	OBJ
12	of	of	IN	_	11	NMOD
13	autoimmunity	autoimmunity	NN	_	12	PMOD
14	in	in	IN	_	9	LOC
15	gene	gene	NN	_	17	AMOD
16	-	-	HYPH	_	15	P
17	targeted	target	VBN	_	18	NMOD
18	mice	mouse	NNS	_	14	PMOD
19	.	.	.	_	2	P

1	Here	here	RB	_	3	ADV
2	we	we	PRP	_	3	SBJ
3	report	report	VBP	_	0	ROOT
4	what	what	WP	_	5	SBJ
5	is	be	VBZ	_	3	OBJ
6	to	to	IN	_	5	ADV
7	our	our	PRP$	_	8	NMOD
8	knowledge	knowledge	NN	_	6	PMOD
9	the	the	DT	_	12	NMOD
10	first	$#ORD#$	JJ	_	12	NMOD
11	systematic	systematic	JJ	_	12	NMOD
12	study	study	NN	_	5	PRD
13	that	that	WDT	_	14	SBJ
14	has	have	VBZ	_	12	NMOD
15	examined	examine	VBN	_	14	VC
16	this	this	DT	_	15	OBJ
17	in	in	IN	_	15	LOC
18	the	the	DT	_	25	NMOD
19	129	0	CD	_	25	NMOD
20	and	and	CC	_	19	COORD
21	C57BL	c0bl	NN	_	20	CONJ
22	/	/	HYPH	_	21	P
23	6	0	CD	_	21	NMOD
24	mouse	mouse	NN	_	25	NMOD
25	strains	strain	NNS	_	17	PMOD
26	,	,	,	_	25	P
27	widely	widely	RB	_	28	ADV
28	used	use	VBN	_	25	NMOD
29	for	for	IN	_	28	PRP
30	gene	gene	NN	_	31	NMOD
31	targeting	targeting	NN	_	29	PMOD
32	.	.	.	_	3	P

1	Our	our	PRP$	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	demonstrate	demonstrate	VBP	_	0	ROOT
4	interacting	interact	VBG	_	5	NMOD
5	loci	locus	NNS	_	3	OBJ
6	between	between	IN	_	5	NMOD
7	129	0	CD	_	12	NMOD
8	and	and	CC	_	7	COORD
9	C57BL	c0bl	NN	_	8	CONJ
10	/	/	HYPH	_	9	P
11	6	0	CD	_	9	NMOD
12	mice	mouse	NNS	_	6	PMOD
13	that	that	WDT	_	14	SBJ
14	can	can	MD	_	5	NMOD
15	cause	cause	VB	_	14	VC
16	the	the	DT	_	17	NMOD
17	expression	expression	NN	_	15	OBJ
18	of	of	IN	_	17	NMOD
19	a	a	DT	_	22	NMOD
20	powerful	powerful	JJ	_	22	NMOD
21	autoimmune	autoimmune	JJ	_	22	NMOD
22	phenotype	phenotype	NN	_	18	PMOD
23	in	in	IN	_	15	LOC
24	these	these	DT	_	25	NMOD
25	animals	animal	NNS	_	23	PMOD
26	,	,	,	_	15	P
27	in	in	IN	_	15	ADV
28	the	the	DT	_	29	NMOD
29	absence	absence	NN	_	27	PMOD
30	of	of	IN	_	29	NMOD
31	any	any	DT	_	35	NMOD
32	gene	gene	NN	_	34	AMOD
33	-	-	HYPH	_	32	P
34	targeted	target	VBN	_	35	NMOD
35	mutations	mutation	NNS	_	30	PMOD
36	.	.	.	_	3	P

1	We	we	PRP	_	3	SBJ
2	also	also	RB	_	3	ADV
3	developed	develop	VBD	_	0	ROOT
4	a	a	DT	_	7	NMOD
5	congenic	congenic	JJ	_	7	NMOD
6	mouse	mouse	NN	_	7	NMOD
7	strain	strain	NN	_	3	OBJ
8	bearing	bear	VBG	_	7	NMOD
9	a	a	DT	_	10	NMOD
10	portion	portion	NN	_	8	OBJ
11	of	of	IN	_	10	NMOD
12	129	0	CD	_	13	NMOD
13	Chromosome	chromosome	NN	_	11	PMOD
14	1	0	CD	_	13	NMOD
15	on	on	IN	_	8	LOC
16	a	a	DT	_	20	NMOD
17	C57BL	c0bl	NN	_	20	NMOD
18	/	/	HYPH	_	17	P
19	6	0	CD	_	17	NMOD
20	background	background	NN	_	15	PMOD
21	and	and	CC	_	3	COORD
22	showed	show	VBD	_	21	CONJ
23	that	that	IN	_	22	OBJ
24	this	this	DT	_	29	NMOD
25	wild	wild	JJ	_	27	NMOD
26	-	-	HYPH	_	25	P
27	type	type	NN	_	29	NMOD
28	congenic	congenic	JJ	_	29	NMOD
29	line	line	NN	_	30	SBJ
30	expressed	express	VBD	_	23	SUB
31	striking	striking	JJ	_	33	NMOD
32	anti-nuclear	anti-nuclear	JJ	_	33	NMOD
33	autoimmunity	autoimmunity	NN	_	30	OBJ
34	.	.	.	_	3	P

1	By	by	IN	_	18	MNR
2	comparing	compare	VBG	_	1	PMOD
3	this	this	DT	_	7	NMOD
4	Chromosome	chromosome	NN	_	7	NMOD
5	1	0	CD	_	4	NMOD
6	congenic	congenic	JJ	_	7	NMOD
7	strain	strain	NN	_	2	OBJ
8	with	with	IN	_	2	ADV
9	matched	match	VBN	_	11	NMOD
10	congenic	congenic	JJ	_	11	NMOD
11	mice	mouse	NNS	_	8	PMOD
12	lacking	lack	VBG	_	11	NMOD
13	the	the	DT	_	15	NMOD
14	Apcs	apc	NN	_	15	NMOD
15	gene	gene	NN	_	12	OBJ
16	,	,	,	_	18	P
17	we	we	PRP	_	18	SBJ
18	demonstrated	demonstrate	VBD	_	0	ROOT
19	that	that	IN	_	18	OBJ
20	serum	serum	NN	_	23	NMOD
21	amyloid	amyloid	NN	_	23	NMOD
22	P	p	NN	_	23	NMOD
23	component	component	NN	_	24	NMOD
24	deficiency	deficiency	NN	_	25	SBJ
25	influences	influence	VBZ	_	19	SUB
26	the	the	DT	_	27	NMOD
27	severity	severity	NN	_	25	OBJ
28	of	of	IN	_	27	NMOD
29	glomerulonephritis	glomerulonephritis	NN	_	28	PMOD
30	,	,	,	_	25	P
31	but	but	CC	_	25	COORD
32	is	be	VBZ	_	31	CONJ
33	not	not	RB	_	32	ADV
34	the	the	DT	_	36	NMOD
35	prime	prime	JJ	_	36	NMOD
36	mover	mover	NN	_	32	PRD
37	in	in	IN	_	32	ADV
38	the	the	DT	_	39	NMOD
39	induction	induction	NN	_	37	PMOD
40	of	of	IN	_	39	NMOD
41	anti-nuclear	anti-nuclear	JJ	_	42	NMOD
42	autoimmunity	autoimmunity	NN	_	40	PMOD
43	,	,	,	_	32	P
44	contrary	contrary	JJ	_	32	ADV
45	to	to	IN	_	44	AMOD
46	our	our	PRP$	_	49	NMOD
47	own	own	JJ	_	49	NMOD
48	original	original	JJ	_	49	NMOD
49	interpretation	interpretation	NN	_	45	PMOD
50	of	of	IN	_	49	NMOD
51	our	our	PRP$	_	52	NMOD
52	data	datum	NNS	_	50	PMOD
53	(	(	-LRB-	_	54	P
54	Bickerstaff	bickerstaff	NNP	_	25	CIT
55	et	et	FW	_	54	DEP
56	al.	al.	FW	_	54	DEP
57	1999	0	CD	_	54	DEP
58	)	)	-RRB-	_	54	P
59	.	.	.	_	18	P

1	The	the	DT	_	3	NMOD
2	same	same	JJ	_	3	NMOD
3	consideration	consideration	NN	_	4	SBJ
4	applies	apply	VBZ	_	0	ROOT
5	to	to	IN	_	4	ADV
6	other	other	JJ	_	7	NMOD
7	genes	gene	NNS	_	5	PMOD
8	located	locate	VBN	_	7	NMOD
9	in	in	IN	_	8	LOC
10	the	the	DT	_	14	NMOD
11	same	same	JJ	_	14	NMOD
12	Chromosome	chromosome	NN	_	14	NMOD
13	1	0	CD	_	12	NMOD
14	region	region	NN	_	9	PMOD
15	that	that	WDT	_	16	SBJ
16	have	have	VBP	_	7	NMOD
17	been	be	VBN	_	16	VC
18	implicated	implicate	VBN	_	17	VC
19	in	in	IN	_	18	ADV
20	the	the	DT	_	21	NMOD
21	development	development	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	SLE	sle	NN	_	22	PMOD
24	when	when	WRB	_	25	TMP
25	inactivated	inactivate	VBN	_	18	TMP
26	by	by	IN	_	25	LGS
27	gene	gene	NN	_	26	PMOD
28	-	-	HYPH	_	27	P
29	targeting	target	VBG	_	27	NMOD
30	in	in	IN	_	25	LOC
31	129	0	CD	_	34	NMOD
32	embryonic	embryonic	JJ	_	34	NMOD
33	stem	stem	NN	_	34	NMOD
34	cells	cell	NNS	_	30	PMOD
35	and	and	CC	_	25	COORD
36	then	then	RB	_	37	TMP
37	backcrossed	backcross	VBD	_	35	CONJ
38	onto	onto	IN	_	37	ADV
39	a	a	DT	_	42	NMOD
40	pure	pure	JJ	_	42	NMOD
41	genetic	genetic	JJ	_	42	NMOD
42	background	background	NN	_	38	PMOD
43	(	(	-LRB-	_	44	P
44	Bolland	bolland	NNP	_	25	CIT
45	and	and	CC	_	44	COORD
46	Ravetch	ravetch	NNP	_	45	CONJ
47	2000	0	CD	_	44	DEP
48	;	;	:	_	44	P
49	Miwa	miwa	NNP	_	44	DEP
50	et	et	FW	_	44	DEP
51	al.	al.	FW	_	44	DEP
52	2002	0	CD	_	44	DEP
53	;	;	:	_	44	P
54	Wu	wu	NNP	_	44	DEP
55	et	et	FW	_	44	DEP
56	al.	al.	FW	_	44	DEP
57	2002	0	CD	_	44	DEP
58	)	)	-RRB-	_	44	P
59	.	.	.	_	4	P

1	For	for	IN	_	5	ADV
2	each	each	DT	_	1	PMOD
3	,	,	,	_	5	P
4	there	there	EX	_	5	SBJ
5	has	have	VBZ	_	0	ROOT
6	to	to	TO	_	5	OPRD
7	be	be	VB	_	6	IM
8	a	a	DT	_	9	NMOD
9	question	question	NN	_	7	PRD
10	as	as	IN	_	9	NMOD
11	to	to	IN	_	10	PMOD
12	whether	whether	IN	_	11	PMOD
13	the	the	DT	_	15	NMOD
14	anti-nuclear	anti-nuclear	JJ	_	15	NMOD
15	autoimmunity	autoimmunity	NN	_	16	SBJ
16	is	be	VBZ	_	12	SUB
17	due	due	IN	_	16	PRD
18	to	to	IN	_	17	PMOD
19	the	the	DT	_	24	NMOD
20	gene	gene	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	targeted	target	VBN	_	24	NMOD
23	mutant	mutant	NN	_	24	NMOD
24	gene	gene	NN	_	18	PMOD
25	or	or	CC	_	18	COORD
26	to	to	IN	_	25	CONJ
27	the	the	DT	_	30	NMOD
28	normal	normal	JJ	_	30	NMOD
29	129	0	CD	_	30	NMOD
30	genes	gene	NNS	_	26	PMOD
31	expressed	express	VBN	_	30	NMOD
32	in	in	IN	_	31	LOC
33	the	the	DT	_	35	NMOD
34	same	same	JJ	_	35	NMOD
35	region	region	NN	_	32	PMOD
36	as	as	IN	_	35	NMOD
37	the	the	DT	_	39	NMOD
38	targeted	target	VBN	_	39	NMOD
39	gene	gene	NN	_	36	PMOD
40	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	influence	influence	NN	_	13	SBJ
3	of	of	IN	_	2	NMOD
4	background	background	NN	_	5	NMOD
5	genes	gene	NNS	_	3	PMOD
6	on	on	IN	_	2	NMOD
7	the	the	DT	_	8	NMOD
8	development	development	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	spontaneous	spontaneous	JJ	_	12	NMOD
11	autoimmune	autoimmune	JJ	_	12	NMOD
12	disease	disease	NN	_	9	PMOD
13	is	be	VBZ	_	0	ROOT
14	well	well	RB	_	15	AMOD
15	known	know	VBN	_	13	PRD
16	,	,	,	_	13	P
17	especially	especially	RB	_	18	PMOD
18	with	with	IN	_	13	ADV
19	respect	respect	NN	_	18	PMOD
20	to	to	IN	_	19	NMOD
21	the	the	DT	_	28	NMOD
22	lpr	lpr	NN	_	28	NMOD
23	and	and	CC	_	22	COORD
24	Yaa	yaa	NN	_	23	CONJ
25	disease	disease	NN	_	27	NMOD
26	-	-	HYPH	_	25	P
27	susceptibility	susceptibility	NN	_	28	NMOD
28	genes	gene	NNS	_	20	PMOD
29	.	.	.	_	13	P

1	In	in	IN	_	13	LOC
2	MRL	mrl	NN	_	4	NMOD
3	/	/	HYPH	_	2	P
4	Mp	mp	NN	_	5	NMOD
5	mice	mouse	NNS	_	1	PMOD
6	,	,	,	_	13	P
7	the	the	DT	_	8	NMOD
8	presence	presence	NN	_	13	SBJ
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	lpr	lpr	NN	_	12	NMOD
12	gene	gene	NN	_	9	PMOD
13	accelerates	accelerate	VBZ	_	0	ROOT
14	the	the	DT	_	15	NMOD
15	development	development	NN	_	13	OBJ
16	of	of	IN	_	15	NMOD
17	high	high	JJ	_	18	NMOD
18	level	level	NN	_	24	NMOD
19	and	and	CC	_	18	COORD
20	broad	broad	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	spectrum	spectrum	NN	_	19	CONJ
23	auto-Ab	auto-ab	NN	_	24	NMOD
24	production	production	NN	_	16	PMOD
25	and	and	CC	_	24	COORD
26	lethal	lethal	JJ	_	27	NMOD
27	glomerulonephritis	glomerulonephritis	NN	_	25	CONJ
28	,	,	,	_	24	P
29	in	in	IN	_	24	NMOD
30	addition	addition	NN	_	29	PMOD
31	to	to	IN	_	30	NMOD
32	marked	marked	JJ	_	34	NMOD
33	lymphoproliferative	lymphoproliferative	JJ	_	34	NMOD
34	disease	disease	NN	_	31	PMOD
35	.	.	.	_	13	P

1	In	in	IN	_	26	ADV
2	contrast	contrast	NN	_	1	PMOD
3	,	,	,	_	26	P
4	homozygosity	homozygosity	NN	_	26	SBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	8	NMOD
7	lpr	lpr	NN	_	8	NMOD
8	gene	gene	NN	_	5	PMOD
9	in	in	IN	_	4	NMOD
10	other	other	JJ	_	11	NMOD
11	strains	strain	NNS	_	9	PMOD
12	such	such	JJ	_	13	PMOD
13	as	as	IN	_	11	NMOD
14	C57BL	c0bl	NN	_	13	PMOD
15	/	/	HYPH	_	14	P
16	6	0	CD	_	14	NMOD
17	,	,	,	_	14	P
18	AKR	akr	NN	_	14	CONJ
19	,	,	,	_	18	P
20	LG	lg	NN	_	22	NMOD
21	/	/	HYPH	_	20	P
22	J	j	NN	_	18	CONJ
23	,	,	,	_	22	P
24	and	and	CC	_	22	COORD
25	C3H	c0h	NN	_	24	CONJ
26	leads	lead	VBZ	_	0	ROOT
27	only	only	RB	_	26	ADV
28	to	to	IN	_	26	ADV
29	auto-Ab	auto-ab	NN	_	30	NMOD
30	production	production	NN	_	28	PMOD
31	(	(	-LRB-	_	32	P
32	Izui	izui	NNP	_	26	CIT
33	et	et	FW	_	32	DEP
34	al.	al.	FW	_	32	DEP
35	1984	0	CD	_	32	DEP
36	)	)	-RRB-	_	32	P
37	.	.	.	_	26	P

1	Similarly	similarly	RB	_	18	ADV
2	,	,	,	_	18	P
3	the	the	DT	_	10	NMOD
4	Y	y	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	chromosome	chromosome	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	linked	link	VBN	_	10	NMOD
9	Yaa	yaa	NN	_	10	NMOD
10	gene	gene	NN	_	18	SBJ
11	in	in	IN	_	10	LOC
12	BXSB	bxsb	NN	_	17	NMOD
13	and	and	CC	_	12	COORD
14	MRL	mrl	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	Mp	mp	NN	_	13	CONJ
17	males	male	NNS	_	11	PMOD
18	enhances	enhance	VBZ	_	0	ROOT
19	the	the	DT	_	21	NMOD
20	rapid	rapid	JJ	_	21	NMOD
21	development	development	NN	_	18	OBJ
22	of	of	IN	_	21	NMOD
23	auto-Abs	auto-abs	NNS	_	22	PMOD
24	and	and	CC	_	23	COORD
25	glomerulonephritis	glomerulonephritis	NN	_	24	CONJ
26	(	(	-LRB-	_	27	P
27	Izui	izui	NNP	_	18	CIT
28	et	et	FW	_	27	DEP
29	al.	al.	FW	_	27	DEP
30	1988	0	CD	_	27	DEP
31	;	;	:	_	27	P
32	Merino	merino	NNP	_	27	DEP
33	et	et	FW	_	27	DEP
34	al.	al.	FW	_	27	DEP
35	1989	0	CD	_	27	DEP
36	)	)	-RRB-	_	27	P
37	.	.	.	_	18	P

1	However	however	RB	_	13	ADV
2	,	,	,	_	13	P
3	in	in	IN	_	13	LOC
4	the	the	DT	_	8	NMOD
5	C57BL	c0bl	NN	_	8	NMOD
6	/	/	HYPH	_	5	P
7	6	0	CD	_	5	NMOD
8	background	background	NN	_	3	PMOD
9	,	,	,	_	13	P
10	the	the	DT	_	12	NMOD
11	Yaa	yaa	NN	_	12	NMOD
12	gene	gene	NN	_	13	SBJ
13	does	do	VBZ	_	0	ROOT
14	not	not	RB	_	13	ADV
15	lead	lead	VB	_	13	VC
16	to	to	IN	_	15	ADV
17	an	an	DT	_	19	NMOD
18	autoimmune	autoimmune	JJ	_	19	NMOD
19	phenotype	phenotype	NN	_	16	PMOD
20	(	(	-LRB-	_	21	P
21	Izui	izui	NNP	_	15	CIT
22	et	et	FW	_	21	DEP
23	al.	al.	FW	_	21	DEP
24	1988	0	CD	_	21	DEP
25	)	)	-RRB-	_	21	P
26	.	.	.	_	13	P

1	Not	not	RB	_	2	AMOD
2	surprisingly	surprisingly	RB	_	15	ADV
3	,	,	,	_	15	P
4	important	important	JJ	_	5	NMOD
5	effects	effect	NNS	_	15	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	genetic	genetic	JJ	_	9	NMOD
9	background	background	NN	_	6	PMOD
10	on	on	IN	_	5	NMOD
11	the	the	DT	_	12	NMOD
12	expression	expression	NN	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	autoimmunity	autoimmunity	NN	_	13	PMOD
15	have	have	VBP	_	0	ROOT
16	also	also	RB	_	15	ADV
17	been	be	VBN	_	15	VC
18	reported	report	VBN	_	17	VC
19	in	in	IN	_	18	LOC
20	gene	gene	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	targeted	target	VBN	_	23	NMOD
23	mice	mouse	NNS	_	19	PMOD
24	(	(	-LRB-	_	25	P
25	Bolland	bolland	NNP	_	18	CIT
26	and	and	CC	_	25	COORD
27	Ravetch	ravetch	NNP	_	26	CONJ
28	2000	0	CD	_	25	DEP
29	;	;	:	_	25	P
30	Santiago	santiago	NNP	_	25	DEP
31	-	-	HYPH	_	30	P
32	Raber	raber	NNP	_	25	DEP
33	et	et	FW	_	25	DEP
34	al.	al.	FW	_	25	DEP
35	2001	0	CD	_	25	DEP
36	;	;	:	_	25	P
37	Mitchell	mitchell	NNP	_	25	DEP
38	et	et	FW	_	25	DEP
39	al.	al.	FW	_	25	DEP
40	2002	0	CD	_	25	DEP
41	)	)	-RRB-	_	25	P
42	.	.	.	_	15	P

1	Thus	thus	RB	_	4	ADV
2	,	,	,	_	4	P
3	SLE	sle	NN	_	4	SBJ
4	exists	exist	VBZ	_	0	ROOT
5	as	as	IN	_	4	ADV
6	a	a	DT	_	10	NMOD
7	complex	complex	JJ	_	9	NMOD
8	-	-	HYPH	_	7	P
9	trait	trait	NN	_	10	NMOD
10	disorder	disorder	NN	_	5	PMOD
11	in	in	IN	_	19	ADV
12	which	which	WDT	_	11	PMOD
13	specific	specific	JJ	_	14	NMOD
14	combinations	combination	NNS	_	18	SBJ
15	of	of	IN	_	14	NMOD
16	susceptibility	susceptibility	NN	_	17	NMOD
17	alleles	allele	NNS	_	15	PMOD
18	are	be	VBP	_	10	NMOD
19	required	require	VBN	_	18	VC
20	for	for	IN	_	19	PRP
21	the	the	DT	_	22	NMOD
22	expression	expression	NN	_	20	PMOD
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	26	NMOD
25	full	full	JJ	_	26	NMOD
26	phenotype	phenotype	NN	_	23	PMOD
27	.	.	.	_	4	P

1	Through	through	IN	_	19	ADV
2	the	the	DT	_	3	NMOD
3	use	use	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	microsatellite	microsatellite	NN	_	7	NMOD
6	marker	marker	NN	_	7	NMOD
7	maps	map	NNS	_	4	PMOD
8	,	,	,	_	19	P
9	the	the	DT	_	10	NMOD
10	identification	identification	NN	_	19	SBJ
11	of	of	IN	_	10	NMOD
12	murine	murine	JJ	_	15	NMOD
13	SLE	sle	NN	_	14	NMOD
14	susceptibility	susceptibility	NN	_	15	NMOD
15	intervals	interval	NNS	_	11	PMOD
16	in	in	IN	_	10	LOC
17	experimental	experimental	JJ	_	18	NMOD
18	crosses	crosse	NNS	_	16	PMOD
19	has	have	VBZ	_	0	ROOT
20	been	be	VBN	_	19	VC
21	made	make	VBN	_	20	VC
22	possible	possible	JJ	_	21	OPRD
23	.	.	.	_	19	P

1	These	these	DT	_	3	NMOD
2	mapping	mapping	NN	_	3	NMOD
3	studies	study	NNS	_	4	SBJ
4	have	have	VBP	_	0	ROOT
5	shown	show	VBN	_	4	VC
6	that	that	IN	_	5	OBJ
7	the	the	DT	_	9	NMOD
8	disease	disease	NN	_	9	NMOD
9	expression	expression	NN	_	19	SBJ
10	in	in	IN	_	9	NMOD
11	relation	relation	NN	_	10	PMOD
12	to	to	IN	_	11	NMOD
13	the	the	DT	_	14	NMOD
14	inheritance	inheritance	NN	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	the	the	DT	_	18	NMOD
17	different	different	JJ	_	18	NMOD
18	alleles	allele	NNS	_	15	PMOD
19	followed	follow	VBD	_	6	SUB
20	a	a	DT	_	23	NMOD
21	threshold	threshold	NN	_	23	NMOD
22	liability	liability	NN	_	23	NMOD
23	pattern	pattern	NN	_	19	OBJ
24	in	in	IN	_	29	ADV
25	which	which	WDT	_	24	PMOD
26	a	a	DT	_	28	NMOD
27	positive	positive	JJ	_	28	NMOD
28	phenotype	phenotype	NN	_	29	SBJ
29	depended	depend	VBD	_	23	NMOD
30	upon	upon	IN	_	29	ADV
31	the	the	DT	_	32	NMOD
32	presence	presence	NN	_	30	PMOD
33	of	of	IN	_	32	NMOD
34	multiple	multiple	JJ	_	37	NMOD
35	discrete	discrete	JJ	_	37	NMOD
36	susceptibility	susceptibility	NN	_	37	NMOD
37	loci	locus	NNS	_	33	PMOD
38	with	with	IN	_	29	ADV
39	no	no	DT	_	41	NMOD
40	single	single	JJ	_	41	NMOD
41	locus	locus	NN	_	42	SBJ
42	being	be	VBG	_	38	PMOD
43	a	a	DT	_	45	NMOD
44	prerequisite	prerequisite	JJ	_	45	NMOD
45	factor	factor	NN	_	42	PRD
46	.	.	.	_	4	P

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	employed	employ	VBN	_	2	VC
4	the	the	DT	_	6	NMOD
5	same	same	JJ	_	6	NMOD
6	approach	approach	NN	_	3	OBJ
7	to	to	TO	_	3	PRP
8	analyse	analyse	VB	_	7	IM
9	the	the	DT	_	11	NMOD
10	genetic	genetic	JJ	_	11	NMOD
11	basis	base	NN	_	8	OBJ
12	of	of	IN	_	11	NMOD
13	disease	disease	NN	_	14	NMOD
14	inheritance	inheritance	NN	_	12	PMOD
15	in	in	IN	_	11	NMOD
16	the	the	DT	_	25	NMOD
17	(	(	-LRB-	_	25	P
18	129	0	CD	_	20	NMOD
19	×	×	SYM	_	20	P
20	C57BL	c0bl	NN	_	25	NMOD
21	/	/	HYPH	_	20	P
22	6	0	CD	_	20	NMOD
23	)	)	-RRB-	_	25	P
24	hybrid	hybrid	NN	_	25	NMOD
25	strain	strain	NN	_	15	PMOD
26	,	,	,	_	25	P
27	the	the	DT	_	31	NMOD
28	most	most	RBS	_	29	AMOD
29	common	common	JJ	_	31	NMOD
30	genetic	genetic	JJ	_	31	NMOD
31	background	background	NN	_	25	APPO
32	in	in	IN	_	31	LOC
33	gene	gene	NN	_	35	AMOD
34	-	-	HYPH	_	33	P
35	targeted	target	VBN	_	36	NMOD
36	mice	mouse	NNS	_	32	PMOD
37	.	.	.	_	2	P

1	Although	although	IN	_	26	ADV
2	spontaneous	spontaneous	JJ	_	3	NMOD
3	autoimmunity	autoimmunity	NN	_	4	SBJ
4	has	have	VBZ	_	1	SUB
5	not	not	RB	_	4	ADV
6	been	be	VBN	_	4	VC
7	documented	document	VBN	_	6	VC
8	in	in	IN	_	7	LOC
9	either	either	DT	_	8	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	18	NMOD
12	pure	pure	JJ	_	18	NMOD
13	129	0	CD	_	18	NMOD
14	or	or	CC	_	13	COORD
15	C57BL	c0bl	NN	_	14	CONJ
16	/	/	HYPH	_	15	P
17	6	0	CD	_	15	NMOD
18	strains	strain	NNS	_	10	PMOD
19	,	,	,	_	26	P
20	a	a	DT	_	25	NMOD
21	spontaneous	spontaneous	JJ	_	25	NMOD
22	lupus	lupus	NN	_	24	AMOD
23	-	-	HYPH	_	22	P
24	like	like	JJ	_	25	NMOD
25	phenotype	phenotype	NN	_	26	SBJ
26	has	have	VBZ	_	0	ROOT
27	been	be	VBN	_	26	VC
28	described	describe	VBN	_	27	VC
29	in	in	IN	_	28	LOC
30	(	(	-LRB-	_	38	P
31	129	0	CD	_	33	NMOD
32	×	×	SYM	_	33	P
33	C57BL	c0bl	NN	_	38	NMOD
34	/	/	HYPH	_	33	P
35	6	0	CD	_	33	NMOD
36	)	)	-RRB-	_	38	P
37	hybrid	hybrid	NN	_	38	NMOD
38	strains	strain	NNS	_	29	PMOD
39	(	(	-LRB-	_	40	P
40	Obata	obata	NNP	_	28	CIT
41	et	et	FW	_	40	DEP
42	al.	al.	FW	_	40	DEP
43	1979	0	CD	_	40	DEP
44	;	;	:	_	40	P
45	Botto	botto	NNP	_	40	DEP
46	et	et	FW	_	40	DEP
47	al.	al.	FW	_	40	DEP
48	1998	0	CD	_	40	DEP
49	;	;	:	_	40	P
50	Bickerstaff	bickerstaff	NNP	_	40	DEP
51	et	et	FW	_	40	DEP
52	al.	al.	FW	_	40	DEP
53	1999	0	CD	_	40	DEP
54	;	;	:	_	40	P
55	Santiago	santiago	NNP	_	40	DEP
56	-	-	HYPH	_	55	P
57	Raber	raber	NNP	_	40	DEP
58	et	et	FW	_	40	DEP
59	al.	al.	FW	_	40	DEP
60	2001	0	CD	_	40	DEP
61	)	)	-RRB-	_	40	P
62	,	,	,	_	28	P
63	suggesting	suggest	VBG	_	28	ADV
64	that	that	IN	_	63	OBJ
65	the	the	DT	_	66	NMOD
66	predisposition	predisposition	NN	_	71	SBJ
67	in	in	IN	_	66	LOC
68	these	these	DT	_	70	NMOD
69	hybrid	hybrid	JJ	_	70	NMOD
70	mice	mouse	NNS	_	67	PMOD
71	may	may	MD	_	64	SUB
72	arise	arise	VB	_	71	VC
73	as	as	IN	_	72	ADV
74	a	a	DT	_	75	NMOD
75	result	result	NN	_	73	PMOD
76	of	of	IN	_	75	NMOD
77	the	the	DT	_	78	NMOD
78	interaction	interaction	NN	_	76	PMOD
79	between	between	IN	_	78	NMOD
80	specific	specific	JJ	_	81	NMOD
81	combinations	combination	NNS	_	79	PMOD
82	of	of	IN	_	81	NMOD
83	alleles	allele	NNS	_	82	PMOD
84	inherited	inherit	VBN	_	83	NMOD
85	from	from	IN	_	84	ADV
86	both	both	CC	_	94	COORD
87	the	the	DT	_	94	NMOD
88	129	0	CD	_	94	NMOD
89	and	and	CC	_	88	COORD
90	C57BL	c0bl	NN	_	89	CONJ
91	/	/	HYPH	_	90	P
92	6	0	CD	_	90	NMOD
93	parental	parental	JJ	_	94	NMOD
94	strains	strain	NNS	_	85	PMOD
95	.	.	.	_	26	P

1	This	this	DT	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	confirmed	confirm	VBN	_	2	VC
4	by	by	IN	_	3	LGS
5	the	the	DT	_	7	NMOD
6	mapping	mapping	NN	_	7	NMOD
7	study	study	NN	_	4	PMOD
8	reported	report	VBN	_	7	NMOD
9	here	here	RB	_	8	ADV
10	.	.	.	_	2	P

1	We	we	PRP	_	2	SBJ
2	showed	show	VBD	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	there	there	EX	_	5	SBJ
5	are	be	VBP	_	3	SUB
6	multiple	multiple	JJ	_	8	NMOD
7	genetic	genetic	JJ	_	8	NMOD
8	loci	locus	NNS	_	5	PRD
9	contributing	contribute	VBG	_	8	NMOD
10	to	to	IN	_	9	ADV
11	the	the	DT	_	12	NMOD
12	disease	disease	NN	_	10	PMOD
13	and	and	CC	_	2	COORD
14	these	these	DT	_	15	SBJ
15	are	be	VBP	_	13	CONJ
16	derived	derive	VBN	_	15	VC
17	from	from	IN	_	16	ADV
18	both	both	CC	_	19	COORD
19	129	0	CD	_	24	NMOD
20	and	and	CC	_	19	COORD
21	C57BL	c0bl	NN	_	20	CONJ
22	/	/	HYPH	_	21	P
23	6	0	CD	_	21	NMOD
24	mice	mouse	NNS	_	17	PMOD
25	.	.	.	_	2	P

1	We	we	PRP	_	2	SBJ
2	demonstrated	demonstrate	VBD	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	a	a	DT	_	8	NMOD
5	129	0	CD	_	7	AMOD
6	-	-	HYPH	_	5	P
7	derived	derive	VBN	_	8	NMOD
8	segment	segment	NN	_	12	SBJ
9	of	of	IN	_	8	NMOD
10	Chromosome	chromosome	NN	_	9	PMOD
11	1	0	CD	_	10	NMOD
12	was	be	VBD	_	3	SUB
13	strongly	strongly	RB	_	14	AMOD
14	linked	link	VBN	_	12	PRD
15	to	to	IN	_	14	AMOD
16	the	the	DT	_	17	NMOD
17	expression	expression	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	auto-Abs	auto-abs	NNS	_	18	PMOD
20	.	.	.	_	2	P

1	This	this	DT	_	2	NMOD
2	region	region	NN	_	3	SBJ
3	is	be	VBZ	_	23	DEP
4	probably	probably	RB	_	3	ADV
5	capable	capable	JJ	_	3	PRD
6	of	of	IN	_	5	AMOD
7	causing	cause	VBG	_	6	PMOD
8	the	the	DT	_	9	NMOD
9	initiation	initiation	NN	_	7	OBJ
10	of	of	IN	_	9	NMOD
11	a	a	DT	_	14	NMOD
12	humoral	humoral	JJ	_	14	NMOD
13	autoimmune	autoimmune	JJ	_	14	NMOD
14	response	response	NN	_	10	PMOD
15	to	to	IN	_	14	NMOD
16	nuclear	nuclear	JJ	_	17	NMOD
17	antigens	antigen	NNS	_	15	PMOD
18	;	;	:	_	23	P
19	however	however	RB	_	23	ADV
20	,	,	,	_	23	P
21	this	this	DT	_	22	NMOD
22	response	response	NN	_	23	SBJ
23	does	do	VBZ	_	0	ROOT
24	not	not	RB	_	23	ADV
25	occur	occur	VB	_	23	VC
26	in	in	IN	_	25	ADV
27	the	the	DT	_	28	NMOD
28	absence	absence	NN	_	26	PMOD
29	of	of	IN	_	28	NMOD
30	C57BL	c0bl	NN	_	33	NMOD
31	/	/	HYPH	_	30	P
32	6	0	CD	_	30	NMOD
33	genes	gene	NNS	_	29	PMOD
34	.	.	.	_	23	P

1	In	in	IN	_	7	ADV
2	support	support	NN	_	1	PMOD
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	3	PMOD
5	,	,	,	_	7	P
6	we	we	PRP	_	7	SBJ
7	identified	identify	VBD	_	0	ROOT
8	a	a	DT	_	12	NMOD
9	C57BL	c0bl	NN	_	12	NMOD
10	/	/	HYPH	_	9	P
11	6	0	CD	_	9	NMOD
12	segment	segment	NN	_	7	OBJ
13	on	on	IN	_	12	LOC
14	Chromosome	chromosome	NN	_	13	PMOD
15	3	0	CD	_	14	NMOD
16	,	,	,	_	12	P
17	which	which	WDT	_	18	SBJ
18	may	may	MD	_	12	NMOD
19	interact	interact	VB	_	18	VC
20	with	with	IN	_	19	ADV
21	the	the	DT	_	23	NMOD
22	129	0	CD	_	23	NMOD
23	genes	gene	NNS	_	20	PMOD
24	on	on	IN	_	23	NMOD
25	Chromosome	chromosome	NN	_	24	PMOD
26	1	0	CD	_	25	NMOD
27	to	to	TO	_	19	PRP
28	mediate	mediate	VB	_	27	IM
29	the	the	DT	_	30	NMOD
30	loss	loss	NN	_	28	OBJ
31	of	of	IN	_	30	NMOD
32	tolerance	tolerance	NN	_	31	PMOD
33	.	.	.	_	7	P

1	Interestingly	interestingly	RB	_	32	ADV
2	,	,	,	_	32	P
3	although	although	IN	_	32	ADV
4	the	the	DT	_	11	NMOD
5	C57BL	c0bl	NN	_	11	NMOD
6	/	/	HYPH	_	5	P
7	6	0	CD	_	5	NMOD
8	SLE	sle	NN	_	10	NMOD
9	-	-	HYPH	_	8	P
10	susceptibility	susceptibility	NN	_	11	NMOD
11	region	region	NN	_	15	SBJ
12	on	on	IN	_	11	LOC
13	Chromosome	chromosome	NN	_	12	PMOD
14	3	0	CD	_	13	NMOD
15	is	be	VBZ	_	3	SUB
16	novel	novel	JJ	_	15	PRD
17	,	,	,	_	32	P
18	disease	disease	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	modifying	modify	VBG	_	21	NMOD
21	alleles	allele	NNS	_	32	SBJ
22	derived	derive	VBN	_	21	NMOD
23	from	from	IN	_	22	ADV
24	C57BL	c0bl	NN	_	31	NMOD
25	/	/	HYPH	_	24	P
26	10	0	CD	_	24	NMOD
27	and	and	CC	_	24	COORD
28	C57BL	c0bl	NN	_	27	CONJ
29	/	/	HYPH	_	28	P
30	6	0	CD	_	28	NMOD
31	strains	strain	NNS	_	23	PMOD
32	have	have	VBP	_	0	ROOT
33	been	be	VBN	_	32	VC
34	mapped	map	VBN	_	33	VC
35	to	to	IN	_	34	ADV
36	a	a	DT	_	37	NMOD
37	portion	portion	NN	_	35	PMOD
38	of	of	IN	_	37	NMOD
39	Chromosome	chromosome	NN	_	38	PMOD
40	3	0	CD	_	39	NMOD
41	close	close	JJ	_	37	NMOD
42	to	to	IN	_	41	AMOD
43	the	the	DT	_	44	NMOD
44	region	region	NN	_	42	PMOD
45	identified	identify	VBN	_	44	NMOD
46	in	in	IN	_	45	LOC
47	this	this	DT	_	48	NMOD
48	study	study	NN	_	46	PMOD
49	(	(	-LRB-	_	50	P
50	Morel	morel	NNP	_	34	CIT
51	et	et	FW	_	50	DEP
52	al.	al.	FW	_	50	DEP
53	1999	0	CD	_	50	DEP
54	;	;	:	_	50	P
55	Haywood	haywood	NNP	_	50	DEP
56	et	et	FW	_	50	DEP
57	al.	al.	FW	_	50	DEP
58	2000	0	CD	_	50	DEP
59	)	)	-RRB-	_	50	P
60	.	.	.	_	32	P

1	Furthermore	furthermore	RB	_	15	ADV
2	,	,	,	_	15	P
3	the	the	DT	_	4	NMOD
4	region	region	NN	_	15	SBJ
5	on	on	IN	_	4	LOC
6	Chromosome	chromosome	NN	_	5	PMOD
7	7	0	CD	_	6	NMOD
8	associated	associate	VBN	_	4	NMOD
9	with	with	IN	_	8	ADV
10	the	the	DT	_	11	NMOD
11	development	development	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	lupus	lupus	NN	_	14	NMOD
14	nephritis	nephritis	NN	_	12	PMOD
15	has	have	VBZ	_	0	ROOT
16	been	be	VBN	_	15	VC
17	linked	link	VBN	_	16	VC
18	to	to	IN	_	17	ADV
19	the	the	DT	_	21	NMOD
20	same	same	JJ	_	21	NMOD
21	trait	trait	NN	_	18	PMOD
22	in	in	IN	_	17	LOC
23	other	other	JJ	_	25	NMOD
24	murine	murine	JJ	_	25	NMOD
25	models	model	NNS	_	22	PMOD
26	of	of	IN	_	25	NMOD
27	SLE	sle	NN	_	26	PMOD
28	(	(	-LRB-	_	29	P
29	Santiago	santiago	NNP	_	17	CIT
30	et	et	FW	_	29	DEP
31	al.	al.	FW	_	29	DEP
32	1998	0	CD	_	29	DEP
33	;	;	:	_	29	P
34	Morel	morel	NNP	_	29	DEP
35	et	et	FW	_	29	DEP
36	al.	al.	FW	_	29	DEP
37	1999	0	CD	_	29	DEP
38	;	;	:	_	29	P
39	Xie	xie	NNP	_	29	DEP
40	et	et	FW	_	29	DEP
41	al.	al.	FW	_	29	DEP
42	2002	0	CD	_	29	DEP
43	)	)	-RRB-	_	29	P
44	,	,	,	_	17	P
45	suggesting	suggest	VBG	_	17	ADV
46	the	the	DT	_	47	NMOD
47	possibility	possibility	NN	_	45	OBJ
48	of	of	IN	_	47	NMOD
49	shared	share	VBN	_	51	NMOD
50	susceptibility	susceptibility	NN	_	51	NMOD
51	loci	locus	NNS	_	48	PMOD
52	.	.	.	_	15	P

1	Taken	take	VBN	_	5	ADV
2	together	together	RB	_	1	ADV
3	our	our	PRP$	_	4	NMOD
4	results	result	NNS	_	5	SBJ
5	suggest	suggest	VBP	_	0	ROOT
6	a	a	DT	_	9	NMOD
7	complex	complex	JJ	_	9	NMOD
8	genetic	genetic	JJ	_	9	NMOD
9	contribution	contribution	NN	_	5	OBJ
10	from	from	IN	_	9	NMOD
11	the	the	DT	_	21	NMOD
12	(	(	-LRB-	_	21	P
13	129	0	CD	_	15	NMOD
14	×	×	SYM	_	15	P
15	C57BL	c0bl	NN	_	21	NMOD
16	/	/	HYPH	_	15	P
17	6	0	CD	_	15	NMOD
18	)	)	-RRB-	_	21	P
19	hybrid	hybrid	JJ	_	21	NMOD
20	background	background	NN	_	21	NMOD
21	genome	genome	NN	_	10	PMOD
22	,	,	,	_	21	P
23	with	with	IN	_	21	NMOD
24	both	both	DT	_	30	NMOD
25	enhancing	enhance	VBG	_	30	NMOD
26	as	as	RB	_	28	ADV
27	well	well	RB	_	28	ADV
28	as	as	IN	_	25	COORD
29	inhibitory	inhibitory	JJ	_	28	CONJ
30	loci	locus	NNS	_	23	PMOD
31	from	from	IN	_	30	NMOD
32	the	the	DT	_	34	NMOD
33	129	0	CD	_	34	NMOD
34	mouse	mouse	NN	_	31	PMOD
35	,	,	,	_	21	P
36	in	in	IN	_	21	NMOD
37	addition	addition	NN	_	36	PMOD
38	to	to	IN	_	37	NMOD
39	genes	gene	NNS	_	38	PMOD
40	promoting	promote	VBG	_	39	NMOD
41	autoimmunity	autoimmunity	NN	_	40	OBJ
42	from	from	IN	_	40	ADV
43	the	the	DT	_	47	NMOD
44	C57BL	c0bl	NN	_	47	NMOD
45	/	/	HYPH	_	44	P
46	6	0	CD	_	44	NMOD
47	mice	mouse	NNS	_	42	PMOD
48	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	impact	impact	NN	_	22	SBJ
3	that	that	WDT	_	8	OBJ
4	these	these	DT	_	6	NMOD
5	interacting	interact	VBG	_	6	NMOD
6	loci	locus	NNS	_	7	SBJ
7	may	may	MD	_	2	NMOD
8	have	have	VB	_	7	VC
9	on	on	IN	_	2	NMOD
10	the	the	DT	_	14	NMOD
11	lupus	lupus	NN	_	13	AMOD
12	-	-	HYPH	_	11	P
13	like	like	JJ	_	14	NMOD
14	disease	disease	NN	_	9	PMOD
15	present	present	JJ	_	14	NMOD
16	in	in	IN	_	15	LOC
17	several	several	JJ	_	21	NMOD
18	gene	gene	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	targeted	target	VBN	_	21	NMOD
21	animals	animal	NNS	_	16	PMOD
22	was	be	VBD	_	0	ROOT
23	further	far	RB	_	22	ADV
24	assessed	assess	VBN	_	22	VC
25	by	by	IN	_	24	MNR
26	comparing	compare	VBG	_	25	PMOD
27	Apcs	apc	NN	_	31	NMOD
28	−	−	SYM	_	27	P
29	/	/	HYPH	_	27	P
30	−	−	SYM	_	27	P
31	mice	mouse	NNS	_	26	OBJ
32	with	with	IN	_	26	ADV
33	Chromosome	chromosome	NN	_	36	AMOD
34	1	0	CD	_	33	NMOD
35	genetically	genetically	RB	_	36	AMOD
36	matched	match	VBN	_	37	NMOD
37	controls	control	NNS	_	32	PMOD
38	.	.	.	_	22	P

1	In	in	IN	_	20	ADV
2	the	the	DT	_	3	NMOD
3	context	context	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	SLE	sle	NN	_	6	NMOD
6	susceptibility	susceptibility	NN	_	4	PMOD
7	,	,	,	_	20	P
8	one	one	CD	_	20	SBJ
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	15	NMOD
11	most	most	RBS	_	12	AMOD
12	consistently	consistently	RB	_	13	AMOD
13	mapped	map	VBN	_	15	NMOD
14	non-MHC	non-mhc	JJ	_	15	NMOD
15	regions	region	NNS	_	9	PMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	mouse	mouse	NN	_	19	NMOD
19	genome	genome	NN	_	16	PMOD
20	is	be	VBZ	_	0	ROOT
21	the	the	DT	_	25	NMOD
22	telomeric	telomeric	JJ	_	25	NMOD
23	Chromosome	chromosome	NN	_	25	NMOD
24	1	0	CD	_	23	NMOD
25	segment	segment	NN	_	20	PRD
26	,	,	,	_	25	P
27	where	where	WRB	_	70	LOC
28	several	several	JJ	_	30	NMOD
29	disease	disease	NN	_	30	NMOD
30	loci	locus	NNS	_	68	SBJ
31	,	,	,	_	30	P
32	designated	designate	VBN	_	30	NMOD
33	Sle1	sle0	NN	_	32	OPRD
34	(	(	-LRB-	_	35	P
35	Morel	morel	NNP	_	33	NMOD
36	et	et	FW	_	35	DEP
37	al.	al.	FW	_	35	DEP
38	2001	0	CD	_	35	DEP
39	)	)	-RRB-	_	35	P
40	,	,	,	_	33	P
41	Nba2	nba0	NN	_	33	CONJ
42	(	(	-LRB-	_	43	P
43	Drake	drake	NNP	_	41	NMOD
44	et	et	FW	_	43	DEP
45	al.	al.	FW	_	43	DEP
46	1995	0	CD	_	43	DEP
47	;	;	:	_	43	P
48	Rozzo	rozzo	NNP	_	43	DEP
49	et	et	FW	_	43	DEP
50	al.	al.	FW	_	43	DEP
51	1996	0	CD	_	43	DEP
52	;	;	:	_	43	P
53	Vyse	vyse	NNP	_	43	DEP
54	et	et	FW	_	43	DEP
55	al.	al.	FW	_	43	DEP
56	1997	0	CD	_	43	DEP
57	)	)	-RRB-	_	43	P
58	,	,	,	_	41	P
59	and	and	CC	_	41	COORD
60	Bxs3	bxs0	NN	_	59	CONJ
61	(	(	-LRB-	_	62	P
62	Hogarth	hogarth	NNP	_	60	NMOD
63	et	et	FW	_	62	DEP
64	al.	al.	FW	_	62	DEP
65	1998	0	CD	_	62	DEP
66	)	)	-RRB-	_	62	P
67	,	,	,	_	68	P
68	have	have	VBP	_	25	NMOD
69	been	be	VBN	_	68	VC
70	mapped	map	VBN	_	69	VC
71	in	in	IN	_	70	LOC
72	lupus	lupus	NN	_	74	AMOD
73	-	-	HYPH	_	72	P
74	prone	prone	JJ	_	75	NMOD
75	strains	strain	NNS	_	71	PMOD
76	.	.	.	_	20	P

1	Moreover	moreover	RB	_	9	ADV
2	,	,	,	_	9	P
3	this	this	DT	_	4	NMOD
4	region	region	NN	_	9	SBJ
5	of	of	IN	_	4	NMOD
6	mouse	mouse	NN	_	7	NMOD
7	Chromosome	chromosome	NN	_	5	PMOD
8	1	0	CD	_	7	NMOD
9	is	be	VBZ	_	0	ROOT
10	orthologous	orthologous	JJ	_	9	PRD
11	to	to	IN	_	10	AMOD
12	a	a	DT	_	13	NMOD
13	region	region	NN	_	11	PMOD
14	on	on	IN	_	13	NMOD
15	human	human	JJ	_	17	NMOD
16	Chromosome	chromosome	NN	_	17	NMOD
17	1q22	0q0	NN	_	14	PMOD
18	–	–	SYM	_	19	P
19	1q25	0q0	NN	_	17	NMOD
20	,	,	,	_	13	P
21	which	which	WDT	_	22	SBJ
22	has	have	VBZ	_	13	NMOD
23	also	also	RB	_	22	ADV
24	been	be	VBN	_	22	VC
25	linked	link	VBN	_	24	VC
26	with	with	IN	_	25	ADV
27	human	human	JJ	_	28	NMOD
28	SLE	sle	NN	_	26	PMOD
29	(	(	-LRB-	_	30	P
30	Moser	moser	NNP	_	25	CIT
31	et	et	FW	_	30	DEP
32	al.	al.	FW	_	30	DEP
33	1998	0	CD	_	30	DEP
34	)	)	-RRB-	_	30	P
35	.	.	.	_	9	P

1	The	the	DT	_	3	NMOD
2	Apcs	apc	NN	_	3	NMOD
3	gene	gene	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	one	one	CD	_	4	PRD
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	candidate	candidate	NN	_	9	NMOD
9	genes	gene	NNS	_	6	PMOD
10	known	know	VBN	_	9	NMOD
11	to	to	TO	_	10	OPRD
12	lie	lie	VB	_	11	IM
13	within	within	IN	_	12	LOC
14	this	this	DT	_	15	NMOD
15	region	region	NN	_	13	PMOD
16	.	.	.	_	4	P

1	The	the	DT	_	6	NMOD
2	human	human	JJ	_	6	NMOD
3	serum	serum	NN	_	5	NMOD
4	amyloid	amyloid	NN	_	5	NMOD
5	P	p	NN	_	6	NMOD
6	component	component	NN	_	7	SBJ
7	binds	bind	VBZ	_	0	ROOT
8	avidly	avidly	RB	_	7	ADV
9	to	to	IN	_	7	ADV
10	DNA	dna	NN	_	9	PMOD
11	,	,	,	_	10	P
12	chromatin	chromatin	NN	_	10	CONJ
13	,	,	,	_	12	P
14	and	and	CC	_	12	COORD
15	apoptotic	apoptotic	JJ	_	16	NMOD
16	cells	cell	NNS	_	14	CONJ
17	in	in	IN	_	10	LOC
18	physiological	physiological	JJ	_	19	NMOD
19	conditions	condition	NNS	_	17	PMOD
20	in	in	FW	_	21	AMOD
21	vitro	vitro	FW	_	10	LOC
22	(	(	-LRB-	_	23	P
23	Pepys	pepys	NNP	_	10	NMOD
24	1974	0	CD	_	23	DEP
25	;	;	:	_	23	P
26	Pepys	pepys	NNP	_	23	DEP
27	and	and	CC	_	26	COORD
28	Butler	butler	NNP	_	27	CONJ
29	1987	0	CD	_	23	DEP
30	;	;	:	_	23	P
31	Butler	butler	NNP	_	23	DEP
32	et	et	FW	_	23	DEP
33	al.	al.	FW	_	23	DEP
34	1990	0	CD	_	23	DEP
35	)	)	-RRB-	_	23	P
36	and	and	CC	_	9	COORD
37	also	also	RB	_	36	ADV
38	to	to	IN	_	36	CONJ
39	exposed	expose	VBN	_	40	NMOD
40	chromatin	chromatin	NN	_	38	PMOD
41	and	and	CC	_	40	COORD
42	apoptotic	apoptotic	JJ	_	43	NMOD
43	cells	cell	NNS	_	41	CONJ
44	in	in	FW	_	45	AMOD
45	vivo	vivo	FW	_	40	LOC
46	(	(	-LRB-	_	47	P
47	Hintner	hintner	NNP	_	40	NMOD
48	et	et	FW	_	47	DEP
49	al.	al.	FW	_	47	DEP
50	1988	0	CD	_	47	DEP
51	;	;	:	_	47	P
52	Breathnach	breathnach	NNP	_	47	DEP
53	et	et	FW	_	47	DEP
54	al.	al.	FW	_	47	DEP
55	1989	0	CD	_	47	DEP
56	;	;	:	_	47	P
57	Familian	familian	NNP	_	47	DEP
58	et	et	FW	_	47	DEP
59	al.	al.	FW	_	47	DEP
60	2001	0	CD	_	47	DEP
61	)	)	-RRB-	_	47	P
62	.	.	.	_	7	P

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	previously	previously	RB	_	2	ADV
4	reported	report	VBN	_	2	VC
5	that	that	IN	_	4	OBJ
6	(	(	-LRB-	_	20	P
7	129	0	CD	_	9	NMOD
8	×	×	SYM	_	9	P
9	C57BL	c0bl	NN	_	14	NMOD
10	/	/	HYPH	_	9	P
11	6	0	CD	_	9	NMOD
12	)	)	-RRB-	_	14	P
13	.	.	HYPH	_	9	P
14	Apcs	apc	NN	_	18	NMOD
15	−	−	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	−	−	SYM	_	14	P
18	mice	mouse	NNS	_	20	SBJ
19	spontaneously	spontaneously	RB	_	20	ADV
20	produce	produce	VBP	_	5	SUB
21	a	a	DT	_	23	NMOD
22	wide	wide	JJ	_	23	NMOD
23	range	range	NN	_	20	OBJ
24	of	of	IN	_	23	NMOD
25	ANAs	ana	NNS	_	24	PMOD
26	and	and	CC	_	20	COORD
27	develop	develop	VB	_	26	CONJ
28	significant	significant	JJ	_	31	NMOD
29	immune	immune	JJ	_	30	NMOD
30	complex	complex	NN	_	31	NMOD
31	glomerulonephritis	glomerulonephritis	NN	_	27	OBJ
32	(	(	-LRB-	_	33	P
33	Bickerstaff	bickerstaff	NNP	_	20	CIT
34	et	et	FW	_	33	DEP
35	al.	al.	FW	_	33	DEP
36	1999	0	CD	_	33	DEP
37	)	)	-RRB-	_	33	P
38	.	.	.	_	2	P

1	On	on	IN	_	9	ADV
2	the	the	DT	_	3	NMOD
3	basis	base	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	these	these	DT	_	6	NMOD
6	observations	observation	NNS	_	4	PMOD
7	,	,	,	_	9	P
8	it	it	PRP	_	9	SBJ
9	was	be	VBD	_	0	ROOT
10	postulated	postulate	VBN	_	9	VC
11	that	that	IN	_	10	OBJ
12	Apcs	apc	NN	_	21	SBJ
13	,	,	,	_	21	P
14	by	by	IN	_	21	MNR
15	altering	alter	VBG	_	14	PMOD
16	the	the	DT	_	17	NMOD
17	clearance	clearance	NN	_	15	OBJ
18	of	of	IN	_	17	NMOD
19	chromatin	chromatin	NN	_	18	PMOD
20	,	,	,	_	21	P
21	contributes	contribute	VBZ	_	11	SUB
22	to	to	IN	_	21	ADV
23	the	the	DT	_	24	NMOD
24	pathogenesis	pathogenesis	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	SLE	sle	NN	_	25	PMOD
27	.	.	.	_	9	P

1	However	however	RB	_	7	ADV
2	,	,	,	_	7	P
3	in	in	IN	_	7	LOC
4	this	this	DT	_	5	NMOD
5	study	study	NN	_	3	PMOD
6	we	we	PRP	_	7	SBJ
7	found	find	VBD	_	0	ROOT
8	that	that	IN	_	7	OBJ
9	only	only	RB	_	14	NMOD
10	ANA	ana	NN	_	14	NMOD
11	and	and	CC	_	10	COORD
12	anti-chromatin	anti-chromatin	JJ	_	13	NMOD
13	Ab	ab	NN	_	11	CONJ
14	levels	level	NNS	_	15	SBJ
15	were	be	VBD	_	8	SUB
16	significantly	significantly	RB	_	15	ADV
17	increased	increase	VBN	_	15	VC
18	in	in	IN	_	17	ADV
19	the	the	DT	_	33	NMOD
20	(	(	-LRB-	_	33	P
21	129	0	CD	_	23	NMOD
22	×	×	SYM	_	23	P
23	C57BL	c0bl	NN	_	27	NMOD
24	/	/	HYPH	_	23	P
25	6	0	CD	_	23	NMOD
26	)	)	-RRB-	_	27	P
27	F2	f0	NN	_	29	NMOD
28	.	.	HYPH	_	27	P
29	Apcs	apc	NN	_	33	NMOD
30	−	−	SYM	_	29	P
31	/	/	HYPH	_	29	P
32	−	−	SYM	_	29	P
33	mice	mouse	NNS	_	18	PMOD
34	.	.	.	_	7	P

1	A	a	DT	_	3	NMOD
2	possible	possible	JJ	_	3	NMOD
3	explanation	explanation	NN	_	7	SBJ
4	for	for	IN	_	3	NMOD
5	this	this	DT	_	6	NMOD
6	discrepancy	discrepancy	NN	_	4	PMOD
7	may	may	MD	_	0	ROOT
8	lie	lie	VB	_	7	VC
9	in	in	IN	_	8	ADV
10	the	the	DT	_	11	NMOD
11	fact	fact	NN	_	9	PMOD
12	that	that	IN	_	11	NMOD
13	the	the	DT	_	18	NMOD
14	Apcs	apc	NN	_	18	NMOD
15	−	−	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	−	−	SYM	_	14	P
18	mice	mouse	NNS	_	24	SBJ
19	analysed	analyse	VBN	_	18	NMOD
20	in	in	IN	_	19	LOC
21	the	the	DT	_	23	NMOD
22	original	original	JJ	_	23	NMOD
23	study	study	NN	_	20	PMOD
24	were	be	VBD	_	12	SUB
25	generated	generate	VBN	_	24	VC
26	from	from	IN	_	25	ADV
27	a	a	DT	_	29	NMOD
28	limited	limited	JJ	_	29	NMOD
29	number	number	NN	_	26	PMOD
30	of	of	IN	_	29	NMOD
31	founders	founder	NNS	_	30	PMOD
32	and	and	CC	_	12	COORD
33	that	that	IN	_	32	CONJ
34	this	this	DT	_	35	SBJ
35	may	may	MD	_	33	SUB
36	have	have	VB	_	35	VC
37	caused	cause	VBN	_	36	VC
38	a	a	DT	_	40	NMOD
39	nonrandom	nonrandom	JJ	_	40	NMOD
40	inheritance	inheritance	NN	_	37	OBJ
41	of	of	IN	_	40	NMOD
42	the	the	DT	_	43	NMOD
43	loci	locus	NNS	_	41	PMOD
44	from	from	IN	_	40	NMOD
45	the	the	DT	_	47	NMOD
46	parental	parental	JJ	_	47	NMOD
47	strains	strain	NNS	_	44	PMOD
48	.	.	.	_	7	P

1	Furthermore	furthermore	RB	_	8	ADV
2	,	,	,	_	8	P
3	the	the	DT	_	7	NMOD
4	whole	whole	JJ	_	6	NMOD
5	-	-	HYPH	_	4	P
6	genome	genome	NN	_	7	NMOD
7	analysis	analysis	NN	_	8	SBJ
8	identified	identify	VBD	_	0	ROOT
9	the	the	DT	_	11	NMOD
10	129	0	CD	_	11	NMOD
11	region	region	NN	_	8	OBJ
12	surrounding	surround	VBG	_	11	NMOD
13	the	the	DT	_	15	NMOD
14	Apcs	apc	NN	_	15	NMOD
15	gene	gene	NN	_	12	OBJ
16	as	as	IN	_	8	ADV
17	the	the	DT	_	19	NMOD
18	main	main	JJ	_	19	NMOD
19	locus	locus	NN	_	16	PMOD
20	contributing	contribute	VBG	_	19	NMOD
21	to	to	IN	_	20	ADV
22	the	the	DT	_	23	NMOD
23	development	development	NN	_	21	PMOD
24	of	of	IN	_	23	NMOD
25	ANA	ana	NN	_	24	PMOD
26	and	and	CC	_	25	COORD
27	anti-chromatin	anti-chromatin	JJ	_	28	NMOD
28	Ab	ab	NN	_	26	CONJ
29	.	.	.	_	8	P

1	In	in	IN	_	37	ADV
2	agreement	agreement	NN	_	1	PMOD
3	with	with	IN	_	2	NMOD
4	this	this	DT	_	3	PMOD
5	,	,	,	_	37	P
6	when	when	WRB	_	8	TMP
7	we	we	PRP	_	8	SBJ
8	carried	carry	VBD	_	37	TMP
9	out	out	RP	_	8	PRT
10	a	a	DT	_	12	NMOD
11	selective	selective	JJ	_	12	NMOD
12	comparison	comparison	NN	_	8	OBJ
13	between	between	IN	_	12	NMOD
14	the	the	DT	_	28	NMOD
15	(	(	-LRB-	_	28	P
16	129	0	CD	_	18	NMOD
17	×	×	SYM	_	18	P
18	C57BL	c0bl	NN	_	22	NMOD
19	/	/	HYPH	_	18	P
20	6	0	CD	_	18	NMOD
21	)	)	-RRB-	_	22	P
22	F2	f0	NN	_	24	NMOD
23	.	.	HYPH	_	22	P
24	Apcs	apc	NN	_	28	NMOD
25	−	−	SYM	_	24	P
26	/	/	HYPH	_	24	P
27	−	−	SYM	_	24	P
28	mice	mouse	NNS	_	13	PMOD
29	and	and	CC	_	28	COORD
30	Chromosome	chromosome	NN	_	34	NMOD
31	1	0	CD	_	30	NMOD
32	genetically	genetically	RB	_	33	AMOD
33	matched	match	VBN	_	34	NMOD
34	controls	control	NNS	_	29	CONJ
35	,	,	,	_	37	P
36	we	we	PRP	_	37	SBJ
37	failed	fail	VBD	_	0	ROOT
38	to	to	TO	_	37	OPRD
39	detect	detect	VB	_	38	IM
40	any	any	DT	_	42	NMOD
41	significant	significant	JJ	_	42	NMOD
42	difference	difference	NN	_	39	OBJ
43	in	in	IN	_	42	NMOD
44	the	the	DT	_	45	NMOD
45	levels	level	NNS	_	43	PMOD
46	of	of	IN	_	45	NMOD
47	these	these	DT	_	49	NMOD
48	two	two	CD	_	49	NMOD
49	auto-Abs	auto-abs	NNS	_	46	PMOD
50	.	.	.	_	37	P

1	These	these	DT	_	2	NMOD
2	findings	finding	NNS	_	7	SBJ
3	,	,	,	_	7	P
4	taken	take	VBN	_	7	ADV
5	together	together	RB	_	4	ADV
6	,	,	,	_	7	P
7	indicated	indicate	VBD	_	0	ROOT
8	that	that	IN	_	7	OBJ
9	the	the	DT	_	10	NMOD
10	phenotype	phenotype	NN	_	15	SBJ
11	associated	associate	VBN	_	10	NMOD
12	with	with	IN	_	11	ADV
13	Apcs	apc	NN	_	14	NMOD
14	deficiency	deficiency	NN	_	12	PMOD
15	was	be	VBD	_	8	SUB
16	caused	cause	VBN	_	15	VC
17	by	by	IN	_	16	LGS
18	the	the	DT	_	19	NMOD
19	presence	presence	NN	_	17	PMOD
20	of	of	IN	_	19	NMOD
21	unaltered	unaltered	JJ	_	23	NMOD
22	129	0	CD	_	23	NMOD
23	genes	gene	NNS	_	20	PMOD
24	from	from	IN	_	23	NMOD
25	the	the	DT	_	27	NMOD
26	telomeric	telomeric	JJ	_	27	NMOD
27	region	region	NN	_	24	PMOD
28	of	of	IN	_	27	NMOD
29	Chromosome	chromosome	NN	_	28	PMOD
30	1	0	CD	_	29	NMOD
31	operating	operate	VBG	_	23	NMOD
32	in	in	IN	_	31	LOC
33	the	the	DT	_	38	NMOD
34	C57BL	c0bl	NN	_	38	NMOD
35	/	/	HYPH	_	34	P
36	6	0	CD	_	34	NMOD
37	genomic	genomic	JJ	_	38	NMOD
38	background	background	NN	_	32	PMOD
39	.	.	.	_	7	P

1	Strong	strong	JJ	_	3	NMOD
2	supportive	supportive	JJ	_	3	NMOD
3	evidence	evidence	NN	_	6	SBJ
4	for	for	IN	_	3	NMOD
5	this	this	DT	_	4	PMOD
6	was	be	VBD	_	0	ROOT
7	provided	provide	VBN	_	6	VC
8	by	by	IN	_	7	LGS
9	the	the	DT	_	10	NMOD
10	analysis	analysis	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	16	NMOD
13	C57BL	c0bl	NN	_	16	NMOD
14	/	/	HYPH	_	13	P
15	6	0	CD	_	13	NMOD
16	mice	mouse	NNS	_	11	PMOD
17	congenic	congenic	JJ	_	10	NMOD
18	for	for	IN	_	17	AMOD
19	this	this	DT	_	21	NMOD
20	129	0	CD	_	21	NMOD
21	region	region	NN	_	18	PMOD
22	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	generation	generation	NN	_	8	SBJ
3	and	and	CC	_	2	COORD
4	analysis	analysis	NN	_	3	CONJ
5	of	of	IN	_	2	NMOD
6	congenic	congenic	JJ	_	7	NMOD
7	strains	strain	NNS	_	5	PMOD
8	have	have	VBP	_	0	ROOT
9	successfully	successfully	RB	_	8	ADV
10	been	be	VBN	_	8	VC
11	used	use	VBN	_	10	VC
12	to	to	TO	_	11	PRP
13	dissect	dissect	VB	_	12	IM
14	the	the	DT	_	15	NMOD
15	contribution	contribution	NN	_	13	OBJ
16	of	of	IN	_	15	NMOD
17	individual	individual	JJ	_	19	NMOD
18	susceptibility	susceptibility	NN	_	19	NMOD
19	alleles	allele	NNS	_	16	PMOD
20	to	to	IN	_	15	NMOD
21	a	a	DT	_	23	NMOD
22	multigenic	multigenic	JJ	_	23	NMOD
23	trait	trait	NN	_	20	PMOD
24	such	such	JJ	_	25	PMOD
25	as	as	IN	_	23	NMOD
26	SLE	sle	NN	_	25	PMOD
27	.	.	.	_	8	P

1	We	we	PRP	_	2	SBJ
2	adopted	adopt	VBD	_	0	ROOT
3	the	the	DT	_	5	NMOD
4	same	same	JJ	_	5	NMOD
5	strategy	strategy	NN	_	2	OBJ
6	to	to	TO	_	2	PRP
7	investigate	investigate	VB	_	6	IM
8	the	the	DT	_	10	NMOD
9	relative	relative	JJ	_	10	NMOD
10	contribution	contribution	NN	_	7	OBJ
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	16	NMOD
13	129	0	CD	_	16	NMOD
14	Chromosome	chromosome	NN	_	16	NMOD
15	1	0	CD	_	14	NMOD
16	segment	segment	NN	_	11	PMOD
17	and	and	CC	_	16	COORD
18	the	the	DT	_	20	NMOD
19	Apcs	apc	NN	_	20	NMOD
20	gene	gene	NN	_	17	CONJ
21	to	to	IN	_	10	NMOD
22	each	each	DT	_	24	NMOD
23	disease	disease	NN	_	24	NMOD
24	trait	trait	NN	_	21	PMOD
25	.	.	.	_	2	P

1	Using	use	VBG	_	6	MNR
2	this	this	DT	_	3	NMOD
3	approach	approach	NN	_	1	OBJ
4	,	,	,	_	6	P
5	we	we	PRP	_	6	SBJ
6	demonstrated	demonstrate	VBD	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	the	the	DT	_	10	NMOD
9	129	0	CD	_	10	NMOD
10	interval	interval	NN	_	44	SBJ
11	on	on	IN	_	10	LOC
12	distal	distal	JJ	_	13	NMOD
13	Chromosome	chromosome	NN	_	11	PMOD
14	1	0	CD	_	13	NMOD
15	,	,	,	_	44	P
16	when	when	WRB	_	17	TMP
17	transferred	transfer	VBN	_	44	TMP
18	onto	onto	IN	_	17	ADV
19	the	the	DT	_	23	NMOD
20	C57BL	c0bl	NN	_	23	NMOD
21	/	/	HYPH	_	20	P
22	6	0	CD	_	20	NMOD
23	genome	genome	NN	_	18	PMOD
24	,	,	,	_	23	P
25	a	a	DT	_	26	NMOD
26	combination	combination	NN	_	23	APPO
27	commonly	commonly	RB	_	28	TMP
28	created	create	VBN	_	26	NMOD
29	by	by	IN	_	28	ADV
30	backcrossing	backcross	VBG	_	29	PMOD
31	onto	onto	IN	_	30	ADV
32	C57BL	c0bl	NN	_	31	PMOD
33	/	/	HYPH	_	32	P
34	6	0	CD	_	32	NMOD
35	a	a	DT	_	37	NMOD
36	mutated	mutate	VBN	_	37	NMOD
37	gene	gene	NN	_	30	OBJ
38	located	locate	VBN	_	37	NMOD
39	in	in	IN	_	38	LOC
40	that	that	DT	_	42	NMOD
41	chromosomal	chromosomal	JJ	_	42	NMOD
42	region	region	NN	_	39	PMOD
43	,	,	,	_	44	P
44	was	be	VBD	_	7	SUB
45	sufficient	sufficient	JJ	_	44	PRD
46	to	to	TO	_	45	AMOD
47	mediate	mediate	VB	_	46	IM
48	the	the	DT	_	49	NMOD
49	production	production	NN	_	47	OBJ
50	of	of	IN	_	49	NMOD
51	auto-Abs	auto-abs	NNS	_	50	PMOD
52	.	.	.	_	6	P

1	In	in	IN	_	6	ADV
2	this	this	DT	_	3	NMOD
3	context	context	NN	_	1	PMOD
4	,	,	,	_	6	P
5	it	it	PRP	_	6	SBJ
6	is	be	VBZ	_	0	ROOT
7	of	of	IN	_	6	PRD
8	note	note	NN	_	7	PMOD
9	that	that	IN	_	6	OBJ
10	several	several	JJ	_	11	NMOD
11	strains	strain	NNS	_	23	SBJ
12	of	of	IN	_	11	NMOD
13	mice	mouse	NNS	_	12	PMOD
14	with	with	IN	_	13	NMOD
15	targeted	target	VBN	_	16	NMOD
16	mutations	mutation	NNS	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	genes	gene	NNS	_	17	PMOD
19	encoded	encode	VBN	_	18	NMOD
20	in	in	IN	_	19	LOC
21	this	this	DT	_	22	NMOD
22	region	region	NN	_	20	PMOD
23	have	have	VBP	_	9	SUB
24	been	be	VBN	_	23	VC
25	reported	report	VBN	_	24	VC
26	to	to	TO	_	25	OPRD
27	express	express	VB	_	26	IM
28	a	a	DT	_	32	NMOD
29	lupus	lupus	NN	_	31	AMOD
30	-	-	HYPH	_	29	P
31	like	like	JJ	_	32	NMOD
32	illness	illness	NN	_	27	OBJ
33	,	,	,	_	25	P
34	including	include	VBG	_	25	ADV
35	mice	mouse	NNS	_	34	PMOD
36	lacking	lack	VBG	_	35	NMOD
37	FcγRIIB	fcγriib	NN	_	36	OBJ
38	(	(	-LRB-	_	39	P
39	Bolland	bolland	NNP	_	37	NMOD
40	and	and	CC	_	39	COORD
41	Ravetch	ravetch	NNP	_	40	CONJ
42	2000	0	CD	_	39	DEP
43	)	)	-RRB-	_	39	P
44	,	,	,	_	37	P
45	complement	complement	NN	_	46	NMOD
46	receptors	receptor	NNS	_	48	NMOD
47	(	(	-LRB-	_	48	P
48	CR1	cr0	NN	_	37	CONJ
49	/	/	HYPH	_	48	P
50	2	0	CD	_	48	NMOD
51	)	)	-RRB-	_	48	P
52	(	(	-LRB-	_	53	P
53	Prodeus	prodeus	NNP	_	48	NMOD
54	et	et	FW	_	53	DEP
55	al.	al.	FW	_	53	DEP
56	1998	0	CD	_	53	DEP
57	;	;	:	_	53	P
58	Wu	wu	NNP	_	53	DEP
59	et	et	FW	_	53	DEP
60	al.	al.	FW	_	53	DEP
61	2002	0	CD	_	53	DEP
62	)	)	-RRB-	_	53	P
63	,	,	,	_	48	P
64	and	and	CC	_	48	COORD
65	decay	decay	NN	_	67	AMOD
66	-	-	HYPH	_	65	P
67	accelerating	accelerate	VBG	_	68	NMOD
68	factor	factor	NN	_	70	NMOD
69	(	(	-LRB-	_	70	P
70	CD55	cd0	NN	_	64	CONJ
71	)	)	-RRB-	_	70	P
72	(	(	-LRB-	_	73	P
73	Miwa	miwa	NNP	_	70	NMOD
74	et	et	FW	_	73	DEP
75	al.	al.	FW	_	73	DEP
76	2002	0	CD	_	73	DEP
77	)	)	-RRB-	_	73	P
78	.	.	.	_	6	P

1	In	in	IN	_	8	ADV
2	each	each	DT	_	3	NMOD
3	case	case	NN	_	1	PMOD
4	,	,	,	_	8	P
5	the	the	DT	_	7	NMOD
6	autoimmune	autoimmune	JJ	_	7	NMOD
7	phenotype	phenotype	NN	_	8	SBJ
8	was	be	VBD	_	0	ROOT
9	described	describe	VBN	_	8	VC
10	in	in	IN	_	9	LOC
11	mice	mouse	NNS	_	10	PMOD
12	in	in	IN	_	18	LOC
13	which	which	WDT	_	12	PMOD
14	the	the	DT	_	16	NMOD
15	null	null	JJ	_	16	NMOD
16	mutation	mutation	NN	_	17	SBJ
17	was	be	VBD	_	11	NMOD
18	generated	generate	VBN	_	17	VC
19	in	in	IN	_	18	LOC
20	129	0	CD	_	23	NMOD
21	embryonic	embryonic	JJ	_	23	NMOD
22	stem	stem	NN	_	23	NMOD
23	cells	cell	NNS	_	19	PMOD
24	and	and	CC	_	18	COORD
25	then	then	RB	_	26	TMP
26	backcrossed	backcross	VBD	_	24	CONJ
27	to	to	IN	_	26	ADV
28	the	the	DT	_	29	NMOD
29	C57BL	c0bl	NN	_	27	PMOD
30	/	/	HYPH	_	29	P
31	6	0	CD	_	29	NMOD
32	or	or	CC	_	29	COORD
33	another	another	DT	_	35	NMOD
34	genetic	genetic	JJ	_	35	NMOD
35	background	background	NN	_	32	CONJ
36	.	.	.	_	8	P

1	Thus	thus	RB	_	10	ADV
2	,	,	,	_	10	P
3	in	in	IN	_	10	ADV
4	view	view	NN	_	3	PMOD
5	of	of	IN	_	4	NMOD
6	our	our	PRP$	_	7	NMOD
7	findings	finding	NNS	_	5	PMOD
8	,	,	,	_	10	P
9	one	one	PRP	_	10	SBJ
10	may	may	MD	_	0	ROOT
11	postulate	postulate	VB	_	10	VC
12	that	that	IN	_	11	OBJ
13	in	in	IN	_	29	ADV
14	each	each	DT	_	13	PMOD
15	of	of	IN	_	14	NMOD
16	these	these	DT	_	18	NMOD
17	murine	murine	JJ	_	18	NMOD
18	models	model	NNS	_	15	PMOD
19	of	of	IN	_	18	NMOD
20	SLE	sle	NN	_	19	PMOD
21	,	,	,	_	29	P
22	the	the	DT	_	23	NMOD
23	effects	effect	NNS	_	29	SBJ
24	of	of	IN	_	23	NMOD
25	the	the	DT	_	28	NMOD
26	targeted	target	VBN	_	28	NMOD
27	null	null	JJ	_	28	NMOD
28	gene	gene	NN	_	24	PMOD
29	were	be	VBD	_	12	SUB
30	irrelevant	irrelevant	JJ	_	29	PRD
31	.	.	.	_	10	P

1	Similar	similar	JJ	_	2	NMOD
2	conclusions	conclusion	NNS	_	3	SBJ
3	may	may	MD	_	0	ROOT
4	apply	apply	VB	_	3	VC
5	to	to	IN	_	4	ADV
6	other	other	JJ	_	10	NMOD
7	gene	gene	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	targeted	target	VBN	_	10	NMOD
10	animals	animal	NNS	_	5	PMOD
11	carrying	carry	VBG	_	10	NMOD
12	mutations	mutation	NNS	_	11	OBJ
13	of	of	IN	_	12	NMOD
14	genes	gene	NNS	_	13	PMOD
15	mapped	map	VBN	_	14	NMOD
16	in	in	IN	_	15	ADV
17	the	the	DT	_	22	NMOD
18	129	0	CD	_	20	AMOD
19	-	-	HYPH	_	18	P
20	derived	derive	VBN	_	22	NMOD
21	susceptibility	susceptibility	NN	_	22	NMOD
22	allele	allele	NN	_	16	PMOD
23	on	on	IN	_	15	LOC
24	Chromosome	chromosome	NN	_	23	PMOD
25	7	0	CD	_	24	NMOD
26	(	(	-LRB-	_	27	P
27	O'Keefe	o'keefe	NNP	_	4	CIT
28	et	et	FW	_	27	DEP
29	al.	al.	FW	_	27	DEP
30	1996	0	CD	_	27	DEP
31	,	,	,	_	27	P
32	1999	0	CD	_	27	DEP
33	)	)	-RRB-	_	27	P
34	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	expression	expression	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	anti-nuclear	anti-nuclear	JJ	_	5	NMOD
5	autoimmunity	autoimmunity	NN	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	identical	identical	JJ	_	6	PRD
8	comparing	compare	VBG	_	6	ADV
9	the	the	DT	_	10	NMOD
10	congenic	congenic	JJ	_	8	OBJ
11	with	with	IN	_	8	ADV
12	the	the	DT	_	13	NMOD
13	Apcs	apc	NN	_	11	PMOD
14	−	−	SYM	_	13	P
15	/	/	HYPH	_	13	P
16	−	−	SYM	_	13	P
17	mice	mouse	NNS	_	13	NMOD
18	.	.	.	_	6	P

1	The	the	DT	_	3	NMOD
2	only	only	JJ	_	3	NMOD
3	difference	difference	NN	_	9	SBJ
4	in	in	IN	_	3	NMOD
5	phenotype	phenotype	NN	_	4	PMOD
6	between	between	IN	_	3	NMOD
7	these	these	DT	_	8	NMOD
8	mice	mouse	NNS	_	6	PMOD
9	was	be	VBD	_	0	ROOT
10	in	in	IN	_	9	PRD
11	the	the	DT	_	12	NMOD
12	expression	expression	NN	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	glomerulonephritis	glomerulonephritis	NN	_	13	PMOD
15	,	,	,	_	12	P
16	which	which	WDT	_	17	SBJ
17	was	be	VBD	_	12	NMOD
18	more	more	RBR	_	19	AMOD
19	pronounced	pronounced	JJ	_	17	PRD
20	in	in	IN	_	17	LOC
21	the	the	DT	_	26	NMOD
22	Apcs	apc	NN	_	26	NMOD
23	−	−	SYM	_	22	P
24	/	/	HYPH	_	22	P
25	−	−	SYM	_	22	P
26	mice	mouse	NNS	_	20	PMOD
27	compared	compare	VBN	_	17	ADV
28	with	with	IN	_	27	PMOD
29	the	the	DT	_	31	NMOD
30	congenic	congenic	JJ	_	31	NMOD
31	mice	mouse	NNS	_	28	PMOD
32	.	.	.	_	9	P

1	Although	although	IN	_	24	ADV
2	these	these	DT	_	3	NMOD
3	findings	finding	NNS	_	4	SBJ
4	demonstrate	demonstrate	VBP	_	1	SUB
5	that	that	IN	_	4	OBJ
6	Apcs	apc	NN	_	7	SBJ
7	is	be	VBZ	_	5	SUB
8	not	not	RB	_	7	ADV
9	implicated	implicate	VBN	_	7	VC
10	in	in	IN	_	9	ADV
11	the	the	DT	_	12	NMOD
12	processing	processing	NN	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	autoantigens	autoantigens	NNS	_	13	PMOD
15	,	,	,	_	9	P
16	as	as	IN	_	9	ADV
17	it	it	PRP	_	18	SBJ
18	had	have	VBD	_	16	SUB
19	previously	previously	RB	_	18	TMP
20	been	be	VBN	_	18	VC
21	suggested	suggest	VBN	_	20	VC
22	,	,	,	_	24	P
23	they	they	PRP	_	24	SBJ
24	indicate	indicate	VBP	_	0	ROOT
25	that	that	IN	_	24	OBJ
26	Apcs	apc	NN	_	27	SBJ
27	might	might	MD	_	25	SUB
28	still	still	RB	_	27	ADV
29	play	play	VB	_	27	VC
30	an	an	DT	_	33	NMOD
31	important	important	JJ	_	33	NMOD
32	protective	protective	JJ	_	33	NMOD
33	role	role	NN	_	29	OBJ
34	in	in	IN	_	29	ADV
35	lupus	lupus	NN	_	36	NMOD
36	nephritis	nephritis	NN	_	34	PMOD
37	.	.	.	_	24	P

1	In	in	IN	_	26	ADV
2	support	support	NN	_	1	PMOD
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	3	PMOD
5	,	,	,	_	26	P
6	the	the	DT	_	7	NMOD
7	expression	expression	NN	_	26	SBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	14	NMOD
10	human	human	JJ	_	14	NMOD
11	C	c	NN	_	13	AMOD
12	-	-	HYPH	_	11	P
13	reactive	reactive	JJ	_	14	NMOD
14	protein	protein	NN	_	8	PMOD
15	,	,	,	_	14	P
16	an	an	DT	_	20	NMOD
17	acute	acute	JJ	_	19	NMOD
18	-	-	HYPH	_	17	P
19	phase	phase	NN	_	20	NMOD
20	protein	protein	NN	_	14	APPO
21	closely	closely	RB	_	22	AMOD
22	related	related	JJ	_	20	NMOD
23	to	to	IN	_	22	AMOD
24	Apcs	apc	NN	_	23	PMOD
25	,	,	,	_	26	P
26	has	have	VBZ	_	0	ROOT
27	been	be	VBN	_	26	VC
28	shown	show	VBN	_	27	VC
29	to	to	TO	_	28	OPRD
30	delay	delay	VB	_	29	IM
31	the	the	DT	_	32	NMOD
32	onset	onset	NN	_	30	OBJ
33	and	and	CC	_	32	COORD
34	severity	severity	NN	_	33	CONJ
35	of	of	IN	_	32	NMOD
36	lupus	lupus	NN	_	37	NMOD
37	nephritis	nephritis	NN	_	35	PMOD
38	in	in	IN	_	30	LOC
39	the	the	DT	_	43	NMOD
40	NZB	nzb	NN	_	42	NMOD
41	/	/	HYPH	_	40	P
42	W	w	NN	_	43	NMOD
43	strain	strain	NN	_	38	PMOD
44	by	by	IN	_	30	MNR
45	preventing	prevent	VBG	_	44	PMOD
46	the	the	DT	_	47	NMOD
47	deposition	deposition	NN	_	45	OBJ
48	of	of	IN	_	47	NMOD
49	immune	immune	JJ	_	50	NMOD
50	complexes	complex	NNS	_	48	PMOD
51	in	in	IN	_	45	LOC
52	the	the	DT	_	54	NMOD
53	renal	renal	JJ	_	54	NMOD
54	cortex	cortex	NN	_	51	PMOD
55	(	(	-LRB-	_	56	P
56	Szalai	szalai	NNP	_	30	CIT
57	et	et	FW	_	56	DEP
58	al.	al.	FW	_	56	DEP
59	2003	0	CD	_	56	DEP
60	)	)	-RRB-	_	56	P
61	.	.	.	_	26	P

1	Consistent	consistent	JJ	_	17	ADV
2	with	with	IN	_	1	AMOD
3	this	this	DT	_	2	PMOD
4	,	,	,	_	17	P
5	a	a	DT	_	6	NMOD
6	polymorphism	polymorphism	NN	_	17	SBJ
7	associated	associate	VBN	_	6	NMOD
8	with	with	IN	_	7	ADV
9	reduced	reduce	VBN	_	11	NMOD
10	basal	basal	JJ	_	11	NMOD
11	level	level	NN	_	8	PMOD
12	of	of	IN	_	11	NMOD
13	C	c	NN	_	15	AMOD
14	-	-	HYPH	_	13	P
15	reactive	reactive	JJ	_	16	NMOD
16	protein	protein	NN	_	12	PMOD
17	has	have	VBZ	_	0	ROOT
18	been	be	VBN	_	17	VC
19	reported	report	VBN	_	18	VC
20	to	to	TO	_	19	OPRD
21	be	be	VB	_	20	IM
22	linked	link	VBN	_	21	VC
23	to	to	IN	_	22	ADV
24	SLE	sle	NN	_	23	PMOD
25	in	in	IN	_	22	LOC
26	humans	human	NNS	_	25	PMOD
27	(	(	-LRB-	_	28	P
28	Russell	russell	NNP	_	22	CIT
29	et	et	FW	_	28	DEP
30	al.	al.	FW	_	28	DEP
31	2004	0	CD	_	28	DEP
32	)	)	-RRB-	_	28	P
33	.	.	.	_	17	P

1	However	however	RB	_	31	ADV
2	,	,	,	_	31	P
3	as	as	IN	_	31	ADV
4	the	the	DT	_	6	NMOD
5	congenic	congenic	JJ	_	6	NMOD
6	mice	mouse	NNS	_	14	SBJ
7	and	and	CC	_	6	COORD
8	the	the	DT	_	13	NMOD
9	Apcs	apc	NN	_	13	NMOD
10	−	−	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	−	−	SYM	_	9	P
13	mice	mouse	NNS	_	7	CONJ
14	carried	carry	VBN	_	3	SUB
15	similar	similar	JJ	_	20	NMOD
16	but	but	CC	_	15	COORD
17	not	not	RB	_	16	ADV
18	identical	identical	JJ	_	16	CONJ
19	129	0	CD	_	20	NMOD
20	regions	region	NNS	_	14	OBJ
21	on	on	IN	_	14	LOC
22	Chromosome	chromosome	NN	_	21	PMOD
23	1	0	CD	_	22	NMOD
24	,	,	,	_	31	P
25	an	an	DT	_	27	NMOD
26	alternative	alternative	JJ	_	27	NMOD
27	explanation	explanation	NN	_	31	SBJ
28	for	for	IN	_	27	NMOD
29	our	our	PRP$	_	30	NMOD
30	findings	finding	NNS	_	28	PMOD
31	may	may	MD	_	0	ROOT
32	still	still	RB	_	31	ADV
33	lay	lie	VB	_	31	VC
34	in	in	IN	_	33	ADV
35	the	the	DT	_	42	NMOD
36	numerous	numerous	JJ	_	42	NMOD
37	and	and	CC	_	36	COORD
38	complex	complex	JJ	_	37	CONJ
39	synergistic	synergistic	JJ	_	42	NMOD
40	and	and	CC	_	39	COORD
41	counteractive	counteractive	JJ	_	40	CONJ
42	interactions	interaction	NNS	_	34	PMOD
43	between	between	IN	_	42	NMOD
44	129	0	CD	_	49	NMOD
45	and	and	CC	_	44	COORD
46	C57BL	c0bl	NN	_	45	CONJ
47	/	/	HYPH	_	46	P
48	6	0	CD	_	46	NMOD
49	genes	gene	NNS	_	43	PMOD
50	involved	involve	VBN	_	49	NMOD
51	in	in	IN	_	50	ADV
52	self	self	NN	_	54	NMOD
53	-	-	HYPH	_	52	P
54	tolerance	tolerance	NN	_	51	PMOD
55	and	and	CC	_	54	COORD
56	end	end	NN	_	58	NMOD
57	organ	organ	NN	_	58	NMOD
58	damage	damage	NN	_	55	CONJ
59	.	.	.	_	31	P

1	Thus	thus	RB	_	31	ADV
2	,	,	,	_	31	P
3	whilst	whilst	IN	_	31	ADV
4	the	the	DT	_	5	NMOD
5	lack	lack	NN	_	13	SBJ
6	of	of	IN	_	5	NMOD
7	lupus	lupus	NN	_	8	NMOD
8	nephritis	nephritis	NN	_	6	PMOD
9	in	in	IN	_	5	LOC
10	the	the	DT	_	12	NMOD
11	congenic	congenic	JJ	_	12	NMOD
12	mice	mouse	NNS	_	9	PMOD
13	is	be	VBZ	_	3	SUB
14	consistent	consistent	JJ	_	13	PRD
15	with	with	IN	_	14	AMOD
16	the	the	DT	_	17	NMOD
17	need	need	NN	_	15	PMOD
18	for	for	IN	_	17	NMOD
19	multiple	multiple	JJ	_	21	NMOD
20	susceptibility	susceptibility	NN	_	21	NMOD
21	genes	gene	NNS	_	18	PMOD
22	for	for	IN	_	17	NMOD
23	the	the	DT	_	25	NMOD
24	full	full	JJ	_	25	NMOD
25	expression	expression	NN	_	22	PMOD
26	of	of	IN	_	25	NMOD
27	lupus	lupus	NN	_	26	PMOD
28	,	,	,	_	31	P
29	further	further	JJ	_	30	NMOD
30	studies	study	NNS	_	31	SBJ
31	will	will	MD	_	0	ROOT
32	be	be	VB	_	31	VC
33	required	require	VBN	_	32	VC
34	to	to	TO	_	33	PRP
35	fully	fully	RB	_	34	ADV
36	elucidate	elucidate	VB	_	34	IM
37	the	the	DT	_	38	NMOD
38	role	role	NN	_	36	OBJ
39	of	of	IN	_	38	NMOD
40	Apcs	apc	NN	_	39	PMOD
41	in	in	IN	_	38	NMOD
42	the	the	DT	_	43	NMOD
43	pathogenesis	pathogenesis	NN	_	41	PMOD
44	of	of	IN	_	43	NMOD
45	renal	renal	JJ	_	46	NMOD
46	damage	damage	NN	_	44	PMOD
47	.	.	.	_	31	P

1	In	in	IN	_	6	ADV
2	summary	summary	NN	_	1	PMOD
3	,	,	,	_	6	P
4	our	our	PRP$	_	5	NMOD
5	findings	finding	NNS	_	6	SBJ
6	demonstrate	demonstrate	VBP	_	0	ROOT
7	the	the	DT	_	8	NMOD
8	impact	impact	NN	_	6	OBJ
9	of	of	IN	_	8	NMOD
10	epistatic	epistatic	JJ	_	11	NMOD
11	interactions	interaction	NNS	_	9	PMOD
12	between	between	IN	_	11	NMOD
13	129	0	CD	_	18	NMOD
14	and	and	CC	_	13	COORD
15	C57BL	c0bl	NN	_	14	CONJ
16	/	/	HYPH	_	15	P
17	6	0	CD	_	15	NMOD
18	genomes	genome	NNS	_	12	PMOD
19	on	on	IN	_	8	NMOD
20	the	the	DT	_	21	NMOD
21	development	development	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	SLE	sle	NN	_	22	PMOD
24	and	and	CC	_	6	COORD
25	illustrate	illustrate	VBP	_	24	CONJ
26	how	how	WRB	_	32	MNR
27	these	these	DT	_	30	NMOD
28	background	background	NN	_	29	NMOD
29	gene	gene	NN	_	30	NMOD
30	effects	effect	NNS	_	31	SBJ
31	may	may	MD	_	25	OBJ
32	lead	lead	VB	_	31	VC
33	to	to	IN	_	32	ADV
34	incorrect	incorrect	JJ	_	35	NMOD
35	interpretations	interpretation	NNS	_	33	PMOD
36	when	when	WRB	_	37	TMP
37	analysing	analyse	VBG	_	32	TMP
38	the	the	DT	_	40	NMOD
39	autoimmune	autoimmune	JJ	_	40	NMOD
40	phenotype	phenotype	NN	_	37	OBJ
41	of	of	IN	_	40	NMOD
42	specific	specific	JJ	_	44	NMOD
43	genetic	genetic	JJ	_	44	NMOD
44	disruptions	disruption	NNS	_	41	PMOD
45	.	.	.	_	6	P

1	Materials	material	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Methods	method	NNS	_	2	CONJ

1	Mice	mouse	NNS	_	0	ROOT
2	.	.	.	_	1	P

1	All	all	PDT	_	3	NMOD
2	the	the	DT	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	females	female	NNS	_	4	PRD
6	.	.	.	_	4	P

1	Wild	wild	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	type	type	NN	_	4	NMOD
4	C57BL	c0bl	NN	_	20	SBJ
5	/	/	HYPH	_	4	P
6	6	0	CD	_	4	NMOD
7	and	and	CC	_	4	COORD
8	129	0	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	Sv	sv	NN	_	12	NMOD
11	(	(	-LRB-	_	12	P
12	129S6	0s0	NN	_	7	CONJ
13	,	,	,	_	12	P
14	according	accord	VBG	_	12	NMOD
15	to	to	IN	_	14	PMOD
16	the	the	DT	_	18	NMOD
17	revised	revise	VBN	_	18	NMOD
18	nomenclature	nomenclature	NN	_	15	PMOD
19	)	)	-RRB-	_	12	P
20	were	be	VBD	_	0	ROOT
21	bred	breed	VBN	_	20	VC
22	and	and	CC	_	21	COORD
23	maintained	maintain	VBN	_	22	CONJ
24	in	in	IN	_	21	LOC
25	the	the	DT	_	28	NMOD
26	animal	animal	NN	_	27	NMOD
27	care	care	NN	_	28	NMOD
28	facility	facility	NN	_	24	PMOD
29	at	at	IN	_	21	LOC
30	Imperial	imperial	NNP	_	31	NMOD
31	College	college	NNP	_	29	PMOD
32	,	,	,	_	31	P
33	London	london	NNP	_	31	APPO
34	,	,	,	_	33	P
35	United	united	NNP	_	36	NMOD
36	Kingdom	kingdom	NNP	_	33	APPO
37	.	.	.	_	20	P

1	(	(	-LRB-	_	9	P
2	129	0	CD	_	4	NMOD
3	×	×	SYM	_	4	P
4	C57BL	c0bl	NN	_	9	NMOD
5	/	/	HYPH	_	4	P
6	6	0	CD	_	4	NMOD
7	)	)	-RRB-	_	9	P
8	F1	f0	NN	_	9	NMOD
9	mice	mouse	NNS	_	10	SBJ
10	were	be	VBD	_	0	ROOT
11	generated	generate	VBN	_	10	VC
12	by	by	IN	_	11	ADV
13	intercrossing	intercrossing	VBG	_	12	PMOD
14	the	the	DT	_	19	NMOD
15	two	two	CD	_	19	NMOD
16	wild	wild	JJ	_	18	NMOD
17	-	-	HYPH	_	16	P
18	type	type	NN	_	19	NMOD
19	strains	strain	NNS	_	13	OBJ
20	and	and	CC	_	11	COORD
21	(	(	-LRB-	_	29	P
22	129	0	CD	_	24	NMOD
23	×	×	SYM	_	24	P
24	C57BL	c0bl	NN	_	29	NMOD
25	/	/	HYPH	_	24	P
26	6	0	CD	_	24	NMOD
27	)	)	-RRB-	_	29	P
28	F2	f0	NN	_	29	NMOD
29	mice	mouse	NNS	_	20	GAP-SBJ
30	by	by	IN	_	29	ADV
31	interbreeding	interbreed	VBG	_	30	PMOD
32	the	the	DT	_	41	NMOD
33	(	(	-LRB-	_	41	P
34	129	0	CD	_	36	NMOD
35	×	×	SYM	_	36	P
36	C57BL	c0bl	NN	_	41	NMOD
37	/	/	HYPH	_	36	P
38	6	0	CD	_	36	NMOD
39	)	)	-RRB-	_	41	P
40	F1	f0	NN	_	41	NMOD
41	mice	mouse	NNS	_	31	OBJ
42	.	.	.	_	10	P

1	The	the	DT	_	6	NMOD
2	Apcs	apc	NN	_	6	NMOD
3	−	−	SYM	_	2	P
4	/	/	HYPH	_	2	P
5	−	−	SYM	_	2	P
6	mice	mouse	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	generated	generate	VBN	_	7	VC
9	as	as	IN	_	8	MNR
10	previously	previously	RB	_	11	TMP
11	reported	report	VBN	_	9	SUB
12	(	(	-LRB-	_	13	P
13	Botto	botto	NNP	_	11	CIT
14	et	et	FW	_	13	DEP
15	al.	al.	FW	_	13	DEP
16	1997	0	CD	_	13	DEP
17	)	)	-RRB-	_	13	P
18	,	,	,	_	7	P
19	and	and	CC	_	7	COORD
20	the	the	DT	_	34	NMOD
21	(	(	-LRB-	_	28	P
22	129	0	CD	_	24	NMOD
23	×	×	SYM	_	24	P
24	C57BL	c0bl	NN	_	28	NMOD
25	/	/	HYPH	_	24	P
26	6	0	CD	_	24	NMOD
27	)	)	-RRB-	_	28	P
28	F2	f0	NN	_	30	NMOD
29	.	.	HYPH	_	28	P
30	Apcs	apc	NN	_	34	NMOD
31	−	−	SYM	_	30	P
32	/	/	HYPH	_	30	P
33	−	−	SYM	_	30	P
34	mice	mouse	NNS	_	35	SBJ
35	were	be	VBD	_	19	CONJ
36	generated	generate	VBN	_	35	VC
37	by	by	IN	_	36	ADV
38	intercrossing	intercrossing	VBG	_	37	PMOD
39	Apcs	apc	NNP	_	43	NMOD
40	−	−	SYM	_	39	P
41	/	/	HYPH	_	39	P
42	−	−	SYM	_	39	P
43	mice	mouse	NNS	_	38	OBJ
44	on	on	IN	_	38	ADV
45	the	the	DT	_	48	NMOD
46	129	0	CD	_	48	NMOD
47	genetic	genetic	JJ	_	48	NMOD
48	background	background	NN	_	44	PMOD
49	with	with	IN	_	38	ADV
50	Apcs	apc	NN	_	54	NMOD
51	−	−	SYM	_	50	P
52	/	/	HYPH	_	50	P
53	−	−	SYM	_	50	P
54	animals	animal	NNS	_	49	PMOD
55	backcrossed	backcross	VBN	_	54	NMOD
56	onto	onto	IN	_	55	ADV
57	C57BL	c0bl	NN	_	56	PMOD
58	/	/	HYPH	_	57	P
59	6	0	CD	_	57	NMOD
60	for	for	IN	_	55	TMP
61	ten	ten	CD	_	62	NMOD
62	generations	generation	NNS	_	60	PMOD
63	.	.	.	_	7	P

1	A	a	DT	_	2	NMOD
2	total	total	NN	_	30	SBJ
3	of	of	IN	_	2	NMOD
4	141	0	CD	_	12	NMOD
5	(	(	-LRB-	_	12	P
6	129	0	CD	_	8	NMOD
7	×	×	SYM	_	8	P
8	C57BL	c0bl	NN	_	12	NMOD
9	/	/	HYPH	_	8	P
10	6	0	CD	_	8	NMOD
11	)	)	-RRB-	_	12	P
12	F2	f0	NN	_	3	PMOD
13	and	and	CC	_	12	COORD
14	158	0	CD	_	24	NMOD
15	(	(	-LRB-	_	24	P
16	129	0	CD	_	18	NMOD
17	×	×	SYM	_	18	P
18	C57BL	c0bl	NN	_	22	NMOD
19	/	/	HYPH	_	18	P
20	6	0	CD	_	18	NMOD
21	)	)	-RRB-	_	22	P
22	F2	f0	NN	_	24	NMOD
23	.	.	HYPH	_	22	P
24	Apcs	apc	NN	_	13	CONJ
25	−	−	SYM	_	24	P
26	/	/	HYPH	_	24	P
27	−	−	SYM	_	24	P
28	female	female	JJ	_	29	NMOD
29	mice	mouse	NNS	_	24	NMOD
30	were	be	VBD	_	0	ROOT
31	produced	produce	VBN	_	30	VC
32	and	and	CC	_	31	COORD
33	monitored	monitor	VBN	_	32	CONJ
34	for	for	IN	_	31	TMP
35	1	0	CD	_	36	NMOD
36	y	y	NN	_	34	PMOD
37	.	.	.	_	30	P

1	Wild	wild	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	type	type	NN	_	15	NMOD
4	congenic	congenic	JJ	_	15	NMOD
5	C57BL	c0bl	NN	_	9	NMOD
6	/	/	HYPH	_	5	P
7	6	0	CD	_	5	NMOD
8	.	.	HYPH	_	5	P
9	129	0	CD	_	15	NMOD
10	(	(	-LRB-	_	11	P
11	D1Mit105	d0mit0	NN	_	9	PRN
12	–	–	SYM	_	13	P
13	223	0	CD	_	11	NMOD
14	)	)	-RRB-	_	11	P
15	mice	mouse	NNS	_	16	SBJ
16	were	be	VBD	_	0	ROOT
17	generated	generate	VBN	_	16	VC
18	by	by	IN	_	17	MNR
19	backcrossing	backcross	VBG	_	18	PMOD
20	the	the	DT	_	22	NMOD
21	129	0	CD	_	22	NMOD
22	interval	interval	NN	_	19	OBJ
23	between	between	IN	_	22	NMOD
24	microsatellites	microsatellites	NNS	_	25	NMOD
25	D1Mit105	d0mit0	NN	_	23	PMOD
26	and	and	CC	_	25	COORD
27	D1Mit223	d0mit0	NN	_	26	CONJ
28	(	(	-LRB-	_	30	P
29	80	0	CD	_	30	NMOD
30	cM	cm	NN	_	25	PRN
31	to	to	IN	_	30	NMOD
32	106	0	CD	_	33	NMOD
33	cM	cm	NN	_	31	PMOD
34	)	)	-RRB-	_	30	P
35	onto	onto	IN	_	19	ADV
36	the	the	DT	_	40	NMOD
37	C57BL	c0bl	NN	_	40	NMOD
38	/	/	HYPH	_	37	P
39	6	0	CD	_	37	NMOD
40	strain	strain	NN	_	35	PMOD
41	.	.	.	_	16	P

1	Inherited	inherit	VBN	_	3	NMOD
2	129	0	CD	_	3	NMOD
3	regions	region	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	mapped	map	VBN	_	4	VC
6	with	with	IN	_	5	ADV
7	microsatellite	microsatellite	NN	_	8	NMOD
8	markers	marker	NNS	_	6	PMOD
9	polymorphic	polymorphic	JJ	_	8	NMOD
10	between	between	IN	_	9	AMOD
11	129	0	CD	_	16	NMOD
12	and	and	CC	_	11	COORD
13	C57BL	c0bl	NN	_	12	CONJ
14	/	/	HYPH	_	13	P
15	6	0	CD	_	13	NMOD
16	mice	mouse	NNS	_	10	PMOD
17	(	(	-LRB-	_	18	P
18	see	see	VB	_	16	PRN
19	below	below	RB	_	18	ADV
20	)	)	-RRB-	_	18	P
21	.	.	.	_	4	P

1	After	after	IN	_	8	TMP
2	seven	seven	CD	_	3	NMOD
3	generations	generation	NNS	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	backcrossing	backcross	VBG	_	4	PMOD
6	,	,	,	_	8	P
7	siblings	sibling	NNS	_	8	SBJ
8	were	be	VBD	_	0	ROOT
9	intercrossed	intercrossed	VBN	_	8	VC
10	to	to	TO	_	9	PRP
11	generate	generate	VB	_	10	IM
12	C57BL	c0bl	NN	_	16	NMOD
13	/	/	HYPH	_	12	P
14	6	0	CD	_	12	NMOD
15	.	.	HYPH	_	12	P
16	129	0	CD	_	23	NMOD
17	(	(	-LRB-	_	18	P
18	D1Mit105	d0mit0	NN	_	16	PRN
19	–	–	SYM	_	20	P
20	223	0	CD	_	18	NMOD
21	)	)	-RRB-	_	18	P
22	congenic	congenic	JJ	_	23	NMOD
23	mice	mouse	NNS	_	11	OBJ
24	homozygous	homozygous	JJ	_	23	NMOD
25	for	for	IN	_	24	AMOD
26	the	the	DT	_	30	NMOD
27	129	0	CD	_	30	NMOD
28	Chromosome	chromosome	NN	_	30	NMOD
29	1	0	CD	_	28	NMOD
30	interval	interval	NN	_	25	PMOD
31	.	.	.	_	8	P

1	Inside	inside	JJ	_	3	NMOD
2	129	0	CD	_	3	NMOD
3	markers	marker	NNS	_	33	SBJ
4	at	at	IN	_	3	LOC
5	positions	position	NNS	_	7	NMOD
6	81.6	0	CD	_	7	NMOD
7	cM	cm	NN	_	4	PMOD
8	(	(	-LRB-	_	9	P
9	D1Mit159	d0mit0	NN	_	7	PRN
10	)	)	-RRB-	_	9	P
11	and	and	CC	_	7	COORD
12	105	0	CD	_	13	NMOD
13	cM	cm	NN	_	11	CONJ
14	(	(	-LRB-	_	15	P
15	D1Mit17	d0mit0	NN	_	13	PRN
16	)	)	-RRB-	_	15	P
17	,	,	,	_	7	P
18	respectively	respectively	RB	_	7	NMOD
19	,	,	,	_	3	P
20	and	and	CC	_	3	COORD
21	an	an	DT	_	26	NMOD
22	outside	outside	JJ	_	26	NMOD
23	C57BL	c0bl	NN	_	26	NMOD
24	/	/	HYPH	_	23	P
25	6	0	CD	_	23	NMOD
26	marker	marker	NN	_	20	CONJ
27	at	at	IN	_	26	NMOD
28	position	position	NN	_	29	NMOD
29	74.3cM	0cm	NN	_	27	PMOD
30	(	(	-LRB-	_	31	P
31	D1Mit159	d0mit0	NN	_	29	PRN
32	)	)	-RRB-	_	31	P
33	were	be	VBD	_	0	ROOT
34	used	use	VBN	_	33	VC
35	to	to	TO	_	34	PRP
36	further	far	RB	_	35	ADV
37	define	define	VB	_	35	IM
38	the	the	DT	_	39	NMOD
39	interval	interval	NN	_	37	OBJ
40	.	.	.	_	33	P

1	In	in	IN	_	30	LOC
2	the	the	DT	_	11	NMOD
3	C57BL	c0bl	NN	_	7	NMOD
4	/	/	HYPH	_	3	P
5	6	0	CD	_	3	NMOD
6	.	.	HYPH	_	3	P
7	Apcs	apc	NN	_	11	NMOD
8	−	−	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	−	−	SYM	_	7	P
11	mice	mouse	NNS	_	1	PMOD
12	(	(	-LRB-	_	11	P
13	backcrossed	backcross	VBN	_	11	NMOD
14	onto	onto	IN	_	13	ADV
15	C57BL	c0bl	NN	_	14	PMOD
16	/	/	HYPH	_	15	P
17	6	0	CD	_	15	NMOD
18	for	for	IN	_	13	TMP
19	ten	ten	CD	_	20	NMOD
20	generations	generation	NNS	_	18	PMOD
21	)	)	-RRB-	_	11	P
22	,	,	,	_	30	P
23	the	the	DT	_	25	NMOD
24	129	0	CD	_	25	NMOD
25	genome	genome	NN	_	30	SBJ
26	around	around	IN	_	25	LOC
27	the	the	DT	_	29	NMOD
28	Apcs	apc	NN	_	29	NMOD
29	locus	locus	NN	_	26	PMOD
30	was	be	VBD	_	0	ROOT
31	mapped	map	VBN	_	30	VC
32	as	as	IN	_	31	ADV
33	a	a	DT	_	34	NMOD
34	segment	segment	NN	_	32	PMOD
35	from	from	IN	_	34	NMOD
36	87.9	0	CD	_	37	NMOD
37	cM	cm	NN	_	35	PMOD
38	(	(	-LRB-	_	39	P
39	D1Mit15	d0mit0	NN	_	37	PRN
40	)	)	-RRB-	_	39	P
41	to	to	IN	_	35	PMOD
42	105	0	CD	_	43	NMOD
43	cM	cm	NN	_	41	PMOD
44	(	(	-LRB-	_	45	P
45	D1Mit17	d0mit0	NN	_	43	PRN
46	)	)	-RRB-	_	45	P
47	.	.	.	_	30	P

1	In	in	IN	_	9	LOC
2	this	this	DT	_	3	NMOD
3	analysis	analysis	NN	_	1	PMOD
4	,	,	,	_	9	P
5	the	the	DT	_	8	NMOD
6	inside	inside	JJ	_	8	NMOD
7	129	0	CD	_	8	NMOD
8	markers	marker	NNS	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	at	at	IN	_	9	LOC
11	positions	position	NNS	_	13	NMOD
12	93	0	CD	_	13	NMOD
13	cM	cm	NN	_	10	PMOD
14	(	(	-LRB-	_	15	P
15	D1Mit36	d0mit0	NN	_	13	PRN
16	)	)	-RRB-	_	15	P
17	and	and	CC	_	13	COORD
18	99.7	0	CD	_	19	NMOD
19	cM	cm	NN	_	17	CONJ
20	(	(	-LRB-	_	21	P
21	D1Mit115	d0mit0	NN	_	19	PRN
22	)	)	-RRB-	_	21	P
23	and	and	CC	_	9	COORD
24	the	the	DT	_	29	NMOD
25	outside	outside	JJ	_	29	NMOD
26	C57BL	c0bl	NN	_	29	NMOD
27	/	/	HYPH	_	26	P
28	6	0	CD	_	26	NMOD
29	markers	marker	NNS	_	23	GAP-SBJ
30	at	at	IN	_	29	LOC
31	positions	position	NNS	_	33	NMOD
32	81.6	0	CD	_	33	NMOD
33	cM	cm	NN	_	30	PMOD
34	(	(	-LRB-	_	35	P
35	D1Mit159	d0mit0	NN	_	33	PRN
36	)	)	-RRB-	_	35	P
37	and	and	CC	_	33	COORD
38	106	0	CD	_	39	NMOD
39	cM	cm	NN	_	37	CONJ
40	(	(	-LRB-	_	41	P
41	D1Mit223	d0mit0	NN	_	39	PRN
42	)	)	-RRB-	_	41	P
43	.	.	.	_	9	P

1	Along	along	IN	_	39	ADV
2	with	with	IN	_	1	PMOD
3	28	0	CD	_	12	NMOD
4	C57BL	c0bl	NN	_	8	NMOD
5	/	/	HYPH	_	4	P
6	6	0	CD	_	4	NMOD
7	.	.	HYPH	_	4	P
8	Apcs	apc	NN	_	12	NMOD
9	−	−	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	−	−	SYM	_	8	P
12	mice	mouse	NNS	_	2	PMOD
13	and	and	CC	_	12	COORD
14	30	0	CD	_	21	NMOD
15	C57BL	c0bl	NN	_	21	NMOD
16	/	/	HYPH	_	15	P
17	6	0	CD	_	15	NMOD
18	wild	wild	JJ	_	20	NMOD
19	-	-	HYPH	_	18	P
20	type	type	NN	_	21	NMOD
21	animals	animal	NNS	_	13	CONJ
22	,	,	,	_	39	P
23	26	0	CD	_	35	NMOD
24	C57BL	c0bl	NN	_	28	NMOD
25	/	/	HYPH	_	24	P
26	6	0	CD	_	24	NMOD
27	.	.	HYPH	_	24	P
28	129	0	CD	_	35	NMOD
29	(	(	-LRB-	_	30	P
30	D1Mit105	d0mit0	NN	_	28	PRN
31	–	–	SYM	_	32	P
32	223	0	CD	_	30	NMOD
33	)	)	-RRB-	_	30	P
34	female	female	JJ	_	35	NMOD
35	mice	mouse	NNS	_	39	SBJ
36	−	−	SYM	_	35	P
37	/	/	HYPH	_	35	P
38	−	−	SYM	_	35	P
39	were	be	VBD	_	0	ROOT
40	followed	follow	VBN	_	39	VC
41	up	up	IN	_	40	TMP
42	to	to	IN	_	41	PMOD
43	1	0	CD	_	44	NMOD
44	y	y	NN	_	42	PMOD
45	of	of	IN	_	44	NMOD
46	age	age	NN	_	45	PMOD
47	.	.	.	_	39	P

1	Animals	animal	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	maintained	maintain	VBN	_	2	VC
4	in	in	IN	_	3	LOC
5	specific	specific	JJ	_	9	NMOD
6	pathogen	pathogen	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	free	free	JJ	_	9	NMOD
9	conditions	condition	NNS	_	4	PMOD
10	.	.	.	_	2	P

1	All	all	DT	_	3	NMOD
2	animal	animal	NN	_	3	NMOD
3	procedures	procedure	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	in	in	IN	_	4	PRD
6	accordance	accordance	NN	_	5	PMOD
7	with	with	IN	_	6	NMOD
8	institutional	institutional	JJ	_	9	NMOD
9	guidelines	guideline	NNS	_	7	PMOD
10	.	.	.	_	4	P

1	Serological	serological	JJ	_	2	NMOD
2	analyses	analysis	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	Sera	serum	NNS	_	12	SBJ
2	,	,	,	_	1	P
3	collected	collect	VBN	_	1	NMOD
4	at	at	IN	_	3	TMP
5	6	0	CD	_	8	NMOD
6	and	and	CC	_	5	COORD
7	12	0	CD	_	6	CONJ
8	mo	mo	NN	_	4	PMOD
9	of	of	IN	_	8	NMOD
10	age	age	NN	_	9	PMOD
11	,	,	,	_	12	P
12	were	be	VBD	_	0	ROOT
13	assayed	assay	VBN	_	12	VC
14	for	for	IN	_	13	ADV
15	the	the	DT	_	16	NMOD
16	presence	presence	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	auto-Abs	auto-abs	NNS	_	17	PMOD
19	.	.	.	_	12	P

1	Levels	level	NNS	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	IgG	igg	NN	_	4	NMOD
4	ANA	ana	NN	_	2	PMOD
5	were	be	VBD	_	0	ROOT
6	sought	seek	VBN	_	5	VC
7	by	by	IN	_	6	MNR
8	indirect	indirect	JJ	_	9	NMOD
9	immunofluorescence	immunofluorescence	NN	_	7	PMOD
10	using	use	VBG	_	6	MNR
11	Hep	hep	NN	_	14	NMOD
12	-	-	HYPH	_	11	P
13	2	0	CD	_	11	NMOD
14	cells	cell	NNS	_	10	OBJ
15	,	,	,	_	5	P
16	and	and	CC	_	5	COORD
17	anti-dsDNA	anti-dsdna	JJ	_	18	NMOD
18	Abs	ab	NNS	_	19	SBJ
19	were	be	VBD	_	16	CONJ
20	detected	detect	VBN	_	19	VC
21	by	by	IN	_	20	MNR
22	indirect	indirect	JJ	_	23	NMOD
23	immunofluorescence	immunofluorescence	NN	_	21	PMOD
24	on	on	IN	_	23	LOC
25	Crithidia	crithidia	NNP	_	26	NMOD
26	luciliae	luciliae	NNP	_	24	PMOD
27	as	as	IN	_	20	ADV
28	previously	previously	RB	_	29	TMP
29	described	describe	VBN	_	27	SUB
30	(	(	-LRB-	_	31	P
31	Mitchell	mitchell	NNP	_	29	CIT
32	et	et	FW	_	31	DEP
33	al.	al.	FW	_	31	DEP
34	2002	0	CD	_	31	DEP
35	)	)	-RRB-	_	31	P
36	.	.	.	_	5	P

1	Serum	serum	NN	_	2	NMOD
2	samples	sample	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	screened	screen	VBN	_	3	VC
5	at	at	IN	_	4	ADV
6	a	a	DT	_	20	NMOD
7	1	0	CD	_	20	NMOD
8	:	:	SYM	_	9	P
9	80	0	CD	_	7	NMOD
10	(	(	-LRB-	_	11	P
11	ANA	ana	NN	_	7	PRN
12	)	)	-RRB-	_	11	P
13	or	or	CC	_	7	COORD
14	1	0	CD	_	13	CONJ
15	:	:	SYM	_	16	P
16	20	0	CD	_	14	NMOD
17	(	(	-LRB-	_	18	P
18	anti-dsDNA	anti-dsdna	JJ	_	14	PRN
19	)	)	-RRB-	_	18	P
20	dilution	dilution	NN	_	5	PMOD
21	and	and	CC	_	3	COORD
22	the	the	DT	_	24	NMOD
23	positive	positive	JJ	_	24	NMOD
24	samples	sample	NNS	_	25	SBJ
25	titrated	titrate	VBN	_	21	GAP
26	to	to	IN	_	25	ADV
27	endpoint	endpoint	NN	_	26	PMOD
28	.	.	.	_	3	P

1	Abs	ab	NNS	_	6	SBJ
2	to	to	IN	_	1	NMOD
3	ssDNA	ssdna	NN	_	2	PMOD
4	and	and	CC	_	3	COORD
5	anti-chromatin	anti-chromatin	NN	_	4	CONJ
6	were	be	VBD	_	0	ROOT
7	measured	measure	VBN	_	6	VC
8	by	by	IN	_	7	LGS
9	ELISA	elisa	NNP	_	8	PMOD
10	,	,	,	_	7	P
11	as	as	IN	_	7	ADV
12	previously	previously	RB	_	13	TMP
13	described	describe	VBN	_	11	SUB
14	(	(	-LRB-	_	15	P
15	Mitchell	mitchell	NNP	_	13	CIT
16	et	et	FW	_	15	DEP
17	al.	al.	FW	_	15	DEP
18	2002	0	CD	_	15	DEP
19	)	)	-RRB-	_	15	P
20	.	.	.	_	6	P

1	Samples	sample	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	screened	screen	VBN	_	2	VC
4	at	at	IN	_	3	ADV
5	a	a	DT	_	9	NMOD
6	1	0	CD	_	9	NMOD
7	:	:	SYM	_	8	P
8	100	0	CD	_	6	NMOD
9	dilution	dilution	NN	_	4	PMOD
10	,	,	,	_	2	P
11	and	and	CC	_	2	COORD
12	the	the	DT	_	13	NMOD
13	results	result	NNS	_	14	SBJ
14	were	be	VBD	_	11	CONJ
15	expressed	express	VBN	_	14	VC
16	in	in	IN	_	15	ADV
17	arbitrary	arbitrary	JJ	_	19	NMOD
18	ELISA	elisa	NNP	_	19	NMOD
19	units	unit	NNS	_	21	NMOD
20	(	(	-LRB-	_	21	P
21	AEUs	aeus	NNS	_	16	PMOD
22	)	)	-RRB-	_	21	P
23	relative	relative	JJ	_	21	NMOD
24	to	to	IN	_	23	AMOD
25	a	a	DT	_	28	NMOD
26	standard	standard	JJ	_	28	NMOD
27	positive	positive	JJ	_	28	NMOD
28	sample	sample	NN	_	24	PMOD
29	(	(	-LRB-	_	28	P
30	derived	derive	VBN	_	28	NMOD
31	from	from	IN	_	30	ADV
32	an	an	DT	_	40	NMOD
33	MRL	mrl	NN	_	35	NMOD
34	/	/	HYPH	_	33	P
35	Mp	mp	NN	_	39	NMOD
36	.	.	HYPH	_	35	P
37	lpr	lpr	NN	_	39	NMOD
38	/	/	HYPH	_	37	P
39	lpr	lpr	NN	_	40	NMOD
40	mouse	mouse	NN	_	31	PMOD
41	)	)	-RRB-	_	28	P
42	,	,	,	_	28	P
43	which	which	WDT	_	44	SBJ
44	was	be	VBD	_	28	NMOD
45	assigned	assign	VBN	_	44	VC
46	a	a	DT	_	47	NMOD
47	value	value	NN	_	45	OBJ
48	of	of	IN	_	47	NMOD
49	100	0	CD	_	48	PMOD
50	.	.	.	_	2	P

1	For	for	IN	_	13	ADV
2	interplate	interplate	JJ	_	3	NMOD
3	comparison	comparison	NN	_	1	PMOD
4	,	,	,	_	13	P
5	serial	serial	JJ	_	6	NMOD
6	dilutions	dilution	NNS	_	13	SBJ
7	of	of	IN	_	6	NMOD
8	a	a	DT	_	12	NMOD
9	positive	positive	JJ	_	12	NMOD
10	control	control	NN	_	12	NMOD
11	serum	serum	NN	_	12	NMOD
12	sample	sample	NN	_	7	PMOD
13	were	be	VBD	_	0	ROOT
14	included	include	VBN	_	13	VC
15	on	on	IN	_	14	LOC
16	each	each	DT	_	17	NMOD
17	plate	plate	NN	_	15	PMOD
18	.	.	.	_	13	P

1	Apcs	apc	NN	_	2	NMOD
2	levels	level	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	assessed	assess	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	ELISA	elisa	NNP	_	5	PMOD
7	using	use	VBG	_	4	MNR
8	sheep	sheep	NN	_	10	NMOD
9	anti-mouse	anti-mouse	JJ	_	10	NMOD
10	Apcs	apc	NN	_	15	NMOD
11	and	and	CC	_	10	COORD
12	rabbit	rabbit	NN	_	14	NMOD
13	anti-mouse	anti-mouse	JJ	_	14	NMOD
14	Apcs	apc	NN	_	11	CONJ
15	Abs	ab	NNS	_	7	OBJ
16	(	(	-LRB-	_	17	P
17	Calbiochem	calbiochem	NNP	_	15	PRN
18	,	,	,	_	17	P
19	Nottigham	nottigham	NNP	_	17	APPO
20	,	,	,	_	19	P
21	United	united	NNP	_	22	NMOD
22	Kingdom	kingdom	NNP	_	19	APPO
23	)	)	-RRB-	_	17	P
24	.	.	.	_	3	P

1	Samples	sample	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	screened	screen	VBN	_	2	VC
4	at	at	IN	_	3	ADV
5	a	a	DT	_	9	NMOD
6	1	0	CD	_	9	NMOD
7	:	:	SYM	_	8	P
8	3,000	0	CD	_	6	NMOD
9	dilution	dilution	NN	_	4	PMOD
10	,	,	,	_	2	P
11	and	and	CC	_	2	COORD
12	the	the	DT	_	13	NMOD
13	results	result	NNS	_	14	SBJ
14	were	be	VBD	_	11	CONJ
15	expressed	express	VBN	_	14	VC
16	in	in	IN	_	15	ADV
17	milligrams	milligram	NNS	_	16	PMOD
18	per	per	IN	_	17	NMOD
19	liters	liter	NNS	_	18	PMOD
20	,	,	,	_	15	P
21	referring	refer	VBG	_	15	ADV
22	to	to	IN	_	21	ADV
23	a	a	DT	_	25	NMOD
24	standard	standard	JJ	_	25	NMOD
25	curve	curve	NN	_	22	PMOD
26	derived	derive	VBN	_	25	NMOD
27	from	from	IN	_	26	ADV
28	an	an	DT	_	32	NMOD
29	acute	acute	JJ	_	31	NMOD
30	-	-	HYPH	_	29	P
31	phase	phase	NN	_	32	NMOD
32	serum	serum	NN	_	27	PMOD
33	with	with	IN	_	32	NMOD
34	a	a	DT	_	36	NMOD
35	known	know	VBN	_	36	NMOD
36	concentration	concentration	NN	_	33	PMOD
37	of	of	IN	_	36	NMOD
38	Apcs	apc	NN	_	37	PMOD
39	(	(	-LRB-	_	40	P
40	Calbiochem	calbiochem	NNP	_	32	PRN
41	)	)	-RRB-	_	40	P
42	.	.	.	_	2	P

1	Apcs	apc	NN	_	6	NMOD
2	−	−	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	−	−	SYM	_	1	P
5	mouse	mouse	NN	_	6	NMOD
6	serum	serum	NN	_	7	SBJ
7	was	be	VBD	_	0	ROOT
8	included	include	VBN	_	7	VC
9	as	as	IN	_	8	ADV
10	a	a	DT	_	12	NMOD
11	negative	negative	JJ	_	12	NMOD
12	control	control	NN	_	9	PMOD
13	.	.	.	_	7	P

1	Histological	histological	JJ	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT
3	.	.	.	_	2	P

1	All	all	PDT	_	3	NMOD
2	the	the	DT	_	3	NMOD
3	mice	mouse	NNS	_	17	SBJ
4	,	,	,	_	3	P
5	except	except	IN	_	3	NMOD
6	the	the	DT	_	7	NMOD
7	few	few	JJ	_	5	PMOD
8	that	that	WDT	_	9	SBJ
9	died	die	VBD	_	7	NMOD
10	before	before	IN	_	9	TMP
11	the	the	DT	_	12	NMOD
12	end	end	NN	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	15	NMOD
15	experiment	experiment	NN	_	13	PMOD
16	,	,	,	_	17	P
17	were	be	VBD	_	0	ROOT
18	sacrificed	sacrifice	VBN	_	17	VC
19	at	at	IN	_	18	TMP
20	1	0	CD	_	21	NMOD
21	y	y	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	age	age	NN	_	22	PMOD
24	,	,	,	_	17	P
25	and	and	CC	_	17	COORD
26	kidney	kidney	NN	_	27	NMOD
27	portions	portion	NNS	_	28	SBJ
28	were	be	VBD	_	25	CONJ
29	fixed	fix	VBN	_	28	VC
30	in	in	IN	_	29	LOC
31	Bouin	bouin	NNP	_	33	NMOD
32	's	's	POS	_	31	NMOD
33	solution	solution	NN	_	30	PMOD
34	and	and	CC	_	29	COORD
35	paraffin	paraffin	NN	_	36	DEP
36	embedded	embed	VBN	_	34	CONJ
37	,	,	,	_	28	P
38	and	and	CC	_	28	COORD
39	sections	section	NNS	_	40	SBJ
40	were	be	VBD	_	38	CONJ
41	stained	stain	VBN	_	40	VC
42	with	with	IN	_	41	ADV
43	periodic	periodic	JJ	_	44	NMOD
44	acid	acid	NN	_	47	NMOD
45	–	–	HYPH	_	44	P
46	Schiff	schiff	NNP	_	47	NMOD
47	reagent	reagent	NN	_	42	PMOD
48	.	.	.	_	17	P

1	Glomerular	glomerular	JJ	_	2	NMOD
2	histology	histology	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	graded	grade	VBN	_	3	VC
5	in	in	IN	_	4	MNR
6	a	a	DT	_	8	NMOD
7	blinded	blinded	JJ	_	8	NMOD
8	fashion	fashion	NN	_	5	PMOD
9	as	as	IN	_	4	ADV
10	follows	follow	VBZ	_	9	SUB
11	:	:	:	_	3	P
12	grade	grade	NN	_	3	DEP
13	0	0	CD	_	12	NMOD
14	,	,	,	_	12	P
15	normal	normal	JJ	_	12	DEP
16	;	;	:	_	12	P
17	grade	grade	NN	_	12	DEP
18	1	0	CD	_	17	NMOD
19	,	,	,	_	17	P
20	hypercellularity	hypercellularity	NN	_	17	DEP
21	involving	involve	VBG	_	20	NMOD
22	greater	great	JJR	_	25	NMOD
23	than	than	IN	_	22	QMOD
24	50	0	CD	_	22	QMOD
25	%	%	NN	_	21	OBJ
26	of	of	IN	_	25	NMOD
27	the	the	DT	_	29	NMOD
28	glomerular	glomerular	JJ	_	29	NMOD
29	tuft	tuft	NN	_	26	PMOD
30	in	in	IN	_	21	LOC
31	25	0	CD	_	32	NMOD
32	%	%	NN	_	30	PMOD
33	–	–	SYM	_	35	P
34	50	0	CD	_	35	NMOD
35	%	%	NN	_	32	NMOD
36	of	of	IN	_	35	NMOD
37	glomeruli	glomerulus	NNS	_	36	PMOD
38	;	;	:	_	12	P
39	grade	grade	NN	_	12	DEP
40	2	0	CD	_	39	NMOD
41	,	,	,	_	39	P
42	hypercellularity	hypercellularity	NN	_	39	DEP
43	involving	involve	VBG	_	42	NMOD
44	greater	great	JJR	_	47	NMOD
45	than	than	IN	_	44	QMOD
46	50	0	CD	_	44	QMOD
47	%	%	NN	_	43	OBJ
48	of	of	IN	_	47	NMOD
49	the	the	DT	_	51	NMOD
50	glomerular	glomerular	JJ	_	51	NMOD
51	tuft	tuft	NN	_	48	PMOD
52	in	in	IN	_	51	LOC
53	50	0	CD	_	54	NMOD
54	%	%	NN	_	52	PMOD
55	–	–	SYM	_	57	P
56	75	0	CD	_	57	NMOD
57	%	%	NN	_	54	NMOD
58	of	of	IN	_	54	NMOD
59	glomeruli	glomerulus	NNS	_	58	PMOD
60	;	;	:	_	12	P
61	grade	grade	NN	_	12	DEP
62	3	0	CD	_	61	NMOD
63	,	,	,	_	61	P
64	glomerular	glomerular	JJ	_	65	NMOD
65	hypercellularity	hypercellularity	NN	_	61	DEP
66	in	in	IN	_	65	LOC
67	greater	great	JJR	_	70	NMOD
68	than	than	IN	_	67	QMOD
69	75	0	CD	_	67	QMOD
70	%	%	NN	_	66	PMOD
71	of	of	IN	_	70	NMOD
72	glomeruli	glomerulus	NNS	_	71	PMOD
73	or	or	CC	_	72	COORD
74	crescents	crescent	NNS	_	73	CONJ
75	in	in	IN	_	65	NMOD
76	greater	great	JJR	_	79	NMOD
77	than	than	IN	_	76	QMOD
78	25	0	CD	_	76	QMOD
79	%	%	NN	_	75	PMOD
80	of	of	IN	_	79	NMOD
81	glomeruli	glomerulus	NNS	_	80	PMOD
82	.	.	.	_	3	P

1	Statistical	statistical	JJ	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT

1	Non-parametric	non-parametric	JJ	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	expressed	express	VBN	_	3	VC
5	as	as	IN	_	4	ADV
6	median	median	NN	_	5	PMOD
7	with	with	IN	_	4	ADV
8	range	range	NN	_	7	SUB
9	of	of	IN	_	8	NMOD
10	values	value	NNS	_	9	PMOD
11	in	in	IN	_	8	LOC
12	parentheses	parenthesis	NNS	_	11	PMOD
13	.	.	.	_	3	P

1	All	all	DT	_	2	NMOD
2	statistics	statistic	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	calculated	calculate	VBN	_	3	VC
5	using	use	VBG	_	4	MNR
6	GraphPad	graphpad	NNP	_	7	NMOD
7	PrismTM	prismtm	NNP	_	8	NMOD
8	version	version	NN	_	5	OBJ
9	3.0	0	CD	_	8	NMOD
10	for	for	IN	_	8	NMOD
11	Windows	window	NNP	_	10	PMOD
12	(	(	-LRB-	_	14	P
13	GraphPad	graphpad	NNP	_	14	NMOD
14	Software	software	NNP	_	8	PRN
15	,	,	,	_	14	P
16	San	san	NNP	_	17	NMOD
17	Diego	diego	NNP	_	14	APPO
18	,	,	,	_	17	P
19	California	california	NNP	_	17	APPO
20	,	,	,	_	19	P
21	United	united	NNP	_	22	NMOD
22	States	state	NNP	_	19	APPO
23	)	)	-RRB-	_	14	P
24	.	.	.	_	3	P

1	Non-parametric	non-parametric	JJ	_	2	NMOD
2	tests	test	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	applied	apply	VBN	_	3	VC
5	throughout	throughout	RB	_	4	ADV
6	,	,	,	_	4	P
7	with	with	IN	_	4	ADV
8	differences	difference	NNS	_	9	SBJ
9	being	be	VBG	_	7	PMOD
10	considered	consider	VBN	_	9	VC
11	significant	significant	JJ	_	10	OPRD
12	for	for	IN	_	11	AMOD
13	p	p	NN	_	14	NMOD
14	values	value	NNS	_	12	PMOD
15	<	<	SYM	_	16	P
16	0.05	0	CD	_	14	NMOD
17	.	.	.	_	3	P

1	The	the	DT	_	5	NMOD
2	Mann	mann	NNP	_	4	NMOD
3	–	–	HYPH	_	2	P
4	Whitney	whitney	NNP	_	5	NMOD
5	test	test	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	used	use	VBN	_	6	VC
8	for	for	IN	_	7	ADV
9	comparison	comparison	NN	_	8	PMOD
10	of	of	IN	_	9	NMOD
11	two	two	CD	_	12	NMOD
12	groups	group	NNS	_	10	PMOD
13	,	,	,	_	7	P
14	whilst	whilst	IN	_	7	ADV
15	for	for	IN	_	31	PRP
16	analysis	analysis	NN	_	15	PMOD
17	of	of	IN	_	16	NMOD
18	three	three	CD	_	19	NMOD
19	groups	group	NNS	_	17	PMOD
20	the	the	DT	_	24	NMOD
21	Kruskal	kruskal	NNP	_	23	NMOD
22	–	–	HYPH	_	21	P
23	Wallis	wallis	NNP	_	24	NMOD
24	test	test	NN	_	31	SBJ
25	with	with	IN	_	24	NMOD
26	Dunn	dunn	NNP	_	30	NMOD
27	's	's	POS	_	26	NMOD
28	multiple	multiple	JJ	_	29	NMOD
29	comparison	comparison	NN	_	30	NMOD
30	test	test	NN	_	25	PMOD
31	was	be	VBD	_	14	SUB
32	used	use	VBN	_	31	VC
33	.	.	.	_	6	P

1	Genotypic	genotypic	JJ	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT

1	Genotyping	genotyping	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	carried	carry	VBN	_	2	VC
4	out	out	RP	_	3	PRT
5	by	by	IN	_	3	MNR
6	PCR	pcr	NN	_	5	PMOD
7	of	of	IN	_	6	NMOD
8	genomic	genomic	JJ	_	9	NMOD
9	DNA	dna	NN	_	7	PMOD
10	using	use	VBG	_	3	MNR
11	143	0	CD	_	13	NMOD
12	polymorphic	polymorphic	JJ	_	13	NMOD
13	markers	marker	NNS	_	10	OBJ
14	(	(	-LRB-	_	15	P
15	list	list	NN	_	13	PRN
16	available	available	JJ	_	15	OPRD
17	on	on	IN	_	15	ADV
18	request	request	NN	_	17	PMOD
19	)	)	-RRB-	_	15	P
20	distributed	distribute	VBN	_	13	NMOD
21	throughout	throughout	IN	_	20	LOC
22	all	all	DT	_	24	NMOD
23	19	0	CD	_	24	NMOD
24	autosomes	autosome	NNS	_	21	PMOD
25	.	.	.	_	2	P

1	PCRs	pcrs	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	performed	perform	VBN	_	2	VC
4	using	use	VBG	_	3	MNR
5	standard	standard	JJ	_	6	NMOD
6	reagents	reagent	NNS	_	4	OBJ
7	containing	contain	VBG	_	6	NMOD
8	1.5	0	CD	_	9	NMOD
9	mM	mm	NN	_	10	NMOD
10	MgCl2	mgcl0	NN	_	7	OBJ
11	and	and	CC	_	10	COORD
12	0.4	0	CD	_	13	NMOD
13	μM	μm	NN	_	14	NMOD
14	primers	primer	NNS	_	11	CONJ
15	.	.	.	_	2	P

1	Microsatellite	microsatellite	NN	_	2	NMOD
2	markers	marker	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	screened	screen	VBN	_	3	VC
5	for	for	IN	_	4	PRP
6	size	size	NN	_	7	NMOD
7	polymorphisms	polymorphism	NNS	_	5	PMOD
8	between	between	IN	_	7	NMOD
9	129	0	CD	_	14	NMOD
10	and	and	CC	_	9	COORD
11	C57BL	c0bl	NN	_	10	CONJ
12	/	/	HYPH	_	11	P
13	6	0	CD	_	11	NMOD
14	mice	mouse	NNS	_	8	PMOD
15	.	.	.	_	3	P

1	Only	only	RB	_	2	NMOD
2	primers	primer	NNS	_	19	SBJ
3	with	with	IN	_	2	NMOD
4	differences	difference	NNS	_	3	PMOD
5	detectable	detectable	JJ	_	4	NMOD
6	on	on	IN	_	5	LOC
7	ethidium	ethidium	NN	_	8	NMOD
8	bromide	bromide	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	stained	stain	VBN	_	12	NMOD
11	agarose	agarose	NN	_	12	NMOD
12	gels	gel	NNS	_	6	PMOD
13	or	or	CC	_	6	COORD
14	on	on	IN	_	13	CONJ
15	SDS	sd	NN	_	17	NMOD
16	-	-	HYPH	_	15	P
17	polyacrylamide	polyacrylamide	NN	_	18	NMOD
18	gels	gel	NNS	_	14	PMOD
19	were	be	VBD	_	0	ROOT
20	used	use	VBN	_	19	VC
21	.	.	.	_	19	P

1	Linkage	linkage	NN	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT

1	The	the	DT	_	3	NMOD
2	QTL	qtl	NN	_	3	NMOD
3	program	program	NN	_	4	NMOD
4	MAPMANAGER.QTL	mapmanager.qtl	NNP	_	8	SBJ
5	(	(	-LRB-	_	6	P
6	ftp://mcbio.med.buffalo.edu/pub/MapMgr/	ftp://mcbio.med.buffalo.edu/pub/mapmgr/	NN	_	4	PRN
7	)	)	-RRB-	_	6	P
8	was	be	VBD	_	0	ROOT
9	used	use	VBN	_	8	VC
10	,	,	,	_	8	P
11	and	and	CC	_	8	COORD
12	the	the	DT	_	15	NMOD
13	two	two	CD	_	15	NMOD
14	experimental	experimental	JJ	_	15	NMOD
15	groups	group	NNS	_	16	SBJ
16	were	be	VBD	_	11	CONJ
17	examined	examine	VBN	_	16	VC
18	independently	independently	RB	_	17	MNR
19	.	.	.	_	8	P

1	Only	only	RB	_	2	NMOD
2	data	datum	NNS	_	10	SBJ
3	from	from	IN	_	2	NMOD
4	mice	mouse	NNS	_	3	PMOD
5	at	at	IN	_	4	TMP
6	12	0	CD	_	7	NMOD
7	mo	mo	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	age	age	NN	_	8	PMOD
10	were	be	VBD	_	0	ROOT
11	analysed	analyse	VBN	_	10	VC
12	.	.	.	_	10	P

1	Log	log	NN	_	2	NMOD
2	transformations	transformation	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	auto-Abs	auto-abs	NNS	_	5	NMOD
5	levels	level	NNS	_	3	PMOD
6	resulted	result	VBD	_	0	ROOT
7	in	in	IN	_	6	ADV
8	more	more	RBR	_	9	AMOD
9	normalised	normalise	VBN	_	10	NMOD
10	distribution	distribution	NN	_	7	PMOD
11	and	and	CC	_	6	COORD
12	were	be	VBD	_	11	CONJ
13	used	use	VBN	_	12	VC
14	in	in	IN	_	13	ADV
15	QTL	qtl	NN	_	16	NMOD
16	mapping	mapping	NN	_	14	PMOD
17	.	.	.	_	6	P

1	LOD	lod	NN	_	2	NMOD
2	thresholds	threshold	NNS	_	8	SBJ
3	for	for	IN	_	2	NMOD
4	suggestive	suggestive	JJ	_	7	NMOD
5	and	and	CC	_	4	COORD
6	significant	significant	JJ	_	5	CONJ
7	linkages	linkage	NNS	_	3	PMOD
8	were	be	VBD	_	0	ROOT
9	determined	determine	VBN	_	8	VC
10	by	by	IN	_	9	MNR
11	using	use	VBG	_	10	PMOD
12	a	a	DT	_	20	NMOD
13	cohort	cohort	NN	_	18	AMOD
14	-	-	HYPH	_	13	P
15	and	and	CC	_	13	COORD
16	trait	trait	NN	_	15	CONJ
17	-	-	HYPH	_	16	P
18	specific	specific	JJ	_	20	NMOD
19	permutation	permutation	NN	_	20	NMOD
20	test	test	NN	_	11	OBJ
21	(	(	-LRB-	_	23	P
22	1,000	0	CD	_	23	NMOD
23	permutations	permutation	NNS	_	20	PRN
24	)	)	-RRB-	_	23	P
25	.	.	.	_	8	P

1	The	the	DT	_	3	NMOD
2	average	average	JJ	_	3	NMOD
3	threshold	threshold	NN	_	13	SBJ
4	for	for	IN	_	3	NMOD
5	suggestive	suggestive	JJ	_	12	NMOD
6	,	,	,	_	5	P
7	significant	significant	JJ	_	5	CONJ
8	,	,	,	_	7	P
9	and	and	CC	_	7	COORD
10	highly	highly	RB	_	11	AMOD
11	significant	significant	JJ	_	9	CONJ
12	linkages	linkage	NNS	_	4	PMOD
13	were	be	VBD	_	0	ROOT
14	LOD	lod	NN	_	13	PRD
15	≥	≥	SYM	_	16	P
16	2.1	0	CD	_	14	NMOD
17	(	(	-LRB-	_	20	P
18	p	p	NN	_	20	SBJ
19	≤	≤	SYM	_	20	P
20	7.8	0	CD	_	14	PRN
21	×	×	SYM	_	20	P
22	10	0	CD	_	20	QMOD
23	−	−	SYM	_	20	P
24	3	0	CD	_	20	QMOD
25	)	)	-RRB-	_	20	P
26	,	,	,	_	14	P
27	LOD	lod	NN	_	14	CONJ
28	≥	≥	SYM	_	29	P
29	3.6	0	CD	_	27	NMOD
30	(	(	-LRB-	_	33	P
31	p	p	NN	_	33	SBJ
32	≤	≤	SYM	_	33	P
33	2.4	0	CD	_	27	PRN
34	×	×	SYM	_	33	P
35	10	0	CD	_	33	QMOD
36	−	−	SYM	_	33	P
37	4	0	CD	_	33	QMOD
38	)	)	-RRB-	_	33	P
39	,	,	,	_	27	P
40	and	and	CC	_	27	COORD
41	LOD	lod	NN	_	40	CONJ
42	≥	≥	SYM	_	43	P
43	5	0	CD	_	41	NMOD
44	(	(	-LRB-	_	47	P
45	p	p	NN	_	47	SBJ
46	≤	≤	SYM	_	47	P
47	1	0	CD	_	41	PRN
48	×	×	SYM	_	47	P
49	10	0	CD	_	47	QMOD
50	−	−	SYM	_	47	P
51	5	0	CD	_	47	QMOD
52	)	)	-RRB-	_	47	P
53	,	,	,	_	13	P
54	respectively	respectively	RB	_	13	ADV
55	(	(	-LRB-	_	56	P
56	Manly	manly	NNP	_	13	CIT
57	and	and	CC	_	56	COORD
58	Olson	olson	NNP	_	57	CONJ
59	1999	0	CD	_	56	DEP
60	)	)	-RRB-	_	56	P
61	.	.	.	_	13	P

1	Supporting	support	VBG	_	2	NMOD
2	Information	information	NN	_	0	ROOT

1	Accession	accession	NN	_	2	NMOD
2	Numbers	number	NNS	_	0	ROOT

1	The	the	DT	_	7	NMOD
2	LocusLink	locuslink	NNP	_	7	NMOD
3	(	(	-LRB-	_	4	P
4	http://www.ncbi.nlm.nih.gov/LocusLink/	http://www.ncbi.nlm.nih.gov/locuslink/	NN	_	2	PRN
5	)	)	-RRB-	_	4	P
6	ID	id	NN	_	7	NMOD
7	numbers	number	NNS	_	18	SBJ
8	for	for	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	genes	gene	NNS	_	8	PMOD
11	and	and	CC	_	10	COORD
12	gene	gene	NN	_	13	NMOD
13	products	product	NNS	_	11	CONJ
14	discussed	discuss	VBN	_	10	NMOD
15	in	in	IN	_	14	LOC
16	this	this	DT	_	17	NMOD
17	paper	paper	NN	_	15	PMOD
18	are	be	VBP	_	0	ROOT
19	Apcs	apc	NN	_	18	PRD
20	(	(	-LRB-	_	22	P
21	LocusLink	locuslink	NNP	_	22	NMOD
22	ID	id	NN	_	19	PRN
23	20219	0	CD	_	22	NMOD
24	)	)	-RRB-	_	22	P
25	,	,	,	_	19	P
26	CD35	cd0	NN	_	28	NMOD
27	/	/	HYPH	_	26	P
28	CD21	cd0	NN	_	19	CONJ
29	(	(	-LRB-	_	31	P
30	LocusLink	locuslink	NNP	_	31	NMOD
31	ID	id	NN	_	28	PRN
32	12902	0	CD	_	31	NMOD
33	)	)	-RRB-	_	31	P
34	,	,	,	_	28	P
35	CD55	cd0	NN	_	28	CONJ
36	(	(	-LRB-	_	38	P
37	LocusLink	locuslink	NNP	_	38	NMOD
38	ID	id	NN	_	35	PRN
39	13136	0	CD	_	38	NMOD
40	)	)	-RRB-	_	38	P
41	,	,	,	_	35	P
42	the	the	DT	_	45	NMOD
43	FAS	fa	NN	_	45	NMOD
44	receptor	receptor	NN	_	45	NMOD
45	gene	gene	NN	_	35	CONJ
46	(	(	-LRB-	_	48	P
47	LocusLink	locuslink	NNP	_	48	NMOD
48	ID	id	NN	_	45	PRN
49	14102	0	CD	_	48	NMOD
50	)	)	-RRB-	_	48	P
51	,	,	,	_	45	P
52	and	and	CC	_	45	COORD
53	FcγRII	fcγrii	NN	_	52	CONJ
54	(	(	-LRB-	_	56	P
55	LocusLink	locuslink	NNP	_	56	NMOD
56	ID	id	NN	_	53	PRN
57	14130	0	CD	_	56	NMOD
58	)	)	-RRB-	_	56	P
59	.	.	.	_	18	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	grateful	grateful	JJ	_	2	PRD
4	to	to	IN	_	3	AMOD
5	M.	m.	NNP	_	6	NMOD
6	Lewis	lewis	NNP	_	4	PMOD
7	for	for	IN	_	2	PRP
8	the	the	DT	_	9	NMOD
9	processing	processing	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	12	NMOD
12	samples	sample	NNS	_	10	PMOD
13	for	for	IN	_	9	NMOD
14	histology	histology	NN	_	13	PMOD
15	and	and	CC	_	2	COORD
16	to	to	IN	_	15	GAP
17	F.	f.	NNP	_	18	NMOD
18	Reid	reid	NNP	_	16	PMOD
19	and	and	CC	_	18	COORD
20	D.	d.	NNP	_	21	NMOD
21	Mitchell	mitchell	NNP	_	19	CONJ
22	for	for	IN	_	16	PRP
23	their	their	PRP$	_	24	NMOD
24	help	help	NN	_	22	PMOD
25	.	.	.	_	2	P

1	We	we	PRP	_	2	SBJ
2	thank	thank	VBP	_	0	ROOT
3	all	all	DT	_	2	OBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	staff	staff	NN	_	4	PMOD
7	in	in	IN	_	6	LOC
8	the	the	DT	_	10	NMOD
9	animal	animal	NN	_	10	NMOD
10	facility	facility	NN	_	7	PMOD
11	for	for	IN	_	2	PRP
12	their	their	PRP$	_	14	NMOD
13	technical	technical	JJ	_	14	NMOD
14	assistance	assistance	NN	_	11	PMOD
15	.	.	.	_	2	P

1	This	this	DT	_	2	NMOD
2	work	work	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	supported	support	VBN	_	3	VC
5	by	by	IN	_	4	LGS
6	the	the	DT	_	8	NMOD
7	Wellcome	wellcome	NNP	_	8	NMOD
8	Trust	trust	NNP	_	5	PMOD
9	(	(	-LRB-	_	11	P
10	grant	grant	NN	_	11	NMOD
11	number	number	NN	_	8	PRN
12	061438	0	CD	_	11	NMOD
13	)	)	-RRB-	_	11	P
14	.	.	.	_	3	P

1	JCH	jch	NNP	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	a	a	DT	_	4	NMOD
4	recipient	recipient	NN	_	2	PRD
5	of	of	IN	_	4	NMOD
6	a	a	DT	_	7	NMOD
7	fellowship	fellowship	NN	_	5	PMOD
8	from	from	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	National	national	NNP	_	11	NMOD
11	Institute	institute	NNP	_	8	PMOD
12	of	of	IN	_	11	NMOD
13	Health	health	NNP	_	12	PMOD
14	,	,	,	_	11	P
15	Spain	spain	NNP	_	11	APPO
16	(	(	-LRB-	_	17	P
17	BEFI	befi	NN	_	11	PRN
18	99	0	CD	_	17	NMOD
19	/	/	HYPH	_	18	P
20	9212	0	CD	_	17	NMOD
21	)	)	-RRB-	_	17	P
22	.	.	.	_	2	P

1	Abbreviations	abbreviation	NNS	_	0	ROOT

1	Ab	ab	NN	_	3	NMOD
2	-	-	:	_	3	P
3	antibody	antibody	NN	_	0	ROOT

1	ANA	ana	NN	_	4	NMOD
2	-	-	:	_	4	P
3	anti-nuclear	anti-nuclear	JJ	_	4	NMOD
4	antibody	antibody	NN	_	0	ROOT

1	AEU	aeu	NN	_	5	NMOD
2	-	-	:	_	5	P
3	arbitrary	arbitrary	JJ	_	5	NMOD
4	ELISA	elisa	NNP	_	5	NMOD
5	unit	unit	NN	_	0	ROOT

1	Apcs	apc	NN	_	9	NMOD
2	−	−	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	−	−	SYM	_	1	P
5	-	-	:	_	9	P
6	Apcs	apc	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	deficient	deficient	JJ	_	9	NMOD
9	mice	mouse	NNS	_	0	ROOT

1	Apcs	apc	NN	_	7	NMOD
2	-	-	:	_	7	P
3	serum	serum	NN	_	6	NMOD
4	amyloid	amyloid	NN	_	6	NMOD
5	P	p	NN	_	6	NMOD
6	component	component	NN	_	7	NMOD
7	gene	gene	NN	_	0	ROOT

1	dsDNA	dsdna	NN	_	6	NMOD
2	-	-	:	_	6	P
3	double	double	RB	_	5	AMOD
4	-	-	HYPH	_	3	P
5	stranded	strand	VBN	_	6	NMOD
6	DNA	dna	NN	_	0	ROOT

1	LOD	lod	NN	_	3	NMOD
2	-	-	:	_	3	P
3	logarithm	logarithm	NN	_	0	ROOT
4	of	of	IN	_	3	NMOD
5	odds	odds	NNS	_	4	PMOD

1	QTL	qtl	NN	_	5	NMOD
2	-	-	:	_	5	P
3	quantitative	quantitative	JJ	_	4	NMOD
4	trait	trait	NN	_	5	NMOD
5	linkage	linkage	NN	_	0	ROOT

1	SLE	sle	NN	_	5	NMOD
2	-	-	:	_	5	P
3	systemic	systemic	JJ	_	5	NMOD
4	lupus	lupus	NN	_	5	NMOD
5	erythematosus	erythematosus	NN	_	0	ROOT

1	ssDNA	ssdna	NN	_	6	NMOD
2	-	-	:	_	6	P
3	anti-single	anti-single	JJ	_	5	AMOD
4	-	-	HYPH	_	3	P
5	stranded	strand	VBN	_	6	NMOD
6	DNA	dna	NN	_	0	ROOT

1	Figures	figure	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Tables	table	NNS	_	2	CONJ

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Linkage	linkage	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Chromosome	chromosome	NN	_	2	PMOD
4	2	0	CD	_	3	NMOD
5	with	with	IN	_	1	NMOD
6	ANA	ana	NN	_	5	PMOD
7	and	and	CC	_	6	COORD
8	Anti-Chromatin	anti-chromatin	JJ	_	9	NMOD
9	Abs	ab	NNS	_	7	CONJ
10	in	in	IN	_	1	LOC
11	(	(	-LRB-	_	24	P
12	129	0	CD	_	14	NMOD
13	×	×	SYM	_	14	P
14	C57BL	c0bl	NN	_	18	NMOD
15	/	/	HYPH	_	14	P
16	6	0	CD	_	14	NMOD
17	)	)	-RRB-	_	18	P
18	F2	f0	NN	_	20	NMOD
19	.	.	HYPH	_	18	P
20	Apcs	apc	NN	_	24	NMOD
21	−	−	SYM	_	20	P
22	/	/	HYPH	_	20	P
23	−	−	SYM	_	20	P
24	Mice	mouse	NNS	_	10	PMOD

1	These	these	DT	_	2	NMOD
2	associations	association	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	not	not	RB	_	3	ADV
5	detected	detect	VBN	_	3	VC
6	in	in	IN	_	5	LOC
7	(	(	-LRB-	_	15	P
8	129	0	CD	_	10	NMOD
9	×	×	SYM	_	10	P
10	C57BL	c0bl	NN	_	15	NMOD
11	/	/	HYPH	_	10	P
12	6	0	CD	_	10	NMOD
13	)	)	-RRB-	_	15	P
14	F2	f0	NN	_	15	NMOD
15	animals	animal	NNS	_	6	PMOD
16	.	.	.	_	3	P

1	Centimorgan	centimorgan	NN	_	2	NMOD
2	positions	position	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	deduced	deduce	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	interval	interval	NN	_	7	NMOD
7	mapping	mapping	NN	_	5	PMOD
8	,	,	,	_	4	P
9	anchoring	anchor	VBG	_	4	ADV
10	marker	marker	NN	_	11	NMOD
11	locations	location	NNS	_	9	OBJ
12	to	to	IN	_	9	ADV
13	data	datum	NNS	_	12	PMOD
14	from	from	IN	_	13	NMOD
15	http://www.informatics.jax.org	http://www.informatics.jax.org	NN	_	14	PMOD
16	.	.	.	_	3	P

1	Dotted	dotted	JJ	_	2	NMOD
2	lines	line	NNS	_	7	SBJ
3	and	and	CC	_	2	COORD
4	the	the	DT	_	6	NMOD
5	dashed	dashed	JJ	_	6	NMOD
6	line	line	NN	_	3	CONJ
7	indicate	indicate	VBP	_	0	ROOT
8	the	the	DT	_	9	NMOD
9	threshold	threshold	NN	_	7	OBJ
10	over	over	IN	_	14	ADV
11	which	which	WDT	_	10	PMOD
12	linkages	linkage	NNS	_	13	SBJ
13	were	be	VBD	_	9	NMOD
14	considered	consider	VBN	_	13	VC
15	suggestive	suggestive	JJ	_	14	OPRD
16	or	or	CC	_	15	COORD
17	significant	significant	JJ	_	16	CONJ
18	,	,	,	_	15	P
19	respectively	respectively	RB	_	15	ADV
20	,	,	,	_	14	P
21	as	as	IN	_	14	ADV
22	defined	define	VBN	_	21	SUB
23	in	in	IN	_	22	ADV
24	Materials	material	NNS	_	23	PMOD
25	and	and	CC	_	24	COORD
26	Methods	method	NNS	_	25	CONJ
27	.	.	.	_	7	P

1	Figure	figure	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Linkage	linkage	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Chromosome	chromosome	NN	_	2	PMOD
4	4	0	CD	_	3	NMOD
5	with	with	IN	_	1	NMOD
6	Anti-dsDNA	anti-dsdna	JJ	_	7	NMOD
7	Abs	ab	NNS	_	5	PMOD

1	The	the	DT	_	3	NMOD
2	estimated	estimate	VBN	_	3	NMOD
3	peak	peak	NN	_	14	SBJ
4	in	in	IN	_	3	LOC
5	(	(	-LRB-	_	13	P
6	129	0	CD	_	8	NMOD
7	×	×	SYM	_	8	P
8	C57BL	c0bl	NN	_	13	NMOD
9	/	/	HYPH	_	8	P
10	6	0	CD	_	8	NMOD
11	)	)	-RRB-	_	13	P
12	F2	f0	NN	_	13	NMOD
13	mice	mouse	NNS	_	4	PMOD
14	was	be	VBD	_	0	ROOT
15	at	at	IN	_	14	PRD
16	position	position	NN	_	18	NMOD
17	51.3	0	CD	_	18	NMOD
18	cM	cm	NN	_	15	PMOD
19	,	,	,	_	14	P
20	whilst	whilst	IN	_	14	ADV
21	in	in	IN	_	39	ADV
22	the	the	DT	_	36	NMOD
23	(	(	-LRB-	_	32	P
24	129	0	CD	_	26	NMOD
25	×	×	SYM	_	26	P
26	C57BL	c0bl	NN	_	30	NMOD
27	/	/	HYPH	_	26	P
28	6	0	CD	_	26	NMOD
29	)	)	-RRB-	_	30	P
30	F2	f0	NN	_	32	NMOD
31	.	.	HYPH	_	30	P
32	Apcs	apc	NN	_	36	NMOD
33	−	−	SYM	_	32	P
34	/	/	HYPH	_	32	P
35	−	−	SYM	_	32	P
36	animals	animal	NNS	_	21	PMOD
37	it	it	PRP	_	39	SBJ
38	was	be	VBD	_	39	DEP
39	was	be	VBD	_	20	SUB
40	at	at	IN	_	39	LOC
41	position	position	NN	_	43	NMOD
42	71	0	CD	_	43	NMOD
43	cM	cm	NN	_	40	PMOD
44	,	,	,	_	39	P
45	indicating	indicate	VBG	_	39	ADV
46	that	that	IN	_	45	OBJ
47	most	most	RBS	_	48	AMOD
48	likely	likely	RB	_	50	ADV
49	these	these	DT	_	50	SBJ
50	were	be	VBD	_	46	SUB
51	two	two	CD	_	53	NMOD
52	independent	independent	JJ	_	53	NMOD
53	loci	locus	NNS	_	50	PRD
54	.	.	.	_	14	P

1	Centimorgan	centimorgan	NN	_	2	NMOD
2	positions	position	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	deduced	deduce	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	interval	interval	JJ	_	7	NMOD
7	mapping	mapping	NN	_	5	PMOD
8	,	,	,	_	4	P
9	anchoring	anchor	VBG	_	4	MNR
10	marker	marker	NN	_	11	NMOD
11	locations	location	NNS	_	9	OBJ
12	to	to	IN	_	9	ADV
13	data	datum	NNS	_	12	PMOD
14	from	from	IN	_	13	NMOD
15	http://www.informatics.jax.org	http://www.informatics.jax.org	NN	_	14	PMOD
16	.	.	.	_	3	P

1	Dotted	dotted	JJ	_	2	NMOD
2	lines	line	NNS	_	4	SBJ
3	the	the	DT	_	4	DEP
4	indicate	indicate	VBP	_	0	ROOT
5	threshold	threshold	NN	_	4	OBJ
6	over	over	IN	_	10	ADV
7	which	which	WDT	_	6	PMOD
8	linkage	linkage	NN	_	9	SBJ
9	was	be	VBD	_	5	NMOD
10	considered	consider	VBN	_	9	VC
11	suggestive	suggestive	JJ	_	10	OPRD
12	,	,	,	_	11	P
13	as	as	IN	_	11	ADV
14	defined	define	VBN	_	13	SUB
15	in	in	IN	_	14	LOC
16	Materials	material	NNS	_	15	PMOD
17	and	and	CC	_	16	COORD
18	Methods	method	NNS	_	17	CONJ
19	.	.	.	_	4	P

1	Figure	figure	NN	_	0	ROOT
2	4	0	CD	_	1	NMOD

1	Interval	interval	NN	_	3	NMOD
2	Mapping	mapping	NN	_	3	NMOD
3	Scans	scan	NNS	_	0	ROOT
4	Showing	show	VBG	_	3	NMOD
5	QTL	qtl	NN	_	4	OBJ
6	on	on	IN	_	4	LOC
7	Chromosome	chromosome	NN	_	6	PMOD
8	1	0	CD	_	7	NMOD
9	with	with	IN	_	4	ADV
10	Anti-dsDNA	anti-dsdna	JJ	_	13	NMOD
11	and	and	CC	_	10	COORD
12	Anti-ssDNA	anti-ssdna	JJ	_	11	CONJ
13	Abs	ab	NNS	_	9	PMOD

1	Centimorgan	centimorgan	NN	_	2	NMOD
2	positions	position	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	deduced	deduce	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	interval	interval	JJ	_	7	NMOD
7	mapping	mapping	NN	_	5	PMOD
8	,	,	,	_	4	P
9	anchoring	anchor	VBG	_	4	ADV
10	marker	marker	NN	_	11	NMOD
11	locations	location	NNS	_	9	OBJ
12	to	to	IN	_	9	ADV
13	data	datum	NNS	_	12	PMOD
14	from	from	IN	_	13	NMOD
15	http://www.informatics.jax.org	http://www.informatics.jax.org	NN	_	14	PMOD
16	.	.	.	_	3	P

1	Dotted	dotted	JJ	_	2	NMOD
2	lines	line	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	the	the	DT	_	5	NMOD
5	threshold	threshold	NN	_	3	OBJ
6	over	over	IN	_	10	ADV
7	which	which	WDT	_	6	PMOD
8	linkage	linkage	NN	_	9	SBJ
9	was	be	VBD	_	5	NMOD
10	considered	consider	VBN	_	9	VC
11	suggestive	suggestive	JJ	_	10	OPRD
12	,	,	,	_	3	P
13	dashed	dashed	JJ	_	14	NMOD
14	lines	line	NNS	_	15	SBJ
15	indicate	indicate	VBP	_	3	CONJ
16	the	the	DT	_	17	NMOD
17	threshold	threshold	NN	_	15	OBJ
18	over	over	IN	_	21	DEP
19	which	which	WDT	_	18	PMOD
20	linkage	linkage	NN	_	21	SBJ
21	was	be	VBD	_	17	NMOD
22	considered	consider	VBN	_	21	VC
23	significant	significant	JJ	_	22	OPRD
24	,	,	,	_	15	P
25	and	and	CC	_	15	COORD
26	dotted	dotted	JJ	_	28	AMOD
27	/	/	HYPH	_	26	P
28	dashed	dashed	JJ	_	29	NMOD
29	lines	line	NNS	_	30	SBJ
30	indicate	indicate	VBP	_	25	CONJ
31	highly	highly	RB	_	32	AMOD
32	significant	significant	JJ	_	33	NMOD
33	linkage	linkage	NN	_	30	OBJ
34	,	,	,	_	30	P
35	as	as	IN	_	30	ADV
36	defined	define	VBN	_	35	SUB
37	in	in	IN	_	36	ADV
38	Materials	material	NNS	_	37	PMOD
39	and	and	CC	_	38	COORD
40	Methods	method	NNS	_	39	CONJ
41	.	.	.	_	3	P

1	See	see	VB	_	0	ROOT
2	Table	table	NN	_	1	OBJ
3	3	0	CD	_	2	NMOD
4	for	for	IN	_	1	PRP
5	additional	additional	JJ	_	6	NMOD
6	details	detail	NNS	_	4	PMOD
7	.	.	.	_	1	P

1	Figure	figure	NN	_	0	ROOT
2	5	0	CD	_	1	NMOD

1	Interval	interval	NN	_	3	NMOD
2	Mapping	mapping	NN	_	3	NMOD
3	Scans	scan	NNS	_	4	SBJ
4	Showing	show	VBG	_	0	ROOT
5	QTL	qtl	NN	_	4	OBJ
6	on	on	IN	_	4	LOC
7	Chromosome	chromosome	NN	_	6	PMOD
8	1	0	CD	_	7	NMOD
9	with	with	IN	_	4	ADV
10	ANA	ana	NN	_	9	PMOD
11	and	and	CC	_	10	COORD
12	Anti-Chromatin	anti-chromatin	NN	_	13	NMOD
13	Abs	ab	NNS	_	11	CONJ

1	Centimorgan	centimorgan	NN	_	2	NMOD
2	positions	position	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	deduced	deduce	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	interval	interval	NN	_	7	NMOD
7	mapping	mapping	NN	_	5	PMOD
8	,	,	,	_	4	P
9	anchoring	anchor	VBG	_	4	ADV
10	marker	marker	NN	_	11	NMOD
11	locations	location	NNS	_	9	OBJ
12	to	to	IN	_	9	ADV
13	data	datum	NNS	_	12	PMOD
14	from	from	IN	_	13	NMOD
15	http://www.informatics.jax.org	http://www.informatics.jax.org	NN	_	14	PMOD
16	.	.	.	_	3	P

1	Dotted	dotted	JJ	_	2	NMOD
2	lines	line	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	the	the	DT	_	5	NMOD
5	threshold	threshold	NN	_	3	OBJ
6	over	over	IN	_	10	ADV
7	which	which	WDT	_	6	PMOD
8	linkage	linkage	NN	_	9	SBJ
9	was	be	VBD	_	5	NMOD
10	considered	consider	VBN	_	9	VC
11	suggestive	suggestive	JJ	_	10	OPRD
12	,	,	,	_	3	P
13	and	and	CC	_	3	COORD
14	dashed	dashed	JJ	_	15	NMOD
15	lines	line	NNS	_	16	SBJ
16	indicate	indicate	VBP	_	13	CONJ
17	the	the	DT	_	18	NMOD
18	threshold	threshold	NN	_	16	OBJ
19	over	over	IN	_	23	ADV
20	which	which	WDT	_	19	PMOD
21	linkage	linkage	NN	_	22	SBJ
22	was	be	VBD	_	18	NMOD
23	considered	consider	VBN	_	22	VC
24	significant	significant	JJ	_	23	OPRD
25	,	,	,	_	16	P
26	as	as	IN	_	16	ADV
27	defined	define	VBN	_	26	SUB
28	in	in	IN	_	27	LOC
29	Materials	material	NNS	_	28	PMOD
30	and	and	CC	_	29	COORD
31	Methods	method	NNS	_	30	CONJ
32	.	.	.	_	3	P

1	See	see	VB	_	0	ROOT
2	Table	table	NN	_	1	OBJ
3	3	0	CD	_	2	NMOD
4	for	for	IN	_	1	ADV
5	additional	additional	JJ	_	6	NMOD
6	details	detail	NNS	_	4	PMOD
7	.	.	.	_	1	P

1	Figure	figure	NN	_	0	ROOT
2	6	0	CD	_	1	NMOD

1	Auto-Ab	auto-ab	NN	_	2	NMOD
2	Profiles	profile	NNS	_	0	ROOT

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	ANA	ana	NN	_	5	NMOD
5	titres	titre	NNS	_	0	ROOT
6	in	in	IN	_	5	LOC
7	the	the	DT	_	21	NMOD
8	(	(	-LRB-	_	21	P
9	129	0	CD	_	15	NMOD
10	×	×	SYM	_	15	P
11	C57BL	c0bl	NN	_	15	NMOD
12	/	/	HYPH	_	11	P
13	6	0	CD	_	11	NMOD
14	)	)	-RRB-	_	15	P
15	F2	f0	NN	_	17	NMOD
16	.	.	HYPH	_	15	P
17	Apcs	apc	NN	_	21	NMOD
18	−	−	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	−	−	SYM	_	17	P
21	mice	mouse	NNS	_	6	PMOD
22	and	and	CC	_	21	COORD
23	(	(	-LRB-	_	30	P
24	129	0	CD	_	26	NMOD
25	×	×	SYM	_	26	P
26	C57BL	c0bl	NN	_	30	NMOD
27	/	/	HYPH	_	26	P
28	6	0	CD	_	26	NMOD
29	)	)	-RRB-	_	30	P
30	F2	f0	NN	_	22	CONJ
31	at	at	IN	_	5	TMP
32	1	0	CD	_	33	NMOD
33	y	y	NN	_	31	PMOD
34	of	of	IN	_	33	NMOD
35	age	age	NN	_	34	PMOD
36	.	.	.	_	5	P

1	A	a	DT	_	3	NMOD
2	small	small	JJ	_	3	NMOD
3	circle	circle	NN	_	4	SBJ
4	represents	represent	VBZ	_	0	ROOT
5	one	one	CD	_	6	NMOD
6	mouse	mouse	NN	_	4	OBJ
7	;	;	:	_	4	P
8	a	a	DT	_	10	NMOD
9	large	large	JJ	_	10	NMOD
10	circle	circle	NN	_	4	GAP-SBJ
11	,	,	,	_	10	P
12	a	a	DT	_	14	NMOD
13	variable	variable	JJ	_	14	NMOD
14	number	number	NN	_	10	DEP
15	of	of	IN	_	14	NMOD
16	animals	animal	NNS	_	15	PMOD
17	,	,	,	_	4	P
18	as	as	IN	_	4	ADV
19	indicated	indicate	VBN	_	18	SUB
20	in	in	IN	_	19	ADV
21	parentheses	parenthesis	NNS	_	20	PMOD
22	.	.	.	_	4	P

1	Serum	serum	NN	_	2	NMOD
2	samples	sample	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	titrated	titrate	VBN	_	3	VC
5	to	to	IN	_	4	ADV
6	endpoint	endpoint	NN	_	5	PMOD
7	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	ANA	ana	NN	_	5	NMOD
5	titres	titre	NNS	_	0	ROOT
6	in	in	IN	_	5	NMOD
7	the	the	DT	_	21	NMOD
8	(	(	-LRB-	_	21	P
9	129	0	CD	_	11	NMOD
10	×	×	SYM	_	11	P
11	C57BL	c0bl	NN	_	15	NMOD
12	/	/	HYPH	_	11	P
13	6	0	CD	_	11	NMOD
14	)	)	-RRB-	_	15	P
15	F2	f0	NN	_	17	NMOD
16	.	.	HYPH	_	15	P
17	Apcs	apc	NN	_	21	NMOD
18	−	−	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	−	−	SYM	_	17	P
21	mice	mouse	NNS	_	6	PMOD
22	and	and	CC	_	21	COORD
23	a	a	DT	_	25	NMOD
24	selected	select	VBN	_	25	NMOD
25	number	number	NN	_	22	CONJ
26	of	of	IN	_	25	NMOD
27	wild	wild	JJ	_	29	NMOD
28	-	-	HYPH	_	27	P
29	type	type	NN	_	38	NMOD
30	(	(	-LRB-	_	38	P
31	129	0	CD	_	33	NMOD
32	×	×	SYM	_	33	P
33	C57BL	c0bl	NN	_	37	NMOD
34	/	/	HYPH	_	33	P
35	6	0	CD	_	33	NMOD
36	)	)	-RRB-	_	37	P
37	F2	f0	NN	_	38	NMOD
38	animals	animal	NNS	_	26	PMOD
39	carrying	carry	VBG	_	38	NMOD
40	the	the	DT	_	43	NMOD
41	Chromosome	chromosome	NN	_	43	NMOD
42	1	0	CD	_	41	NMOD
43	region	region	NN	_	39	OBJ
44	between	between	IN	_	43	NMOD
45	D1Mit105	d0mit0	NN	_	44	PMOD
46	and	and	CC	_	45	COORD
47	D1Mit223	d0mit0	NN	_	46	CONJ
48	(	(	-LRB-	_	52	P
49	80	0	CD	_	52	NMOD
50	–	–	SYM	_	49	P
51	106	0	CD	_	49	QMOD
52	cM	cm	NN	_	45	PRN
53	)	)	-RRB-	_	52	P
54	of	of	IN	_	43	NMOD
55	129	0	CD	_	56	NMOD
56	origin	origin	NN	_	54	PMOD
57	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	symbols	symbol	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	as	as	IN	_	3	PRD
5	in	in	IN	_	4	PMOD
6	(	(	-LRB-	_	5	P
7	A	a	NN	_	5	PMOD
8	)	)	-RRB-	_	5	P
9	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	8	NMOD
3	and	and	CC	_	2	COORD
4	D	d	LS	_	3	CONJ
5	)	)	-RRB-	_	2	P
6	Anti-chromatin	anti-chromatin	JJ	_	8	NMOD
7	Ab	ab	NN	_	8	NMOD
8	levels	level	NNS	_	0	ROOT
9	expressed	express	VBN	_	8	NMOD
10	in	in	IN	_	9	ADV
11	AEUs	aeus	NNS	_	10	PMOD
12	related	related	JJ	_	8	NMOD
13	to	to	IN	_	12	AMOD
14	a	a	DT	_	17	NMOD
15	standard	standard	JJ	_	17	NMOD
16	positive	positive	JJ	_	17	NMOD
17	sample	sample	NN	_	13	PMOD
18	,	,	,	_	17	P
19	which	which	WDT	_	20	SBJ
20	was	be	VBD	_	17	NMOD
21	assigned	assign	VBN	_	20	VC
22	a	a	DT	_	23	NMOD
23	value	value	NN	_	21	OBJ
24	of	of	IN	_	23	NMOD
25	100	0	CD	_	26	NMOD
26	AEU	aeu	NN	_	24	PMOD
27	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	comparison	comparison	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	between	between	IN	_	3	PRD
5	the	the	DT	_	7	NMOD
6	same	same	JJ	_	7	NMOD
7	groups	group	NNS	_	4	PMOD
8	of	of	IN	_	7	NMOD
9	mice	mouse	NNS	_	8	PMOD
10	as	as	IN	_	7	NMOD
11	in	in	IN	_	10	PMOD
12	(	(	-LRB-	_	13	P
13	A	a	NN	_	11	PMOD
14	)	)	-RRB-	_	13	P
15	and	and	CC	_	13	COORD
16	(	(	-LRB-	_	17	P
17	B	b	NN	_	15	CONJ
18	)	)	-RRB-	_	13	P
19	,	,	,	_	3	P
20	respectively	respectively	RB	_	3	ADV
21	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	symbols	symbol	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	as	as	IN	_	3	PRD
5	in	in	IN	_	4	PMOD
6	(	(	-LRB-	_	5	P
7	A	a	NN	_	5	PMOD
8	)	)	-RRB-	_	5	P
9	.	.	.	_	3	P

1	Figure	figure	NN	_	0	ROOT
2	7	0	CD	_	1	NMOD

1	Interval	interval	NN	_	3	NMOD
2	Mapping	mapping	NN	_	3	NMOD
3	Scans	scan	NNS	_	0	ROOT
4	Showing	show	VBG	_	3	NMOD
5	QTL	qtl	NN	_	4	OBJ
6	on	on	IN	_	4	LOC
7	Chromosome	chromosome	NN	_	6	PMOD
8	3	0	CD	_	7	NMOD
9	with	with	IN	_	4	ADV
10	ANA	ana	NN	_	16	NMOD
11	,	,	,	_	10	P
12	Anti-Chromatin	anti-chromatin	JJ	_	10	NMOD
13	,	,	,	_	12	P
14	and	and	CC	_	12	COORD
15	Anti-ssDNA	anti-ssdna	JJ	_	14	CONJ
16	Abs	ab	NNS	_	9	PMOD

1	See	see	VB	_	0	ROOT
2	Table	table	NN	_	1	OBJ
3	3	0	CD	_	2	NMOD
4	for	for	IN	_	1	PRP
5	additional	additional	JJ	_	6	NMOD
6	details	detail	NNS	_	4	PMOD
7	.	.	.	_	1	P

1	Centimorgan	centimorgan	NN	_	2	NMOD
2	positions	position	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	deduced	deduce	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	interval	interval	JJ	_	7	NMOD
7	mapping	mapping	NN	_	5	PMOD
8	,	,	,	_	4	P
9	anchoring	anchor	VBG	_	4	ADV
10	marker	marker	NN	_	11	NMOD
11	locations	location	NNS	_	9	OBJ
12	to	to	IN	_	9	ADV
13	data	datum	NNS	_	12	PMOD
14	from	from	IN	_	13	NMOD
15	http://www.informatics.jax.org	http://www.informatics.jax.org	NN	_	14	PMOD
16	.	.	.	_	3	P

1	Dotted	dotted	JJ	_	2	NMOD
2	lines	line	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	the	the	DT	_	5	NMOD
5	threshold	threshold	NN	_	3	OBJ
6	over	over	IN	_	10	ADV
7	which	which	WDT	_	6	PMOD
8	linkage	linkage	NN	_	9	SBJ
9	was	be	VBD	_	5	NMOD
10	considered	consider	VBN	_	9	VC
11	suggestive	suggestive	JJ	_	10	OPRD
12	,	,	,	_	3	P
13	the	the	DT	_	15	NMOD
14	dashed	dashed	JJ	_	15	NMOD
15	line	line	NN	_	16	SBJ
16	indicate	indicate	VBP	_	3	CONJ
17	the	the	DT	_	18	NMOD
18	threshold	threshold	NN	_	16	OBJ
19	over	over	IN	_	22	DEP
20	which	which	WDT	_	19	PMOD
21	linkage	linkage	NN	_	22	SBJ
22	was	be	VBD	_	18	NMOD
23	considered	consider	VBN	_	22	VC
24	significant	significant	JJ	_	23	OPRD
25	,	,	,	_	16	P
26	and	and	CC	_	16	COORD
27	dotted	dotted	JJ	_	29	AMOD
28	/	/	HYPH	_	27	P
29	dashed	dashed	JJ	_	30	NMOD
30	lines	line	NNS	_	31	SBJ
31	indicate	indicate	VBP	_	26	CONJ
32	highly	highly	RB	_	33	AMOD
33	significant	significant	JJ	_	34	NMOD
34	linkage	linkage	NN	_	31	OBJ
35	,	,	,	_	31	P
36	as	as	IN	_	31	ADV
37	defined	define	VBN	_	36	SUB
38	in	in	IN	_	37	ADV
39	Materials	material	NNS	_	38	PMOD
40	and	and	CC	_	39	COORD
41	Methods	method	NNS	_	40	CONJ
42	.	.	.	_	3	P

1	Figure	figure	NN	_	0	ROOT
2	8	0	CD	_	1	NMOD

1	Auto-Ab	auto-ab	NN	_	2	NMOD
2	Profiles	profile	NNS	_	0	ROOT

1	(	(	-LRB-	_	5	P
2	A	a	LS	_	5	NMOD
3	)	)	-RRB-	_	5	P
4	ANA	ana	NN	_	5	NMOD
5	titres	titre	NNS	_	0	ROOT
6	in	in	IN	_	5	LOC
7	C57BL	c0bl	NN	_	10	NMOD
8	/	/	HYPH	_	7	P
9	6	0	CD	_	7	NMOD
10	mice	mouse	NNS	_	6	PMOD
11	,	,	,	_	10	P
12	C57BL	c0bl	NN	_	16	NMOD
13	/	/	HYPH	_	12	P
14	6	0	CD	_	12	NMOD
15	.	.	HYPH	_	12	P
16	Apcs	apc	NN	_	20	NMOD
17	−	−	SYM	_	16	P
18	/	/	HYPH	_	16	P
19	−	−	SYM	_	16	P
20	mice	mouse	NNS	_	10	CONJ
21	,	,	,	_	20	P
22	and	and	CC	_	20	COORD
23	C57BL	c0bl	NN	_	29	NMOD
24	/	/	HYPH	_	23	P
25	6	0	CD	_	23	NMOD
26	.	.	HYPH	_	23	P
27	129	0	CD	_	23	NMOD
28	(	(	-LRB-	_	29	P
29	D1Mit105	d0mit0	NN	_	34	NMOD
30	–	–	SYM	_	31	P
31	223	0	CD	_	29	NMOD
32	)	)	-RRB-	_	34	P
33	congenic	congenic	JJ	_	34	NMOD
34	mice	mouse	NNS	_	22	CONJ
35	at	at	IN	_	5	TMP
36	1	0	CD	_	37	NMOD
37	y	y	NN	_	35	PMOD
38	of	of	IN	_	37	NMOD
39	age	age	NN	_	38	PMOD
40	.	.	.	_	5	P

1	Small	small	JJ	_	2	NMOD
2	symbols	symbol	NNS	_	3	SBJ
3	represent	represent	VBP	_	0	ROOT
4	one	one	CD	_	5	NMOD
5	mouse	mouse	NN	_	3	OBJ
6	;	;	:	_	3	P
7	large	large	JJ	_	8	NMOD
8	symbols	symbol	NNS	_	3	GAP-SBJ
9	,	,	,	_	8	P
10	a	a	DT	_	12	NMOD
11	variable	variable	JJ	_	12	NMOD
12	number	number	NN	_	8	DEP
13	of	of	IN	_	12	NMOD
14	animals	animal	NNS	_	13	PMOD
15	as	as	IN	_	3	ADV
16	indicated	indicate	VBN	_	15	SUB
17	in	in	IN	_	16	LOC
18	parentheses	parenthesis	NNS	_	17	PMOD
19	.	.	.	_	3	P

1	Serum	serum	NN	_	2	NMOD
2	sample	sample	NN	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	titrated	titrate	VBN	_	3	VC
5	to	to	IN	_	4	ADV
6	endpoint	endpoint	NN	_	5	PMOD
7	.	.	.	_	3	P

1	(	(	-LRB-	_	16	P
2	B	b	LS	_	16	NMOD
3	and	and	CC	_	2	COORD
4	C	c	LS	_	3	CONJ
5	)	)	-RRB-	_	16	P
6	Anti-ssDNA	anti-ssdna	NN	_	16	NMOD
7	(	(	-LRB-	_	8	P
8	B	b	NN	_	6	PRN
9	)	)	-RRB-	_	8	P
10	and	and	CC	_	6	COORD
11	anti-chromatin	anti-chromatin	JJ	_	10	CONJ
12	(	(	-LRB-	_	13	P
13	C	c	NN	_	11	PRN
14	)	)	-RRB-	_	13	P
15	Ab	ab	NN	_	16	NMOD
16	levels	level	NNS	_	0	ROOT
17	in	in	IN	_	16	LOC
18	the	the	DT	_	20	NMOD
19	same	same	JJ	_	20	NMOD
20	cohorts	cohort	NNS	_	17	PMOD
21	of	of	IN	_	20	NMOD
22	mice	mouse	NNS	_	21	PMOD
23	as	as	IN	_	20	NMOD
24	in	in	IN	_	23	PMOD
25	(	(	-LRB-	_	24	P
26	A	a	NN	_	24	PMOD
27	)	)	-RRB-	_	24	P
28	.	.	.	_	16	P

1	The	the	DT	_	3	NMOD
2	Ab	ab	NN	_	3	NMOD
3	levels	level	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	expressed	express	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	AEUs	aeus	NNS	_	6	PMOD
8	related	related	JJ	_	7	NMOD
9	to	to	IN	_	8	AMOD
10	a	a	DT	_	13	NMOD
11	standard	standard	JJ	_	13	NMOD
12	positive	positive	JJ	_	13	NMOD
13	sample	sample	NN	_	9	PMOD
14	,	,	,	_	13	P
15	which	which	WDT	_	16	SBJ
16	was	be	VBD	_	13	NMOD
17	assigned	assign	VBN	_	16	VC
18	a	a	DT	_	19	NMOD
19	value	value	NN	_	17	OBJ
20	of	of	IN	_	19	NMOD
21	100	0	CD	_	22	NMOD
22	AEU	aeu	NN	_	20	PMOD
23	.	.	.	_	4	P

1	(	(	-LRB-	_	2	P
2	D	d	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Anti-dsDNA	anti-dsdna	JJ	_	5	NMOD
5	Ab	ab	NN	_	6	NMOD
6	levels	level	NNS	_	0	ROOT
7	.	.	.	_	6	P

1	Serum	serum	NN	_	2	NMOD
2	samples	sample	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	screened	screen	VBN	_	3	VC
5	at	at	IN	_	4	ADV
6	1	0	CD	_	5	PMOD
7	:	:	SYM	_	8	P
8	20	0	CD	_	6	NMOD
9	.	.	.	_	3	P

1	Samples	sample	NNS	_	5	SBJ
2	that	that	WDT	_	3	SBJ
3	were	be	VBD	_	1	NMOD
4	positive	positive	JJ	_	3	PRD
5	were	be	VBD	_	0	ROOT
6	titrated	titrate	VBN	_	5	VC
7	to	to	IN	_	6	ADV
8	endpoint	endpoint	NN	_	7	PMOD
9	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	symbols	symbol	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	as	as	IN	_	3	PRD
5	in	in	IN	_	4	PMOD
6	(	(	-LRB-	_	5	P
7	A	a	NN	_	5	PMOD
8	)	)	-RRB-	_	5	P
9	.	.	.	_	3	P

1	Figure	figure	NN	_	0	ROOT
2	9	0	CD	_	1	NMOD

1	Renal	renal	JJ	_	3	NMOD
2	Histological	histological	JJ	_	3	NMOD
3	Assessment	assessment	NN	_	0	ROOT

1	C57BL	c0bl	NN	_	4	NMOD
2	/	/	HYPH	_	1	P
3	6	0	CD	_	1	NMOD
4	mice	mouse	NNS	_	29	SBJ
5	,	,	,	_	4	P
6	C57BL	c0bl	NN	_	10	NMOD
7	/	/	HYPH	_	6	P
8	6	0	CD	_	6	NMOD
9	.	.	HYPH	_	6	P
10	Apcs	apc	NN	_	14	NMOD
11	−	−	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	−	−	SYM	_	10	P
14	mice	mouse	NNS	_	4	CONJ
15	,	,	,	_	14	P
16	and	and	CC	_	14	COORD
17	C57BL	c0bl	NN	_	23	NMOD
18	/	/	HYPH	_	17	P
19	6	0	CD	_	17	NMOD
20	.	.	HYPH	_	17	P
21	129	0	CD	_	17	NMOD
22	(	(	-LRB-	_	23	P
23	D1Mit105	d0mit0	NN	_	28	NMOD
24	–	–	SYM	_	25	P
25	223	0	CD	_	23	NMOD
26	)	)	-RRB-	_	23	P
27	congenic	congenic	JJ	_	28	NMOD
28	mice	mouse	NNS	_	16	CONJ
29	were	be	VBD	_	0	ROOT
30	sacrificed	sacrifice	VBN	_	29	VC
31	at	at	IN	_	30	TMP
32	1	0	CD	_	33	NMOD
33	y	y	NN	_	31	PMOD
34	of	of	IN	_	33	NMOD
35	age	age	NN	_	34	PMOD
36	to	to	TO	_	30	PRP
37	obtain	obtain	VB	_	36	IM
38	age	age	NN	_	40	AMOD
39	-	-	HYPH	_	38	P
40	matched	match	VBN	_	42	NMOD
41	autopsy	autopsy	NN	_	42	NMOD
42	specimens	specimen	NNS	_	37	OBJ
43	.	.	.	_	29	P

1	Bouin	bouin	NNP	_	5	NMOD
2	's	's	POS	_	1	NMOD
3	fixed	fix	VBN	_	4	NMOD
4	kidney	kidney	NN	_	5	NMOD
5	sections	section	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	scored	score	VBN	_	6	VC
8	blinded	blinded	RB	_	7	MNR
9	for	for	IN	_	7	PRP
10	glomerulonephritis	glomerulonephritis	NN	_	9	PMOD
11	.	.	.	_	6	P

1	Glomerulonephritis	glomerulonephritis	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	graded	grade	VBN	_	2	VC
4	on	on	IN	_	3	ADV
5	a	a	DT	_	9	NMOD
6	0	0	CD	_	9	NMOD
7	–	–	SYM	_	8	P
8	3	0	CD	_	6	NMOD
9	scale	scale	NN	_	4	PMOD
10	(	(	-LRB-	_	11	P
11	see	see	VB	_	3	PRN
12	Materials	material	NNS	_	11	OBJ
13	and	and	CC	_	12	COORD
14	Methods	method	NNS	_	13	CONJ
15	for	for	IN	_	11	PRP
16	details	detail	NNS	_	15	PMOD
17	)	)	-RRB-	_	11	P
18	.	.	.	_	2	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Linkage	linkage	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Chromosome	chromosome	NN	_	2	PMOD
4	8	0	CD	_	3	NMOD
5	with	with	IN	_	1	NMOD
6	Anti-Chromatin	anti-chromatin	JJ	_	9	NMOD
7	and	and	CC	_	6	COORD
8	Anti-dsDNA	anti-dsdna	JJ	_	7	CONJ
9	Abs	ab	NNS	_	5	PMOD
10	in	in	IN	_	1	LOC
11	(	(	-LRB-	_	19	P
12	129	0	CD	_	14	NMOD
13	×	×	SYM	_	14	P
14	C57BL	c0bl	NN	_	19	NMOD
15	/	/	HYPH	_	14	P
16	6	0	CD	_	14	NMOD
17	)	)	-RRB-	_	19	P
18	F2	f0	NN	_	19	NMOD
19	Mice	mouse	NNS	_	10	PMOD

1	These	these	DT	_	2	NMOD
2	linkages	linkage	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	not	not	RB	_	3	ADV
5	detected	detect	VBN	_	3	VC
6	in	in	IN	_	5	LOC
7	(	(	-LRB-	_	14	P
8	129	0	CD	_	10	NMOD
9	×	×	SYM	_	10	P
10	C57BL	c0bl	NN	_	14	NMOD
11	/	/	HYPH	_	10	P
12	6	0	CD	_	10	NMOD
13	)	)	-RRB-	_	14	P
14	F2	f0	NN	_	16	NMOD
15	.	.	HYPH	_	14	P
16	Apcs	apc	NN	_	20	NMOD
17	−	−	SYM	_	16	P
18	/	/	HYPH	_	16	P
19	−	−	SYM	_	16	P
20	animals	animal	NNS	_	6	PMOD
21	.	.	.	_	3	P

1	Centimorgan	centimorgan	NN	_	2	NMOD
2	positions	position	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	deduced	deduce	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	interval	interval	NN	_	7	NMOD
7	mapping	mapping	NN	_	5	PMOD
8	,	,	,	_	4	P
9	anchoring	anchor	VBG	_	4	ADV
10	marker	marker	NN	_	11	NMOD
11	locations	location	NNS	_	9	OBJ
12	to	to	IN	_	9	ADV
13	data	datum	NNS	_	12	PMOD
14	from	from	IN	_	13	NMOD
15	http://www.informatics.jax.org	http://www.informatics.jax.org	NN	_	14	PMOD
16	.	.	.	_	3	P

1	Dotted	dotted	JJ	_	2	NMOD
2	lines	line	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	the	the	DT	_	5	NMOD
5	threshold	threshold	NN	_	3	OBJ
6	over	over	IN	_	10	ADV
7	which	which	WDT	_	6	PMOD
8	linkage	linkage	NN	_	9	SBJ
9	was	be	VBD	_	5	NMOD
10	considered	consider	VBN	_	9	VC
11	suggestive	suggestive	JJ	_	10	OPRD
12	,	,	,	_	3	P
13	as	as	IN	_	3	ADV
14	defined	define	VBN	_	13	SUB
15	in	in	IN	_	14	LOC
16	Materials	material	NNS	_	15	PMOD
17	and	and	CC	_	16	COORD
18	Methods	method	NNS	_	17	CONJ
19	.	.	.	_	3	P

1	Table	table	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Spontaneous	spontaneous	JJ	_	2	NMOD
2	Auto-Abs	auto-abs	NNS	_	0	ROOT
3	in	in	IN	_	2	LOC
4	Apcs	apc	NN	_	21	NMOD
5	−	−	SYM	_	4	P
6	/	/	HYPH	_	4	P
7	−	−	SYM	_	4	P
8	and	and	CC	_	4	COORD
9	Wild	wild	JJ	_	11	NMOD
10	-	-	HYPH	_	9	P
11	Type	type	NN	_	19	NMOD
12	(	(	-LRB-	_	19	P
13	129	0	CD	_	15	NMOD
14	×	×	SYM	_	15	P
15	C57BL	c0bl	NN	_	19	NMOD
16	/	/	HYPH	_	15	P
17	6	0	CD	_	15	NMOD
18	)	)	-RRB-	_	19	P
19	F2	f0	NN	_	8	CONJ
20	Female	female	JJ	_	21	NMOD
21	Mice	mouse	NNS	_	3	PMOD

1	Significant	significant	JJ	_	2	NMOD
2	differences	difference	NNS	_	0	ROOT
3	between	between	IN	_	2	NMOD
4	Apcs	apc	NN	_	12	NMOD
5	−	−	SYM	_	4	P
6	/	/	HYPH	_	4	P
7	−	−	SYM	_	4	P
8	and	and	CC	_	4	COORD
9	wild	wild	JJ	_	11	NMOD
10	-	-	HYPH	_	9	P
11	type	type	NN	_	8	CONJ
12	controls	control	NNS	_	3	PMOD
13	by	by	IN	_	2	NMOD
14	Mann	mann	NNP	_	16	NMOD
15	–	–	HYPH	_	14	P
16	Whitney	whitney	NNP	_	18	NMOD
17	U	u	NNP	_	18	NMOD
18	test	test	NN	_	13	PMOD
19	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	numbers	number	NNS	_	7	SBJ
3	tested	test	VBN	_	2	NMOD
4	for	for	IN	_	3	PRP
5	different	different	JJ	_	6	NMOD
6	phenotypes	phenotype	NNS	_	4	PMOD
7	are	be	VBP	_	0	ROOT
8	not	not	RB	_	7	ADV
9	equal	equal	JJ	_	7	PRD
10	due	due	IN	_	7	PRP
11	to	to	IN	_	10	PMOD
12	the	the	DT	_	14	NMOD
13	limited	limit	VBN	_	14	NMOD
14	amount	amount	NN	_	10	PMOD
15	of	of	IN	_	14	NMOD
16	serum	serum	NN	_	15	PMOD
17	or	or	CC	_	14	COORD
18	death	death	NN	_	17	CONJ
19	of	of	IN	_	18	NMOD
20	the	the	DT	_	21	NMOD
21	mice	mouse	NNS	_	19	PMOD
22	before	before	IN	_	18	TMP
23	the	the	DT	_	24	NMOD
24	end	end	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	27	NMOD
27	experiment	experiment	NN	_	25	PMOD
28	.	.	.	_	7	P

1	NS	ns	JJ	_	0	ROOT
2	,	,	,	_	1	P
3	not	not	RB	_	4	NMOD
4	significant	significant	JJ	_	1	APPO

1	Table	table	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Histological	histological	JJ	_	2	NMOD
2	Assessment	assessment	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	Kidney	kidney	NN	_	5	NMOD
5	Sections	section	NNS	_	3	PMOD
6	in	in	IN	_	2	LOC
7	Apcs	apc	NN	_	24	NMOD
8	−	−	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	−	−	SYM	_	7	P
11	and	and	CC	_	7	COORD
12	Wild	wild	JJ	_	14	NMOD
13	-	-	HYPH	_	12	P
14	Type	type	NN	_	11	CONJ
15	(	(	-LRB-	_	18	P
16	129	0	CD	_	18	NMOD
17	×	×	SYM	_	18	P
18	C57BL	c0bl	NN	_	24	NMOD
19	/	/	HYPH	_	18	P
20	6	0	CD	_	18	NMOD
21	)	)	-RRB-	_	18	P
22	F2	f0	NN	_	24	NMOD
23	Female	female	JJ	_	24	NMOD
24	Mice	mouse	NNS	_	6	PMOD

1	The	the	DT	_	3	NMOD
2	renal	renal	JJ	_	3	NMOD
3	sections	section	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	scored	score	VBN	_	4	VC
6	on	on	IN	_	5	ADV
7	a	a	DT	_	11	NMOD
8	0	0	CD	_	11	NMOD
9	–	–	SYM	_	10	P
10	3	0	CD	_	8	NMOD
11	scale	scale	NN	_	6	PMOD
12	on	on	IN	_	5	ADV
13	the	the	DT	_	14	NMOD
14	intensity	intensity	NN	_	12	PMOD
15	and	and	CC	_	14	COORD
16	extent	extent	NN	_	15	CONJ
17	of	of	IN	_	14	NMOD
18	the	the	DT	_	20	NMOD
19	histopathological	histopathological	JJ	_	20	NMOD
20	changes	change	NNS	_	17	PMOD
21	as	as	IN	_	5	ADV
22	described	describe	VBN	_	21	SUB
23	in	in	IN	_	22	ADV
24	Materials	material	NNS	_	23	PMOD
25	and	and	CC	_	24	COORD
26	Methods	method	NNS	_	25	CONJ
27	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	difference	difference	NN	_	8	SBJ
3	between	between	IN	_	2	NMOD
4	the	the	DT	_	7	NMOD
5	two	two	CD	_	7	NMOD
6	experimental	experimental	JJ	_	7	NMOD
7	groups	group	NNS	_	3	PMOD
8	was	be	VBD	_	0	ROOT
9	not	not	RB	_	8	ADV
10	significant	significant	JJ	_	8	PRD

1	Table	table	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Summary	summary	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Genome	genome	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	Wide	wide	JJ	_	7	NMOD
6	Linkage	linkage	NN	_	7	NMOD
7	Analysis	analysis	NN	_	2	PMOD
8	in	in	IN	_	7	LOC
9	Apcs	apc	NN	_	26	NMOD
10	−	−	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	−	−	SYM	_	9	P
13	and	and	CC	_	9	COORD
14	Wild	wild	JJ	_	16	NMOD
15	-	-	HYPH	_	14	P
16	Type	type	NN	_	24	NMOD
17	(	(	-LRB-	_	24	P
18	129	0	CD	_	20	NMOD
19	×	×	SYM	_	20	P
20	C57BL	c0bl	NN	_	24	NMOD
21	/	/	HYPH	_	20	P
22	6	0	CD	_	20	NMOD
23	)	)	-RRB-	_	24	P
24	F2	f0	NN	_	13	CONJ
25	Female	female	JJ	_	26	NMOD
26	Mice	mouse	NNS	_	8	PMOD

1	a	a	LS	_	4	NMOD
2	 	 	:	_	4	P
3	Suggestive	suggestive	JJ	_	4	NMOD
4	linkage	linkage	NN	_	0	ROOT

1	b	b	LS	_	4	NMOD
2	 	 	:	_	4	P
3	Significant	significant	JJ	_	4	NMOD
4	linkage	linkage	NN	_	0	ROOT

1	c	c	LS	_	5	NMOD
2	 	 	:	_	5	P
3	Highly	highly	RB	_	4	AMOD
4	significant	significant	JJ	_	5	NMOD
5	linkage	linkage	NN	_	0	ROOT
6	as	as	IN	_	5	ADV
7	defined	define	VBN	_	6	SUB
8	in	in	IN	_	7	LOC
9	the	the	DT	_	13	NMOD
10	material	material	NN	_	13	NMOD
11	and	and	CC	_	10	COORD
12	method	method	NN	_	11	CONJ
13	section	section	NN	_	8	PMOD

1	Chr	chr	NN	_	19	NMOD
2	,	,	,	_	1	P
3	Chromosome	chromosome	NN	_	1	APPO
4	;	;	:	_	19	P
5	Est.	est.	VBN	_	6	NMOD
6	Peak	peak	NN	_	19	NMOD
7	,	,	,	_	6	P
8	Estimated	estimate	VBN	_	9	NMOD
9	Peak	peak	NN	_	6	APPO
10	;	;	:	_	19	P
11	LOD	lod	NN	_	19	NMOD
12	,	,	,	_	11	P
13	logarithm	logarithm	NN	_	11	APPO
14	of	of	IN	_	13	NMOD
15	odds	odds	NNS	_	14	PMOD
16	;	;	:	_	19	P
17	N	n	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	A	a	NN	_	0	ROOT
20	,	,	,	_	19	P
21	not	not	RB	_	22	ADV
22	applicable	applicable	JJ	_	19	NMOD

1	Chromosomes	chromosome	NNS	_	11	SBJ
2	where	where	WRB	_	4	LOC
3	linkages	linkage	NNS	_	4	SBJ
4	were	be	VBD	_	1	NMOD
5	not	not	RB	_	4	ADV
6	present	present	JJ	_	4	PRD
7	in	in	IN	_	4	LOC
8	both	both	CC	_	10	COORD
9	experimental	experimental	JJ	_	10	NMOD
10	groups	group	NNS	_	7	PMOD
11	are	be	VBP	_	0	ROOT
12	not	not	RB	_	11	ADV
13	illustrated	illustrate	VBN	_	11	VC
14	.	.	.	_	11	P

1	See	see	VB	_	0	ROOT
2	Materials	material	NNS	_	1	OBJ
3	and	and	CC	_	2	COORD
4	Methods	method	NNS	_	3	CONJ
5	for	for	IN	_	1	PRP
6	details	detail	NNS	_	5	PMOD
7	.	.	.	_	1	P

1	The	the	DT	_	3	NMOD
2	oligonucleotide	oligonucleotide	NN	_	3	NMOD
3	sequences	sequence	NNS	_	12	SBJ
4	and	and	CC	_	3	COORD
5	approximate	approximate	JJ	_	6	NMOD
6	positions	position	NNS	_	4	CONJ
7	of	of	IN	_	6	NMOD
8	the	the	DT	_	10	NMOD
9	microsatellite	microsatellite	NN	_	10	NMOD
10	markers	marker	NNS	_	7	PMOD
11	used	use	VBN	_	10	NMOD
12	were	be	VBD	_	0	ROOT
13	taken	take	VBN	_	12	VC
14	from	from	IN	_	13	ADV
15	the	the	DT	_	18	NMOD
16	Mouse	mouse	NNP	_	18	NMOD
17	Genome	genome	NNP	_	18	NMOD
18	Database	database	NNP	_	14	PMOD
19	,	,	,	_	18	P
20	Mouse	mouse	NNP	_	22	NMOD
21	Genome	genome	NNP	_	22	NMOD
22	Informatics	informatics	NNP	_	18	APPO
23	,	,	,	_	22	P
24	Jackson	jackson	NNP	_	25	NMOD
25	Laboratory	laboratory	NNP	_	22	APPO
26	,	,	,	_	25	P
27	Bar	bar	NNP	_	28	NMOD
28	Harbor	harbor	NNP	_	25	APPO
29	,	,	,	_	28	P
30	Maine	maine	NNP	_	28	APPO
31	,	,	,	_	30	P
32	United	united	NNP	_	33	NMOD
33	States	state	NNP	_	30	APPO
34	(	(	-LRB-	_	35	P
35	http://www.informatics.jax.org	http://www.informatics.jax.org	NN	_	18	PRN
36	)	)	-RRB-	_	35	P

1	Footnotes	footnote	NNS	_	0	ROOT

1	Conflicts	conflict	NNS	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	interest	interest	NN	_	2	PMOD
4	.	.	.	_	1	P

1	The	the	DT	_	2	NMOD
2	authors	author	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	declared	declare	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	no	no	DT	_	7	NMOD
7	conflicts	conflict	NNS	_	10	SBJ
8	of	of	IN	_	7	NMOD
9	interest	interest	NN	_	8	PMOD
10	exist	exist	VBP	_	5	SUB
11	.	.	.	_	3	P

1	Author	author	NN	_	2	NMOD
2	contributions	contribution	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	MJW	mjw	NNP	_	7	SBJ
2	,	,	,	_	1	P
3	TJV	tjv	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	and	and	CC	_	3	COORD
6	MB	mb	NNP	_	5	CONJ
7	conceived	conceive	VBD	_	0	ROOT
8	and	and	CC	_	7	COORD
9	designed	design	VBD	_	8	CONJ
10	the	the	DT	_	11	NMOD
11	experiments	experiment	NNS	_	7	OBJ
12	.	.	.	_	7	P

1	AEB	aeb	NNP	_	13	SBJ
2	,	,	,	_	1	P
3	KLR	klr	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	JW	jw	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	JC	jc	NNP	_	9	NMOD
8	-	-	HYPH	_	7	P
9	H	h	NNP	_	5	CONJ
10	,	,	,	_	9	P
11	and	and	CC	_	9	COORD
12	RJR	rjr	NNP	_	11	CONJ
13	performed	perform	VBD	_	0	ROOT
14	the	the	DT	_	15	NMOD
15	experiments	experiment	NNS	_	13	OBJ
16	.	.	.	_	13	P

1	AEB	aeb	NNP	_	9	SBJ
2	,	,	,	_	1	P
3	KLR	klr	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	RJR	rjr	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	and	and	CC	_	5	COORD
8	HTC	htc	NNP	_	7	CONJ
9	analyzed	analyze	VBD	_	0	ROOT
10	the	the	DT	_	11	NMOD
11	data	datum	NNS	_	9	OBJ
12	.	.	.	_	9	P

1	MB	mb	NNP	_	2	SBJ
2	wrote	write	VBD	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	paper	paper	NN	_	2	OBJ
5	.	.	.	_	2	P

1	Academic	academic	JJ	_	2	NMOD
2	Editor	editor	NN	_	0	ROOT
3	:	:	:	_	2	P
4	David	david	NNP	_	5	NMOD
5	Nemazee	nemazee	NNP	_	2	OPRD
6	,	,	,	_	5	P
7	Scripps	scripps	NNP	_	9	NMOD
8	Research	research	NNP	_	9	NMOD
9	Institute	institute	NNP	_	5	APPO

1	¤	¤	SYM	_	3	P
2	Current	current	JJ	_	3	NMOD
3	address	address	NN	_	0	ROOT
4	:	:	:	_	3	P
5	The	the	DT	_	7	NMOD
6	Wellcome	wellcome	NNP	_	7	NMOD
7	Trust	trust	NNP	_	3	OPRD
8	,	,	,	_	7	P
9	London	london	NNP	_	7	APPO
10	,	,	,	_	9	P
11	United	united	NNP	_	12	NMOD
12	Kingdom	kingdom	NNP	_	9	APPO

1	Citation	citation	NN	_	0	ROOT
2	:	:	:	_	1	P
3	Bygrave	bygrave	NNP	_	1	CIT
4	AE	ae	NNP	_	3	DEP
5	,	,	,	_	4	P
6	Rose	rose	NNP	_	4	CONJ
7	KL	kl	NNP	_	3	DEP
8	,	,	,	_	7	P
9	Cortes	cortes	NNP	_	7	CONJ
10	-	-	HYPH	_	9	P
11	Hernandez	hernandez	NNP	_	3	DEP
12	J	j	NNP	_	3	DEP
13	,	,	,	_	12	P
14	Warren	warren	NNP	_	12	CONJ
15	J	j	NNP	_	3	DEP
16	,	,	,	_	15	P
17	Rigby	rigby	NNP	_	15	CONJ
18	RJ	rj	NNP	_	3	DEP
19	,	,	,	_	3	P
20	et	et	FW	_	3	DEP
21	al.	al.	FW	_	3	DEP
22	(	(	-LRB-	_	3	P
23	2004	0	CD	_	3	DEP
24	)	)	-RRB-	_	3	P
25	Spontaneous	spontaneous	JJ	_	3	DEP
26	autoimmunity	autoimmunity	NN	_	3	DEP
27	in	in	IN	_	3	DEP
28	129	0	CD	_	3	DEP
29	and	and	CC	_	3	COORD
30	C57BL	c0bl	NN	_	3	DEP
31	/	/	HYPH	_	30	P
32	6	0	CD	_	3	DEP
33	mice	mouse	NNS	_	3	DEP
34	—	—	:	_	33	P
35	Implications	implication	NNS	_	33	CONJ
36	for	for	IN	_	3	DEP
37	autoimmunity	autoimmunity	NN	_	3	DEP
38	described	describe	VBN	_	3	DEP
39	in	in	IN	_	3	DEP
40	gene	gene	NN	_	3	DEP
41	-	-	HYPH	_	40	P
42	targeted	target	VBN	_	3	DEP
43	mice	mouse	NNS	_	3	DEP
44	.	.	.	_	1	P

1	PLoS	plo	NNP	_	0	ROOT
2	Biol	biol	NNP	_	1	DEP
3	2	0	CD	_	1	DEP
4	(	(	-LRB-	_	1	P
5	8	0	CD	_	1	DEP
6	)	)	-RRB-	_	1	P
7	:	:	:	_	1	P
8	e243	e0	NN	_	1	DEP
9	.	.	.	_	1	P

